<?xml version="1.0" encoding="utf-8"?>
<ead xmlns="urn:isbn:1-931666-22-9" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:isbn:1-931666-22-9 http://www.loc.gov/ead/ead.xsd"><eadheader countryencoding="iso3166-1" dateencoding="iso8601" langencoding="iso639-2b" repositoryencoding="iso15511"><eadid>FA1103A.xml</eadid><filedesc><titlestmt><titleproper type="filing">Rockefeller University collection of The Medical Letter publication, 1996-2004</titleproper><titleproper>A Guide to the Rockefeller University collection of The Medical Letter publication, 1996-2004 <num>FA1103A</num></titleproper></titlestmt><publicationstmt><publisher>Rockefeller Archive Center</publisher><address><addressline>15 Dayton Avenue</addressline><addressline>Sleepy Hollow 10591</addressline><addressline>archive@rockarch.org</addressline><addressline>URL: <extptr xlink:href="http://www.rockarch.org" xlink:show="new" xlink:title="http://www.rockarch.org" xlink:type="simple"/></addressline></address></publicationstmt></filedesc><profiledesc><creation>This finding aid was produced using ArchivesSpace on <date>2020-03-31 00:33:28 -0400</date>.</creation><descrules>Describing Archives: A Content Standard</descrules></profiledesc></eadheader><archdesc level="collection">
  <did>
    <langmaterial>
      <language langcode="eng">English</language>
    </langmaterial>
    <repository>
      <corpname>Rockefeller Archive Center</corpname>
    </repository>
    <unittitle>Rockefeller University collection of The Medical Letter publication</unittitle>
    <origination label="Creator">
      <corpname role="aut" source="naf">Rockefeller University</corpname>
    </origination>
    <origination label="Creator">
      <corpname role="aut" source="naf">Medical Letter, Inc</corpname>
    </origination>
    <unitid>FA1103A</unitid>
    <physdesc altrender="whole">
      <extent altrender="materialtype spaceoccupied">131.21 Cubic Feet</extent>
    </physdesc>
    <unitdate normal="1996/2004" type="inclusive">1996-2004</unitdate>
  </did>
  <processinfo id="4f6518ea8bae3b64eb48a7b6e5a4ac82">
    <head>Processing Information</head>
<p>Minimal processing</p>  </processinfo>
  <prefercite id="08d6bd5a3343d88ae174562240e1c48c">
    <head>Preferred Citation</head>
<p>Information regarding the Rockefeller Archive Center's preferred elements and forms of citation can be found at <extref href="http://www.rockarch.org/research/citations.php">http://www.rockarch.org/research/citations.php</extref></p>  </prefercite>
  <accessrestrict id="8e22992d16c1acad66ec2350a423e469">
    <head>Conditions Governing Access</head>
<p>Records more than 25 years old are open for research with select materials restricted as noted. Brittle or damaged items are available at the discretion of RAC.</p>  </accessrestrict>
  <fileplan id="b18026630ad0911a346cf5ce064ebdd5">
    <head>File Plan</head>
<p>Former Classification: I 891-U</p>  </fileplan>
  <otherfindaid id="80d67a066600f6ef1d33e75468f27af6">
    <head>Other Finding Aids</head>
<p>For additional Medical Letter materials open for research see:</p><p>FA241 Rockefeller University collection of the Medical Lettter publication</p>  </otherfindaid>
  <scopecontent id="96fc3f4b0ecc38c530137eb411f39ada">
    <head>Scope and Contents</head>
<p>Contents includes: original manuscripts, reprints, advertising and package inserts, sources check, consultatnts drafts, manufacturers replies, and bibliography.</p>  </scopecontent>
  <bioghist id="6c159867ba2a2151b8b7399752c3890b">
    <head>Biographical / Historical</head>
<p>The Medical Letter on Drugs and Therapeutics is an independent, non-profit publication providing unbiased critical evaluation of drugs in terms of their effectiveness, adverse effects and possible alternative medications.</p>  </bioghist>
  <dsc><c id="722d135ab2e6b9a0415068e6118db069" level="file"><did><unittitle>TML, 38-9 - Acarbose for diabetes mellitus</unittitle><unitdate type="inclusive">1996 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="9db3094cdb66d74b0c9607513a9df620" label="mixed materials [A0000000075844]" type="box">1</container><container id="0223b41081b61d80160abe25ae090ee2" parent="9db3094cdb66d74b0c9607513a9df620" type="folder">1-4</container></did><accessrestrict id="6413d819e0f61297a55139d343bc6b2f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8e0dd5900ff39bfca71872aabc11f428" level="file"><did><unittitle>TML, 38-55 - Acetaminophen, NSAIDs and Alcohol</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="2fa9ee3c4a80d3a84409ac38bd2425db" label="mixed materials [A0000000075844]" type="box">1</container><container id="d5af58a5e81ad8dddd054e5f04d62ad9" parent="2fa9ee3c4a80d3a84409ac38bd2425db" type="folder">5-7</container></did><accessrestrict id="656f8049cade326890b44a882a172390"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="92bb9fbbd017dace4f8bbbdfdcec0a7a" level="file"><did><unittitle>TML, 38-43 - Acute reactions to Drugs of Abuse</unittitle><unitdate type="inclusive">1996 May 10</unitdate><container altrender="Record Storage Box (Paige)" id="33c128aaf1089d464e7a3712b78a15b3" label="mixed materials [A0000000075844]" type="box">1</container><container id="4e7bcdc64488d4e597f01dc64fa335f7" parent="33c128aaf1089d464e7a3712b78a15b3" type="folder">8-12</container></did><accessrestrict id="ca3616172a78ef218806617937be4ae3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="299c68349552c9c16b93a8a4762f739e" level="file"><did><unittitle>TML, 38-35 - New drugs for HIV</unittitle><unitdate type="inclusive">1996 April 12</unitdate><container altrender="Record Storage Box (Paige)" id="8db75b8b22e46b5306d9ff618ad9382f" label="mixed materials [A0000000075844]" type="box">1</container><container id="6f493d00f06330154a39ad66c1fde1e2" parent="8db75b8b22e46b5306d9ff618ad9382f" type="folder">13-17</container></did><accessrestrict id="86a00cb09aea1b9f00fe35947afa8c0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c5fa85f3bd2884f1a9dfd36830a4fb4d" level="file"><did><unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="07a2eb5dced3219327e068d4e65fa866" label="mixed materials [A0000000075844]" type="box">1</container><container id="37d632e16bff7aadeb14cf10a0ab7b8b" parent="07a2eb5dced3219327e068d4e65fa866" type="folder">18</container></did><accessrestrict id="6490910db6cb9773d516babe0e3ba2c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="25c672276d8de231f00bfa483bb42cb2" level="file"><did><unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="cea13063d56680ee4854371f172b01cb" label="mixed materials [A0000000075845]" type="box">2</container><container id="5102a0b356f2335c20c9002f0661be84" parent="cea13063d56680ee4854371f172b01cb" type="folder">1-3</container></did><accessrestrict id="2d841e9b213eca4386b5020a0f960ab2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="520cba0819f4d1a661ffbae9d84a72d2" level="file"><did><unittitle>TML, 38-61 - Anatrozle for metastatic breast cancer</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="90b599f18aecde4801f6659ee08bd2bc" label="mixed materials [A0000000075845]" type="box">2</container><container id="e4939850c0f429ddcf9239c352bf7f00" parent="90b599f18aecde4801f6659ee08bd2bc" type="folder">4-6</container></did><accessrestrict id="391e7265783eb309c372f58724caf420"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b466c2ae20545eb902a029aabfadd4a2" level="file"><did><unittitle>TML, 38-25 - Choice of Antimicrobial Drugs</unittitle><unitdate type="inclusive">1996 March 29</unitdate><container altrender="Record Storage Box (Paige)" id="a8c8ccfe942770ae6895e17a96c7ebff" label="mixed materials [A0000000075845]" type="box">2</container><container id="cf16641f93f89a9a255bc16aa138496f" parent="a8c8ccfe942770ae6895e17a96c7ebff" type="folder">7-9</container></did><accessrestrict id="abc8cefbfb0e5ceded73db45b93e2776"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="ef71891079fc8afb056a13746e052f75" level="file"><did><unittitle>TML, 38-52 - Drugs for Cardiac Arrythmias</unittitle><unitdate type="inclusive">1996 August 30</unitdate><container altrender="Record Storage Box (Paige)" id="821ad2bce848dde2de6e5207c6b75a49" label="mixed materials [A0000000075845]" type="box">2</container><container id="fe4d59008c16e55625ef2b8cc4176024" parent="821ad2bce848dde2de6e5207c6b75a49" type="folder">10-16</container></did><accessrestrict id="e9ba90f8f6e01a82041a2cb46e749402"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="630284f8fa9310d4604f35f82942ec99" level="file"><did><unittitle>TML, 38-52 - Azelaic acid a new topical drug for acne</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="19ff0ac7dc3c359adc86e502526171e2" label="mixed materials [A0000000075845]" type="box">2</container><container id="1290ad13a3afc29aa4399ec43553a61d" parent="19ff0ac7dc3c359adc86e502526171e2" type="folder">17-18</container></did><accessrestrict id="7d350d2c114c77a5007cc5bd6bef48d0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4b06c4e94eeae1bbd7e893099db3bb23" level="file"><did><unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="e599255a793e6ec3ed987f2f9cd53c9b" label="mixed materials [A0000000075845]" type="box">2</container><container id="c340814ff8de58a3c92fb96af7ee3c86" parent="e599255a793e6ec3ed987f2f9cd53c9b" type="folder">19-20</container></did><accessrestrict id="c9d5e1a415d2921805aa74b729504b02"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cdf8cc07b4cfdaccc7c2d14cfe460d41" level="file"><did><unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="770636cb3ecf6d139ee1f584f3481d75" label="mixed materials [A0000000075846]" type="box">3</container><container id="326a94f6428682d026ec287c71f8533f" parent="770636cb3ecf6d139ee1f584f3481d75" type="folder">1</container></did><accessrestrict id="bc8ec69f68ddfbb05692b444a9d33f73"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8e8440ccfa5de303b70df4a8556b7da1" level="file"><did><unittitle>TML, 38-103 - Bone Density Testing</unittitle><unitdate type="inclusive">1996 November 26</unitdate><container altrender="Record Storage Box (Paige)" id="8e5be597b8b44cdd67471bb6854189aa" label="mixed materials [A0000000075846]" type="box">3</container><container id="7ec57bf892390bdaba6405ecc6c4e68a" parent="8e5be597b8b44cdd67471bb6854189aa" type="folder">2-3</container></did><accessrestrict id="9371d9820f979006c113e8341494696d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2bc3e056d1f8fa2492e7303d95310131" level="file"><did><unittitle>TML, 37-109 - Dirithromycin</unittitle><unitdate type="inclusive">1995 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="e0bf288ca0cd0646cb8358537d674792" label="mixed materials [A0000000075846]" type="box">3</container><container id="cdee897e2a1e88ef949f5d961b03d571" parent="e0bf288ca0cd0646cb8358537d674792" type="folder">4-7</container></did><accessrestrict id="70e63df474c05d465a52ed6834a63c2e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="404e68490aeea4bc03276bd2e1972297" level="file"><did><unittitle>TML, 38-108 - Calcium Supplements</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="6a899f326ecacaf6b53376c6363d3bde" label="mixed materials [A0000000075846]" type="box">3</container><container id="29909dfbe39da1e632b7f0aa577997b3" parent="6a899f326ecacaf6b53376c6363d3bde" type="folder">8-12</container></did><accessrestrict id="6397bcfd119b8dee01530ad0c01d2fe0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="787f855d64193a39aa5fa640c29b09f9" level="file"><did><unittitle>TML, 38-40 - Radiofrequency cather abilation for treatment of cardiac arrhythmias</unittitle><unitdate type="inclusive">1996 April 26</unitdate><container altrender="Record Storage Box (Paige)" id="88f79eac4dcd39984a3e006d0555c127" label="mixed materials [A0000000075846]" type="box">3</container><container id="9fc0f27a763b491df1751b1e29b8a51d" parent="88f79eac4dcd39984a3e006d0555c127" type="folder">13-16</container></did><accessrestrict id="9407b24c4bbb8b9a8280fd95b434f402"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="6ee9fed32bd765fba31910157fc457da" level="file"><did><unittitle>TML, 38-23 - Cetibuten - a new oral cephalosporin</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="86e9a0ce8faf0d760085863a86fe9313" label="mixed materials [A0000000075846]" type="box">3</container><container id="6b8f9acbeed450b0ebccbe1146bf30bc" parent="86e9a0ce8faf0d760085863a86fe9313" type="folder">17-19</container></did><accessrestrict id="fe428baa314a27bf86569a7a685bf75c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cf9669d33a59dba3ffbe8f50f22fca78" level="file"><did><unittitle>TML, 38-84 - Cefepime (Maxime) - a new parenteral cephalosporin</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="434c86658bd79e3ef923fe39c4ceded8" label="mixed materials [A0000000075847]" type="box">4</container><container id="752562785dc1a46e77001a12c269c852" parent="434c86658bd79e3ef923fe39c4ceded8" type="folder">1-4</container></did><accessrestrict id="cd47248ae2cfc55d2fb4424654263054"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="7dd0747a03e955ecdd43cb4fc77cc296" level="file"><did><unittitle>TML, 38-46 - Chlorzoxazone hepatotoxsicity</unittitle><unitdate type="inclusive">1996 May 10</unitdate><container altrender="Record Storage Box (Paige)" id="fd994506d1a70c429a6a724fdb71e692" label="mixed materials [A0000000075847]" type="box">4</container><container id="5713d33b412e6a716049199c3825e21f" parent="fd994506d1a70c429a6a724fdb71e692" type="folder">5</container></did><accessrestrict id="2fb3ed462271aeec0fb14801053de435"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9050bc8c28970ad791e377582e9c079c" level="file"><did><unittitle>TML, 38-67 - Choice of Lipid-Lowering drugs</unittitle><unitdate type="inclusive">1996 August 2</unitdate><container altrender="Record Storage Box (Paige)" id="667c6dfc5e5324cc8644a6ccc8bb8abe" label="mixed materials [A0000000075847]" type="box">4</container><container id="75d5b015c31ebb15a0c2e44274b3dab3" parent="667c6dfc5e5324cc8644a6ccc8bb8abe" type="folder">6-13</container></did><accessrestrict id="88da501863cd117b47bcae321e4b3b00"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="5c5e7299af1de05e46453f0fea0e1720" level="file"><did><unittitle>TML, 38-21 - Cetirizine - a new antihistamine</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="56691a3d4765ad8a753f43ec4a3171f4" label="mixed materials [A0000000075847]" type="box">4</container><container id="081801b8c5eee066f7df84ad4a9d4312" parent="56691a3d4765ad8a753f43ec4a3171f4" type="folder">14-18</container></did><accessrestrict id="0f7c6d142759503d2196573bb0b89f9a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0f91362447d7a3cdff68d7ebac520b38" level="file"><did><unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="efc1c2ad1e39abefcd5ad21cb42824b2" label="mixed materials [A0000000075847]" type="box">4</container><container id="b931dee8f73fc46d16330e25453ecbfd" parent="efc1c2ad1e39abefcd5ad21cb42824b2" type="folder">19-20</container></did><accessrestrict id="4e5c9545497b1cea799d01d6d8e16965"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c714362a04b8f852b521155e586e0af2" level="file"><did><unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="847a0624abfaa9752ace52db89aaefe3" label="mixed materials [A0000000075848]" type="box">5</container><container id="6688a233d42e1db29cde21ce8b3cae0e" parent="847a0624abfaa9752ace52db89aaefe3" type="folder">1</container></did><accessrestrict id="a545b57ddc41b86449988949e310c707"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="484f5bda82347b92c1fd763adae1bf8a" level="file"><did><unittitle>TML, 38-64 - Dexfenfluramine for obesity</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="3507027ecbeeab827ba9b28143ef2e58" label="mixed materials [A0000000075848]" type="box">5</container><container id="8d4a459b497bf1558caa5d23468966da" parent="3507027ecbeeab827ba9b28143ef2e58" type="folder">2-5</container></did><accessrestrict id="0ae4223f8a683f538d4cd77c366f1250"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8d0423127d33593f9f53a6262dc9f97c" level="file"><did><unittitle>TML, 38-87 - Docetaxel (Taxotere) for advanced breast cancer</unittitle><unitdate type="inclusive">1996 September 27</unitdate><container altrender="Record Storage Box (Paige)" id="5db418d0e57e6ddf8d6ae64702d7225e" label="mixed materials [A0000000075848]" type="box">5</container><container id="4db1780efa505d1a5f4f6c7723ebd93e" parent="5db418d0e57e6ddf8d6ae64702d7225e" type="folder">6-8</container></did><accessrestrict id="ed7cc80f5cac6080418667469e63fcc5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="a348057f4e83121c70f8e63e18862273" level="file"><did><unittitle>TML, 38-14 - Epoprostenol for primary pulmonary hypertension</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="ea9cbf01e42bd2b5cbc0566a047dd51c" label="mixed materials [A0000000075848]" type="box">5</container><container id="29395eee8bcb603a19d8de300a75e292" parent="ea9cbf01e42bd2b5cbc0566a047dd51c" type="folder">9-10</container></did><accessrestrict id="9060f4c1941e62cde507283711c42123"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4fb37dc500fa2658eede9f802e9df8f8" level="file"><did><unittitle>TML, 38-95 - Fexofenadine</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="1e70b658c4ee499b09989b2cd51ced64" label="mixed materials [A0000000075848]" type="box">5</container><container id="03854e19beea4528d679f1a543c4e4cd" parent="1e70b658c4ee499b09989b2cd51ced64" type="folder">11-12</container></did><accessrestrict id="a8ff5bd8f8c9a8beb936876d0ab13404"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="64be8e3eb6b9a7f019087998bc44abd8" level="file"><did><unittitle>TML, 37-13 - Fluvoxamine for obsessive compulsive disorder</unittitle><unitdate type="inclusive">1995 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="4e93f7ede6b7bcb1434021cdb9241e5d" label="mixed materials [A0000000075848]" type="box">5</container><container id="74ef5d32172cd0274b78d2f188c3ffea" parent="4e93f7ede6b7bcb1434021cdb9241e5d" type="folder">13-16</container></did><accessrestrict id="695bcbd1bf632b907b932d7960966f9f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="892b6eca462f2e15ad9ec8aa8eca30aa" level="file"><did><unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="1d5a21b954d31133bfa7d501e46449a0" label="mixed materials [A0000000075848]" type="box">5</container><container id="8c75ac6822761c54d9092f52f3aa0b0e" parent="1d5a21b954d31133bfa7d501e46449a0" type="folder">17-21</container></did><accessrestrict id="beb3673044e9a99bc1e5e6f80a600a9c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="35c106caf84841f600db741ede502382" level="file"><did><unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="743fdac8ec70805345bf4661b15c3be0" label="mixed materials [A0000000075849]" type="box">6</container><container id="04f4a3c573598068534a3cdbe6483b5b" parent="743fdac8ec70805345bf4661b15c3be0" type="folder">1</container></did><accessrestrict id="f54d8351e9c7683733c760ddc9c6386f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9c02c90545e46d220940cf2a507e0a28" level="file"><did><unittitle>TML, 38-10 - Systematic antifungal drugs</unittitle><unitdate type="inclusive">1996 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="259fb7b943029ded2c2cea6b233ed664" label="mixed materials [A0000000075849]" type="box">6</container><container id="530024e6e2c709b3eb501c3ee405d8f5" parent="259fb7b943029ded2c2cea6b233ed664" type="folder">2-3</container></did><accessrestrict id="24650d75f7a4fe5ddaf748532b77d1c8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="af3d9dfc1b1412c493e47fcf1216a75b" level="file"><did><unittitle>TML, 38-102 - Gemcitabine for treatment of pancreatic cancer</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="d4c806dde3a106e6084c2b103bf758ba" label="mixed materials [A0000000075849]" type="box">6</container><container id="55dfb745a3cbd87e0365264458a248f2" parent="d4c806dde3a106e6084c2b103bf758ba" type="folder">4-6</container></did><accessrestrict id="7105d2dd194378e7c1b806e1786142c0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="237f462175824d3b36e04281c83344ac" level="file"><did><unittitle>TML, 38-47 - Glimepiride for NIDDM</unittitle><unitdate type="inclusive">1996 May 24</unitdate><container altrender="Record Storage Box (Paige)" id="322b9a1a4d6ff282efd0fffeffa78ecd" label="mixed materials [A0000000075849]" type="box">6</container><container id="8b851f1fde80cde3b65e4a5dfdd86c45" parent="322b9a1a4d6ff282efd0fffeffa78ecd" type="folder">7-8</container></did><accessrestrict id="d0c68415f609b87b8e322217b54f482b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="f5f43d18d02fa3b8ac7f25b5d2f4bf4e" level="file"><did><unittitle>TML, 38-92 - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">1996 October 11</unitdate><container altrender="Record Storage Box (Paige)" id="fa284814e57128d9fab315f14e71a83f" label="mixed materials [A0000000075849]" type="box">6</container><container id="0ed431bd8e98f162195363249118a7de" parent="fa284814e57128d9fab315f14e71a83f" type="folder">9-13</container></did><accessrestrict id="a3631f3ddc4c9deaa183f2128f324ec8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="df185de80953b9ba72734fc53563026f" level="file"><did><unittitle>TML, 37-73 - Grapefruit juice interactions with drugs</unittitle><unitdate type="inclusive">1995 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="5875490b512874557a3edb230a2b39d3" label="mixed materials [A0000000075849]" type="box">6</container><container id="7dd6d2aa9ca28243c1d33d4bec6867ff" parent="5875490b512874557a3edb230a2b39d3" type="folder">14-16</container></did><accessrestrict id="ee2185b1e98265927be53db9e0fa2dda"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9ea393808d7941a34a9237ff7d3e21d0" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="afc11d9593b3247628507cf2e8a0c89c" label="mixed materials [A0000000075849]" type="box">6</container><container id="4d5e5ab72be2b0d1bb43cabcc95ee49e" parent="afc11d9593b3247628507cf2e8a0c89c" type="folder">17-20</container></did><accessrestrict id="052ebcc34a91845237e97c0df53775e3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b5728f730c61991eb3d049832355c05c" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="c83f8399a0226253626db1ff66128d5e" label="mixed materials [A0000000075850]" type="box">7</container><container id="2795aecb1f2b301813ae3f4d3489e859" parent="c83f8399a0226253626db1ff66128d5e" type="folder">1-2</container></did><accessrestrict id="8725ceb0317248c73c37ce2386f5e01b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="34fded3e81407289cef7298c43db888c" level="file"><did><unittitle>TML - Drugs of Choice - Pain</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="eb5d6900b297548be9831d229525480b" label="mixed materials [A0000000075850]" type="box">7</container><container id="178441698f5b89aa308d94010aabf3db" parent="eb5d6900b297548be9831d229525480b" type="folder">3-7</container></did><accessrestrict id="fd6c1b22c3706f5ee95e16758bf6f9f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="73f114dc6e630afb990634a443031d95" level="file"><did><unittitle>TML, 37-95 - OTC H2 Blockers for heartburn</unittitle><unitdate type="inclusive">1995 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="a6ad355a4d659191bb67843ac400b3cd" label="mixed materials [A0000000075850]" type="box">7</container><container id="d0c93e0baa69a2e8eb5615c88ff725b1" parent="a6ad355a4d659191bb67843ac400b3cd" type="folder">8-10</container></did><accessrestrict id="6f9d54ac52d448a971ae1e70ff68a5a9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e3ff759a8063b390ff0175205e40649d" level="file"><did><unittitle>TML, 38-6 - Rho (D) IV Immune Globulin</unittitle><unitdate type="inclusive">1996 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="beac091fcfac68fd9adcaad90c1ece4a" label="mixed materials [A0000000075850]" type="box">7</container><container id="178ac1744fe7cbe0584c5ab4c24a2acb" parent="beac091fcfac68fd9adcaad90c1ece4a" type="folder">11-13</container></did><accessrestrict id="ce939d07fa2fe96e5b623cff81c37a02"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="343b5e9d7ba1058f32a08341d9be9f4a" level="file"><did><unittitle>TML, 38-17 - Advice for Travelers</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="383686b3ed68304e78909a6a8a1e49db" label="mixed materials [A0000000075850]" type="box">7</container><container id="cd7e74eb567eb6bab8f3534fb5f83677" parent="383686b3ed68304e78909a6a8a1e49db" type="folder">14-16</container></did><accessrestrict id="c3bea7a676bd5b9981068ccf42242297"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="314ebfe0a12d0bad31002df2bbabf782" level="file"><did><unittitle>TML, 37-98 - Influenza Vaccine, 1995-1996</unittitle><unitdate type="inclusive">1995 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="7deb52ea859866a8aec348147e3b253b" label="mixed materials [A0000000075850]" type="box">7</container><container id="8a4ee08f41755e04f87154aed2ee0b0a" parent="7deb52ea859866a8aec348147e3b253b" type="folder">17</container></did><accessrestrict id="aaa5f55ecc1b4da36b3c2d152b9841b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="fa30b8e25d30bd60ee7b9207731748dd" level="file"><did><unittitle>TML, 38-86 - Influenza Vaccine, 1996-1997</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="b9916ffac695b9bccce2e8d6c5e54f55" label="mixed materials [A0000000075850]" type="box">7</container><container id="143eece6dac28c2a2b05b16c82781430" parent="b9916ffac695b9bccce2e8d6c5e54f55" type="folder">18</container></did><accessrestrict id="5726a4d76a933c3152d68d2618f96f58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="76dcb6a56a7b5f83636afb906304e3de" level="file"><did><unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="e33091194d2ea5a84be022310c15d7f1" label="mixed materials [A0000000075850]" type="box">7</container><container id="e63858fb2556251ccf28f6d2fdd7057a" parent="e33091194d2ea5a84be022310c15d7f1" type="folder">19</container></did><accessrestrict id="c85f0b8357c82829d2a4eb5e651846cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="bcfc06fa9fa8a02872f2c29e1146f46b" level="file"><did><unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="14f0bf56a6372f409bc15e0cddb376d7" label="mixed materials [A0000000075851]" type="box">8</container><container id="3f4e0b4ddd5c5624c3a4f427cdc1a29e" parent="14f0bf56a6372f409bc15e0cddb376d7" type="folder">1-4</container></did><accessrestrict id="5afb2bc4dd74607653137719b41bcbd1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="ca2a00af5d69b29922032ebf4abb0fa9" level="file"><did><unittitle>TML, 38-63 - Interferon beta IA for relapsing multiple sclerosis</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="a3f95af2d95a591fa7627255217e1616" label="mixed materials [A0000000075851]" type="box">8</container><container id="66f4272a4fb284ac2ad370f9511a64a2" parent="a3f95af2d95a591fa7627255217e1616" type="folder">5-6</container></did><accessrestrict id="03343319e99b7f0ef24a7fc83ce57bad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c90350a57c09afa4b1edf8990faf82c4" level="file"><did><unittitle>TML, 38-5 - Intraconazole for onychomycosis</unittitle><unitdate type="inclusive">1996 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="68e74953c3cee32db0550c4d808d1165" label="mixed materials [A0000000075851]" type="box">8</container><container id="ff2905ded999c93875dd6e37c29bb347" parent="68e74953c3cee32db0550c4d808d1165" type="folder">7-10</container></did><accessrestrict id="a3ae42f0dfac2f6884835c0dd4cbe74b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="838bd206e5b57f1350c9a04ae42f2583" level="file"><did><unittitle>TML, 38-100 - Latanoprost - A topical prostaglandin for glaucoma</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="da2106fe3c2fd58103e929ebff31a54e" label="mixed materials [A0000000075851]" type="box">8</container><container id="dba4b4d0fdcb483ca55cdbe19ebcd7f4" parent="da2106fe3c2fd58103e929ebff31a54e" type="folder">11-14</container></did><accessrestrict id="2e48e9ac6a735700c373ee378f599caa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="45a205e5a189cb71c6708535b75c4937" level="file"><did><unittitle>TML, 38-97 - Lispro - A rapid onset insulin</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="17e9f39ad900f02dd51a56e7dd768068" label="mixed materials [A0000000075851]" type="box">8</container><container id="a7d6ff92095c5b5fe3eda8fd58173bc5" parent="17e9f39ad900f02dd51a56e7dd768068" type="folder">15-16</container></did><accessrestrict id="0c7d5401af543b0c0983defbe212a6e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2cbe2967f283fa20d7d713e0125238d8" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="c021e0a62d4880c30dfc096a48cfb44f" label="mixed materials [A0000000075851]" type="box">8</container><container id="31713c0f437ef3fb1529a456b2b03256" parent="c021e0a62d4880c30dfc096a48cfb44f" type="folder">17-18</container></did><accessrestrict id="25976cdf1f32d7fc8a1e78cb2f48d34d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="f7093bc2141bbd10998f3dc5ff41875b" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="31e5de8fe6350f8c418d48221e25c8af" label="mixed materials [A0000000075852]" type="box">9</container><container id="49766148cbca4a8dfa506e599c6e87da" parent="31e5de8fe6350f8c418d48221e25c8af" type="folder">1-3</container></did><accessrestrict id="5de98fca91cbe16591ff580840223c8c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e7f67d0b2048a576bdc2a8c6ef1f5674" level="file"><did><unittitle>TML, 38-13 - Nisoldipine - a new calcium-channel blocker for hypertension</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="21dedea89b1013ac33bdaeff3e7e2028" label="mixed materials [A0000000075852]" type="box">9</container><container id="36ca1da76ac5fca23fa41ba16ac8e113" parent="21dedea89b1013ac33bdaeff3e7e2028" type="folder">4-7</container></did><accessrestrict id="310f0f0a8b17bda4d5be0d11e8e3909a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0ab086d0742f0a6f31a054d358cbefcf" level="file"><did><unittitle>TML, 35-62 - Nedocromil for asthma</unittitle><unitdate type="inclusive">1993 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="4cf1e80fadf4b061b039c6814a569bd7" label="mixed materials [A0000000075852]" type="box">9</container><container id="9b140ae29bf2eef2ad558d7bf33d7c72" parent="4cf1e80fadf4b061b039c6814a569bd7" type="folder">8-12</container></did><accessrestrict id="d876b6e0e035d2d97ee9711f878a831c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9f3042b173404cf6a3ccd9df900d20c0" level="file"><did><unittitle>TML, 38-1 - New drugs for osteoporosis</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="88bad439020fa52517b96d37e3cf510c" label="mixed materials [A0000000075852]" type="box">9</container><container id="289319176a586811cabb85b5533ecb2e" parent="88bad439020fa52517b96d37e3cf510c" type="folder">13-18</container></did><accessrestrict id="059f4c0e348f3f79f9eac8942a1b7673"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e20404fc9c2c5857d90b819cb9c70cc0" level="file"><did><unittitle>TML, 38-53 - Prostatron</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="0fd8c11ba1dee14086adfac302bc1e23" label="mixed materials [A0000000075852]" type="box">9</container><container id="1cd4463e067705d0bc05562baad98f6e" parent="0fd8c11ba1dee14086adfac302bc1e23" type="folder">19-20</container></did><accessrestrict id="fa8555c81ed0ff184e52c7e939db327c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cbfa8d04b93b4e3d89a843bbf9e3d7f8" level="file"><did><unittitle>TML, 38-107 - Pallidotomy for Parkinson's Disease</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="2823712b673d7026cd15fe740688756f" label="mixed materials [A0000000075853]" type="box">10</container><container id="d076647e629df7568efa32c5e5f54e09" parent="2823712b673d7026cd15fe740688756f" type="folder">1-3</container></did><accessrestrict id="6ec525e7fd9b38dcd1bce23ad46d101c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c1416d4fc58c7899cbc27ca73d15c172" level="file"><did><unittitle>TML, 38-57 - Simethicone for gastrointestinal gas</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="3ad084e0f5a7b552232c92b1f4b2320d" label="mixed materials [A0000000075853]" type="box">10</container><container id="8f237d29ea58b6e2c9484633ef1479d8" parent="3ad084e0f5a7b552232c92b1f4b2320d" type="folder">4-5</container></did><accessrestrict id="76d78aedee8d1ddf219a07affe27bb10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="26af25957e59124a08f91eba499fc700" level="file"><did><unittitle>TML, 38-106 - Sodium Phenylbutyrate for urea cycle enzyme deficiencies</unittitle><unitdate type="inclusive">1996 November 22</unitdate><container altrender="Record Storage Box (Paige)" id="d1fab5e3824e6e1ebbe89adcf8be1e21" label="mixed materials [A0000000075853]" type="box">10</container><container id="01b2a2176364ea3ce92f93509c80d194" parent="d1fab5e3824e6e1ebbe89adcf8be1e21" type="folder">6-7</container></did><accessrestrict id="8f55e867e223cf7fc8c205180e5bb1b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4273a72d699f99aeabfcab12d5bde513" level="file"><did><unittitle>TML, 38-72 - Terabinafine for onychomycosis</unittitle><unitdate type="inclusive">1996 August 16</unitdate><container altrender="Record Storage Box (Paige)" id="b9514a59837cb2568acfccbdb1c32873" label="mixed materials [A0000000075853]" type="box">10</container><container id="986873e5b2c52a747a2a304b66c9e834" parent="b9514a59837cb2568acfccbdb1c32873" type="folder">8-11</container></did><accessrestrict id="f99d89a3af0b743be45c7d543c9a47b3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="afa8fcead3849c57e46148fac07fdf16" level="file"><did><unittitle>TML, 38-49 - Androderm (Testosterone patches)</unittitle><unitdate type="inclusive">1996 May 24</unitdate><container altrender="Record Storage Box (Paige)" id="0dfa87c2060dbeab97339ef063afd437" label="mixed materials [A0000000075853]" type="box">10</container><container id="dbcba5d87ec9a06c53bfc0bc052d5adb" parent="0dfa87c2060dbeab97339ef063afd437" type="folder">12-15</container></did><accessrestrict id="6c9daad633f6ca6f23f9cb9675ec5725"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e83fc33c009862fb85873ce44225451e" level="file"><did><unittitle>TML, 38-96 - Toptecan hydrochloride for metastic ovarian cancer</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="4503c546d35a0e083b9a22629c390388" label="mixed materials [A0000000075853]" type="box">10</container><container id="c33adf9c4b737292ceaae558dbf0ec8f" parent="4503c546d35a0e083b9a22629c390388" type="folder">16-18</container></did><accessrestrict id="f4f4ca0b76dee28258679841660c3e53"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="1d1e2499f47a2c5a2498c508251c060e" level="file"><did><unittitle>TML, 38-3 - Valacyclovir</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="3458e9d66d1ba3f6b0dfdbb41b273338" label="mixed materials [A0000000075853]" type="box">10</container><container id="d0d88121171977165d1bd1678801d8dc" parent="3458e9d66d1ba3f6b0dfdbb41b273338" type="folder">19</container></did><accessrestrict id="5e026f0f926c42121383574e48a743ca"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e3cd99c272218799e02c72a5e28f33c9" level="file"><did><unittitle>TML, 38-3 - Valacyclovir</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="f0a237bcfcb6b98b464905d2aae93dc7" label="mixed materials [A0000000075946]" type="box">11</container><container id="c4f55b6b464ca604541a25ff5c387791" parent="f0a237bcfcb6b98b464905d2aae93dc7" type="folder">1-2</container></did><accessrestrict id="ed67782a99870c0e712a42cf95c5cfc7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2146f075bfb01adf0c99fddbe6268b26" level="file"><did><unittitle>TML, 38-104 - Trandolapril - An ACE inhibitor for treatment of hypertension</unittitle><unitdate type="inclusive">1996 November 22</unitdate><container altrender="Record Storage Box (Paige)" id="20f5df2587b845cdfc299463a0532863" label="mixed materials [A0000000075946]" type="box">11</container><container id="677e420a5e721424f238afed96ad03f7" parent="20f5df2587b845cdfc299463a0532863" type="folder">3-5</container></did><accessrestrict id="a1dd4aa7256167e609397b035b7478d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="7a2f268994b16b4876604d64167ade0b" level="file"><did><unittitle>TML, 38-71 - Umbilical cord blood for bone marrow transplantation</unittitle><unitdate type="inclusive">1996 August 16</unitdate><container altrender="Record Storage Box (Paige)" id="afe945712c60be6ff92bd9528f67b696" label="mixed materials [A0000000075946]" type="box">11</container><container id="04234bebe3608c785c5d9618da1c1c0d" parent="afe945712c60be6ff92bd9528f67b696" type="folder">6-8</container></did><accessrestrict id="c284795ebfbae6dd142f49e2c3d64449"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c7fa6ad1765f84becedf7fbe8dae1981" level="file"><did><unittitle>TML, 38-51 - Clarithromycine and omeprazole of helliobacter pylori</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="06e78e3f9e88cea24ae46a7d6764e79b" label="mixed materials [A0000000075946]" type="box">11</container><container id="56363f8602ed77ec09f7b9bb85b71cdb" parent="06e78e3f9e88cea24ae46a7d6764e79b" type="folder">9-11</container></did><accessrestrict id="d93e4e485f03621de43519409ecd0ebb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="d2847f832cf8b7dfa8bae10d4079561b" level="file"><did><unittitle>TML, 38-15 - New Uses of Thalidomide</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="529dbf7f9cbf0ed4eef9fc407778def2" label="mixed materials [A0000000075946]" type="box">11</container><container id="f555d1810576fd550085237e8396b566" parent="529dbf7f9cbf0ed4eef9fc407778def2" type="folder">12-14</container></did><accessrestrict id="5a934c0b2b5e5cf25f836a73de95c999"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="07f911d357717fedb196ba2a95b08c6f" level="file"><did><unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="3475aa22a567a92f0a02e843a668add3" label="mixed materials [A0000000075946]" type="box">11</container><container id="ec937144ea5fbbf6fb378cf478aeab3d" parent="3475aa22a567a92f0a02e843a668add3" type="folder">15-19</container></did><accessrestrict id="7ad69902cf7b5b84adb8b1470b88ef97"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c0d2ae8c9a59eb2afc81bad688a8e0d9" level="file"><did><unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="eed38ba8070125be2712c1660a9d536a" label="mixed materials [A0000000075854]" type="box">12</container><container id="426a465e03f44596124ef8aa3fcb26cd" parent="eed38ba8070125be2712c1660a9d536a" type="folder">1-2</container></did><accessrestrict id="42570c5418d18c7d11e5ecb6d56fc38d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0d91fc0adca0e054072c6a3fff1ac1f6" level="file"><did><unittitle>TML, 38-65 - Drugs past their expiration date</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="1f4f791b7bc5eb7680c3b169224bb954" label="mixed materials [A0000000075854]" type="box">12</container><container id="34df35472ded422be1a89d7182ce3be0" parent="1f4f791b7bc5eb7680c3b169224bb954" type="folder">3-4</container></did><accessrestrict id="861175c1c60e1d08ff94909fca12e380"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b6e8488842fc6d3ed56539b8c5e7c344" level="file"><did><unittitle>TML, 38-38 - Ibutilide</unittitle><unitdate type="inclusive">1996 April 12</unitdate><container altrender="Record Storage Box (Paige)" id="1cebc0d39ed96009f6ee746eb914b31a" label="mixed materials [A0000000075854]" type="box">12</container><container id="129284a4362d8fd50ee0478e8d988405" parent="1cebc0d39ed96009f6ee746eb914b31a" type="folder">5-6</container></did><accessrestrict id="d854aa1bc446941f011a8970567a2b37"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="93c5ceb8486269a6440d4a1164bd8a19" level="file"><did><unittitle>TML, 38-91 - DHEA</unittitle><unitdate type="inclusive">1996 October 11</unitdate><container altrender="Record Storage Box (Paige)" id="193252f1d01fc157fefbe351cfdfb9c9" label="mixed materials [A0000000075854]" type="box">12</container><container id="7188d6b72d3d570e828faa7ab752e0a8" parent="193252f1d01fc157fefbe351cfdfb9c9" type="folder">7-9</container></did><accessrestrict id="0b753cb331038a0a1193ae254361f43e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="489aaa51c24f7c3822366d6381860b83" level="file"><did><unittitle>TML, 38-88 - Meropenem - A new parenteral broad-spectrum antibiotic</unittitle><unitdate type="inclusive">1996 September 27</unitdate><container altrender="Record Storage Box (Paige)" id="68d81238325ee21290da73875c84167e" label="mixed materials [A0000000075854]" type="box">12</container><container id="23bbedef4d819e67e119ba0c455e3518" parent="68d81238325ee21290da73875c84167e" type="folder">10-14</container></did><accessrestrict id="06a4c2f05bc64d8b4ee6a3b07e593fe9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="3a54f51aec4a83bee985f1670be2aff6" level="file"><did><unittitle>TML, 38-39 - Methotrexate and Misoprostol for abortion</unittitle><unitdate type="inclusive">1996 April 26</unitdate><container altrender="Record Storage Box (Paige)" id="62816d0fd21fbb09fa290eab5a599bd0" label="mixed materials [A0000000075854]" type="box">12</container><container id="2c0f2ba80779b7181ab548ac2a8fff8b" parent="62816d0fd21fbb09fa290eab5a599bd0" type="folder">15</container></did><accessrestrict id="6b3edef9531f4a2fde2d3628c5d7cdd0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="43193a32312eb0204d12fd64fa6b6993" level="file"><did><unittitle>TML, 38-111 - Zafirlukast for asthma</unittitle><unitdate type="inclusive">1996 December 20</unitdate><container altrender="Record Storage Box (Paige)" id="4803c21aa86a0311ec59d0ef31cb9d89" label="mixed materials [A0000000075854]" type="box">12</container><container id="9174eb6dca8dae9403a96b2d24e57821" parent="4803c21aa86a0311ec59d0ef31cb9d89" type="folder">16-18</container></did><accessrestrict id="13e892949bbc4a48ce8c4285b3b1007e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="49b7007dcadc3c636c88f299dc526e0d" level="file"><did><unittitle>TML, 31-83 - Samarium 153 lexidronam for painful bone metastases</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="f03767aa92c42b96df6829166b481368" label="mixed materials [A0000000075855]" type="box">13</container><container id="5e169322c9000a004224168d04ee8918" parent="f03767aa92c42b96df6829166b481368" type="folder">1-3</container></did><accessrestrict id="592e1bece31e2f3f6b5ae1b6e1a8011e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="61b0c640e3f013a34c64133724020fa2" level="file"><did><unittitle>TML, 38-69 - Drugs for non-HIV viral infections</unittitle><unitdate type="inclusive">1997 August 1</unitdate><container altrender="Record Storage Box (Paige)" id="46021e9da49daf2156bbf3c814d73d21" label="mixed materials [A0000000075855]" type="box">13</container><container id="cf0799d36189c201ac601b67673ba7ab" parent="46021e9da49daf2156bbf3c814d73d21" type="folder">4-12</container></did><accessrestrict id="84c4988675afd57f7b095139aa7bfdfe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="133977107f40fa3272c401b7abcc89de" level="file"><did><unittitle>TML, 39-18 - Zileuton for asthma</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="0262781ca9a5dc402ebbde8e0b7849f6" label="mixed materials [A0000000075855]" type="box">13</container><container id="75a93a56d62fb2413b26ddd82ba43742" parent="0262781ca9a5dc402ebbde8e0b7849f6" type="folder">13-14</container></did><accessrestrict id="4717fa288dd120e806e05499350ddf6f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="be46a606b805462c6cc03b6ec8b2c39e" level="file"><did><unittitle>TML, 39-9 - Zinc for the common cold</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="6339ad89e7208588d4073f3e55a32eef" label="mixed materials [A0000000075855]" type="box">13</container><container id="22f100123b7343cefea1de19b7a85c04" parent="6339ad89e7208588d4073f3e55a32eef" type="folder">15-17</container></did><accessrestrict id="ad1088be46d6652eb0405e32258a0bf9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1a7499e6fbd604c0b75b6d778dc5c0f9" level="file"><did><unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="e890fb134b64d4a63fd735bcb58ed8c1" label="mixed materials [A0000000075855]" type="box">13</container><container id="b8c4a0eee3b5419925d9e617e18125c9" parent="e890fb134b64d4a63fd735bcb58ed8c1" type="folder">18-20</container></did><accessrestrict id="ebe0ac100a42ac94570bd02c0e0ccdbb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c3fee2e8cf6e2d58695098807e086dab" level="file"><did><unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="e86167ff03a1098f1f9fdad240265f52" label="mixed materials [A0000000075856]" type="box">14</container><container id="2086c84b3962efb68e0e3dc7bb454813" parent="e86167ff03a1098f1f9fdad240265f52" type="folder">1</container></did><accessrestrict id="898d939f278bc6e6c335eb092f07c5a8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="393de6e6b75d4f4817695af30349dd68" level="file"><did><unittitle>TML, 39-80 - Ropivocaine - a new local anesthetic</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="bb9b42bafdbf3e7635b520640611e809" label="mixed materials [A0000000075856]" type="box">14</container><container id="793df4acf780a41112ee61cd2d704b53" parent="bb9b42bafdbf3e7635b520640611e809" type="folder">2-4</container></did><accessrestrict id="7af0a96e2cfe06eaffa6999f5bfd2c77"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="4be741eb1bacb7f18527f5b2df647302" level="file"><did><unittitle>TML, 39-41 - Levofloxacin and sparfloxacin</unittitle><unitdate type="inclusive">1997 April 25</unitdate><container altrender="Record Storage Box (Paige)" id="a672cfdbadb2d7942972e0cefc6097b2" label="mixed materials [A0000000075856]" type="box">14</container><container id="397f7288853235b97afa62e10cc4ae9d" parent="a672cfdbadb2d7942972e0cefc6097b2" type="folder">5-10</container></did><accessrestrict id="7550d2d00d3b056285daa384c568544b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b81fc7aadd5fecc407e846095655da0e" level="file"><did><unittitle>TML, 39-10 - Lasers in dermatologic surgery</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="b6ff01d9122c678a49250115c421d61f" label="mixed materials [A0000000075856]" type="box">14</container><container id="5d25eb31787ac88e4db173497d9e1716" parent="b6ff01d9122c678a49250115c421d61f" type="folder">11-15</container></did><accessrestrict id="0f1f31dc544a7820b6b3740572840e2c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="d6a872b6263ad2beca76d2809d741c78" level="file"><did><unittitle>TML, 39-84 - Skin surgery with lasers - an additional note</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="4dab142aa6e6ef247399011d9dd51729" label="mixed materials [A0000000075856]" type="box">14</container><container id="36a217a15a1de9e65181d73a87226244" parent="4dab142aa6e6ef247399011d9dd51729" type="folder">16</container></did><accessrestrict id="37b13c54d0d04ba5299304f96256cfc0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="62572ae54e7b47c32783a5b7f9f92261" level="file"><did><unittitle>TML, 39-51 - Topiramate for epilepsy</unittitle><unitdate type="inclusive">1997 May 23</unitdate><container altrender="Record Storage Box (Paige)" id="eff07b7360fb0c0fdc2df2e9fefe3f68" label="mixed materials [A0000000075856]" type="box">14</container><container id="d66c8cf4d0cabe6303a4d332dbaaecea" parent="eff07b7360fb0c0fdc2df2e9fefe3f68" type="folder">17-19</container></did><accessrestrict id="1f453b72cb65c772c8bbcb8b965fc251"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="bbfc9de7adb6df0701f6173947f38bd2" level="file"><did><unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="c4deb0842f4682c9e3eaa6e5138808d6" label="mixed materials [A0000000075856]" type="box">14</container><container id="9cd8aaa624fe4f7b83a48186323e535c" parent="c4deb0842f4682c9e3eaa6e5138808d6" type="folder">20</container></did><accessrestrict id="63c006cdd8a94fd253916b0a5c2fcbfc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6b378b12b2f16c81d85d36343d81a41b" level="file"><did><unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="f8dec753f80b87ad20664b207c80409c" label="mixed materials [A0000000075857]" type="box">15</container><container id="a67daed1fe444c2cc9d7f9e579525365" parent="f8dec753f80b87ad20664b207c80409c" type="folder">1-2</container></did><accessrestrict id="62290c3388efd25a1b03329c60a4c2c5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="bf256a51de793456a4c7d083f141288c" level="file"><did><unittitle>TML, 39-65 - Tiludronate for Paget's disease of bone</unittitle><unitdate type="inclusive">1997 July 18</unitdate><container altrender="Record Storage Box (Paige)" id="a4fbabbe7707b0dfd144532a726d8a77" label="mixed materials [A0000000075857]" type="box">15</container><container id="a3f94cccd98f5a0e7e49d034b86e692e" parent="a4fbabbe7707b0dfd144532a726d8a77" type="folder">3-5</container></did><accessrestrict id="a0af36cf2f0f39c3b6bf43a2f3d1a8f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e50c791d98c44790d8141d27cd4cfcab" level="file"><did><unittitle>TML, 39-62 - Tizanidine for spasticity</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="5c73d45cee416303e79528429c511fae" label="mixed materials [A0000000075857]" type="box">15</container><container id="54c3cd2e8024e859a942af660ab277c0" parent="5c73d45cee416303e79528429c511fae" type="folder">6-8</container></did><accessrestrict id="264d6479c0b4544b7007e8c452a7cee5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="12444cf584e83734f66bfc290040544a" level="file"><did><unittitle>TML, 39-49 - Troglitazone for non-insulin-dependent diabetes mellitus</unittitle><unitdate type="inclusive">1997 May 23</unitdate><container altrender="Record Storage Box (Paige)" id="7c4a9efee252d407be6d206b1623ed57" label="mixed materials [A0000000075857]" type="box">15</container><container id="d4c3efd7db8164ac928d3a08d6030ccc" parent="7c4a9efee252d407be6d206b1623ed57" type="folder">9-11</container></did><accessrestrict id="c2dbaf70c1400524b9601ade32d9aa09"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="64f0edfa5bd3b5159911a74e751d912b" level="file"><did><unittitle>TML, 39-43 - Valsartan for hypertension</unittitle><unitdate type="inclusive">1997 April 25</unitdate><container altrender="Record Storage Box (Paige)" id="1ea1d5f148ea2bf64bb0e83740600d55" label="mixed materials [A0000000075857]" type="box">15</container><container id="dd4ff3bdbf5921f05ac9be3a174a8125" parent="1ea1d5f148ea2bf64bb0e83740600d55" type="folder">12-14</container></did><accessrestrict id="d5a76faf4ca30d9de5137cfcad807f6e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="eb014687998353d0fb60326357526127" level="file"><did><unittitle>TML, 39-1 - Drugs for treatment of peptic ulcers</unittitle><unitdate type="inclusive">1997 January 3</unitdate><container altrender="Record Storage Box (Paige)" id="71acdad5413ec3d83868e33225deba7a" label="mixed materials [A0000000075857]" type="box">15</container><container id="60aa878b0567933137e782882988809d" parent="71acdad5413ec3d83868e33225deba7a" type="folder">15-20</container></did><accessrestrict id="1fcec8ea591c0f4b6123d11e89e69ddb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3436a17eac9c6f31692eb5d354b51a44" level="file"><did><unittitle>TML, 39-109 - Pramipexole and Ropinirole for Parkinson's disease</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="25374842c2797fedbac6560e6cdc84e6" label="mixed materials [A0000000075858]" type="box">16</container><container id="34d876549c62e2c3aa7ed75a44bfa184" parent="25374842c2797fedbac6560e6cdc84e6" type="folder">1-4</container></did><accessrestrict id="9f23fe9c137d23133c2b5049c5b64530"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="ea94f0229ffb76d4e8a48dbf172eec36" level="file"><did><unittitle>TML, 39-105 - New drugs for psoriasis</unittitle><unitdate type="inclusive">1997 November 7</unitdate><container altrender="Record Storage Box (Paige)" id="f3af5e9a1aa0ba0159e38b50ec0eccf4" label="mixed materials [A0000000075858]" type="box">16</container><container id="b9bf4497d0de6dbaf0bcfeae65a4257d" parent="f3af5e9a1aa0ba0159e38b50ec0eccf4" type="folder">5-8</container></did><accessrestrict id="d1471d567708b0ca9a5c6d93f5f254f0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="12f50952f7ba8eb3afd7e492d332b4a1" level="file"><did><unittitle>TML, 39-33 - New drugs for psychiatric disorders</unittitle><unitdate type="inclusive">1997 April 11</unitdate><container altrender="Record Storage Box (Paige)" id="93fae2e9906f95bf392beb2218035abc" label="mixed materials [A0000000075858]" type="box">16</container><container id="b73340974ec0fb266edf450048ea1c33" parent="93fae2e9906f95bf392beb2218035abc" type="folder">9-15</container></did><accessrestrict id="dbaf4673299ed575f189876448054a58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="123a71748e8ade20af228276bab2d8b6" level="file"><did><unittitle>TML, 39-117 - Quetiapine for schizophrenia</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="f3efcc1e6cd2224f00fc8fc7ea137444" label="mixed materials [A0000000075858]" type="box">16</container><container id="7a5d7091dc06984edc53b8c3ed13e2a8" parent="f3efcc1e6cd2224f00fc8fc7ea137444" type="folder">16-18</container></did><accessrestrict id="8bbc739b2ed931419befe4ab8eb4eb63"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="498df0f2d9dce92679b2aa347629be3f" level="file"><did><unittitle>TML, 39-17 - Reteplase (Retavase)</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="b5ba3b77d4e5ba7cc04be4232bacc44a" label="mixed materials [A0000000075859]" type="box">17</container><container id="919358b1f2d4ec5dbcaf7cc9e94b892e" parent="b5ba3b77d4e5ba7cc04be4232bacc44a" type="folder">1-2</container></did><accessrestrict id="b2dca34162d6868414a816046edfdff2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6ba7d8b0dcb752d130b074f42b440dd7" level="file"><did><unittitle>TML, 39-53 - Donepezil (Aricept) for Alzheimer's disease</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="c22a2b6a642b089b5a0e7bf3f85efff8" label="mixed materials [A0000000075859]" type="box">17</container><container id="215aa63a64bc20fcefb31e05c743f60c" parent="c22a2b6a642b089b5a0e7bf3f85efff8" type="folder">3-5</container></did><accessrestrict id="6532d645696e8a65297e0563e103f695"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="7c2e04e9e7b332289a442e6977a1f7d9" level="file"><did><unittitle>TML, 39-81 - Diagnostic tests for HIV</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="834afeb3ddb7554d397665496544b0e6" label="mixed materials [A0000000075859]" type="box">17</container><container id="c6c0ebb2fd56c002a9f0c91176ee2b39" parent="834afeb3ddb7554d397665496544b0e6" type="folder">6-10</container></did><accessrestrict id="9570ef3f38bf3a851322c3c3fb7d17cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fdd2b028e08760f46ba2467c4b638924" level="file"><did><unittitle>TML, 39-21 - Drugs of Choice - Cancer Chemotherapy</unittitle><unitdate type="inclusive">1997 March 14</unitdate><container altrender="Record Storage Box (Paige)" id="54381d42d4ad09aecb54320084a99026" label="mixed materials [A0000000075859]" type="box">17</container><container id="5ad713a4571cdad14a2b135ee2821732" parent="54381d42d4ad09aecb54320084a99026" type="folder">11-16</container></did><accessrestrict id="28f03f207bd6c378f505103883232f68"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="42935bf2b5b11b084838a1252d3b3db8" level="file"><did><unittitle>TML, 39-77 - Bupropion for smoking cessation</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="d2d958aaad9e01ad2f367c3f28f4c096" label="mixed materials [A0000000075859]" type="box">17</container><container id="298f7975f9c014daceba382fccd2dea0" parent="d2d958aaad9e01ad2f367c3f28f4c096" type="folder">17</container></did><accessrestrict id="6c0f62c3539d7b57d8122eb2501ba830"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="be3b6c8f67d8d9c4ef7e3226b17983fb" level="file"><did><unittitle>TML, 39-63 - Topical butenafine for tinea pedis</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="51293aaa56929e822bd683c650cc6498" label="mixed materials [A0000000075860]" type="box">18</container><container id="05c32cdc4f6fd119bea1f3aa50cf5464" parent="51293aaa56929e822bd683c650cc6498" type="folder">1-2</container></did><accessrestrict id="5cc6b055d5b6e621ab0c71131fdd66e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="856acb144bbba7a94b1cb63f73185f43" level="file"><did><unittitle>TML, 39-56 - Pentosan</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="b440bbd994d592175946337154544f99" label="mixed materials [A0000000075860]" type="box">18</container><container id="fcb959f20a55f24d221025bc45f30d7b" parent="b440bbd994d592175946337154544f99" type="folder">3-4</container></did><accessrestrict id="9279dfdd8fa0fb9cdb6e31006d0ff6a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="afd34d20934d1be77bfc49f4d1241183" level="file"><did><unittitle>TML, 39-103 - Mibefradil - a new calcium-channel blocker</unittitle><unitdate type="inclusive">1997 November 7</unitdate><container altrender="Record Storage Box (Paige)" id="dff5eceb4a32c60ca78348af8845a943" label="mixed materials [A0000000075860]" type="box">18</container><container id="5b954e49c403ebdf1f04fc1450e265e7" parent="dff5eceb4a32c60ca78348af8845a943" type="folder">5-8</container></did><accessrestrict id="bc77a13d4a14fc45f23bfb7a5bb57c5d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="de42e2f43ebae331da9c0b8180abb87c" level="file"><did><unittitle>TML, 39-59 - Midodrine for orthostatic hypotension</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="1fa30ab2bd9c7f5af94d7b710899b15b" label="mixed materials [A0000000075860]" type="box">18</container><container id="2ed28fd848f195af7d93f6af9d0a1af0" parent="1fa30ab2bd9c7f5af94d7b710899b15b" type="folder">9-11</container></did><accessrestrict id="01d73c68e8dd39b1c0b73b6d7700c7a0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="96ceef3812b648bc28698beed66c5d75" level="file"><did><unittitle>TML, 39-47 - Treatment of Lyme disease</unittitle><unitdate type="inclusive">1997 May 9</unitdate><container altrender="Record Storage Box (Paige)" id="ce786f11b49023baf29067b8bc02cb3e" label="mixed materials [A0000000075860]" type="box">18</container><container id="2273d7a57b35f473eca0251fa0a03b4e" parent="ce786f11b49023baf29067b8bc02cb3e" type="folder">12-14</container></did><accessrestrict id="1456685e80bfcccf0ad9c93511c65c4d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="eaedccce6a322747a43e566f8dfc2b7d" level="file"><did><unittitle>TML - Drugs of Choice</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="79fe49c21ebdae92d690a577808b0735" label="mixed materials [A0000000075860]" type="box">18</container><container id="6099d356e0f1e1b21c5f754a228f6be8" parent="79fe49c21ebdae92d690a577808b0735" type="folder">15-17</container></did><accessrestrict id="640807ffbd5e5ea720da4f60f781a4b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="95b6682482a9d062317fcf262cc7f718" level="file"><did><unittitle>TML, 39-85 - Influenza vaccine</unittitle><unitdate type="inclusive">1997 September 12</unitdate><container altrender="Record Storage Box (Paige)" id="bf2667a7c7acfe2c531c575164b66049" label="mixed materials [A0000000075860]" type="box">18</container><container id="d841e8da7797a47105957c7e72516957" parent="bf2667a7c7acfe2c531c575164b66049" type="folder">18</container></did><accessrestrict id="bae55e07ca01b84992a5b395e88b6ccc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="9c5534af6d0a227ae1ad47876c813383" level="file"><did><unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="3ed31ba77498fee13c26e7f952a11506" label="mixed materials [A0000000075860]" type="box">18</container><container id="81d421ba8c5f2de4d1b3c7d2d3f0c15c" parent="3ed31ba77498fee13c26e7f952a11506" type="folder">19</container></did><accessrestrict id="071f86249d57b3a639f1f0ac1e82c1db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="8d02c5507ec798ca4d7bb6188acc62a5" level="file"><did><unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="9360126df101e22eea2e0237b2e629a8" label="mixed materials [A0000000075861]" type="box">19</container><container id="0122fe4a7056a107153cbd5bee6bab64" parent="9360126df101e22eea2e0237b2e629a8" type="folder">1</container></did><accessrestrict id="36454ffdeab70b1b39646403fa3b2960"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="0cdb2a091afd3228142c89eb37d2380a" level="file"><did><unittitle>TML, 39-118 - Imiquimod for genital warts</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="859161ddfb2a86f797b5b154aee2fba5" label="mixed materials [A0000000075861]" type="box">19</container><container id="4d725ac76ba1a97f305de027c5a88bf6" parent="859161ddfb2a86f797b5b154aee2fba5" type="folder">2-3</container></did><accessrestrict id="d975c63ad23263fd275260f9460dcf1e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f4d2ffb826a588ff6c493adbd06a92be" level="file"><did><unittitle>TML, 39-64 - Drugs for epilepsy</unittitle><unitdate type="inclusive">1997 February 6</unitdate><container altrender="Record Storage Box (Paige)" id="c729a606ca57aa83dfbe5fe9a675358b" label="mixed materials [A0000000075861]" type="box">19</container><container id="fd810f4ccdd4e51a80e75d8f57a1126e" parent="c729a606ca57aa83dfbe5fe9a675358b" type="folder">4-6</container></did><accessrestrict id="c20b70cbd97aa855e62537fb259a09f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="028b89ba84e332c879eab9899c191875" level="file"><did><unittitle>TML, 39-66 - Fosfomycin for urinary tract infections</unittitle><unitdate type="inclusive">1997 July 18</unitdate><container altrender="Record Storage Box (Paige)" id="c62adcaeb5d9faf7148ef7bd4b01a299" label="mixed materials [A0000000075861]" type="box">19</container><container id="a27841448a198cc271ff327652a0e250" parent="c62adcaeb5d9faf7148ef7bd4b01a299" type="folder">7-9</container></did><accessrestrict id="e0aa9d9341298313dcd22b6a4157d3bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="73ee7f93d0af26d64d0c1fc7ba0c7201" level="file"><did><unittitle>TML, 39-86 - Systemic antifungal drugs</unittitle><unitdate type="inclusive">1997 September 12</unitdate><container altrender="Record Storage Box (Paige)" id="5eb7325c8b529a9e919580f5ce5fe42e" label="mixed materials [A0000000075861]" type="box">19</container><container id="bba8e0fc2dba4230f799207fe04a8e59" parent="5eb7325c8b529a9e919580f5ce5fe42e" type="folder">10-13</container></did><accessrestrict id="226ecab6ab43654c9c5dd63a5e3e2b52"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6bf77dfe11efd36cf8146b826560cb4c" level="file"><did><unittitle>TML, 39-61 - Glatiramer acetate for relapsing mutiple sclerosis</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="7862fdfe7269571e7519da173812b6ef" label="mixed materials [A0000000075861]" type="box">19</container><container id="c33fc1b168c466eea1a05520aa68f825" parent="7862fdfe7269571e7519da173812b6ef" type="folder">14-16</container></did><accessrestrict id="58267fbb42c582dd03ac8830411c1803"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f36ff800dacbd73013d42dab42cf5f5b" level="file"><did><unittitle>TML, 38-6 - Drugs for head lice</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="3ba824352609b2f9cdf45bdd99b9cc18" label="mixed materials [A0000000075861]" type="box">19</container><container id="1b296e49955d69f4051fb7a45cb22ce8" parent="3ba824352609b2f9cdf45bdd99b9cc18" type="folder">17-18</container></did><accessrestrict id="92296119b0cbe67e59973a003090f421"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e13f3fa0ec576057f7033815a81111e1" level="file"><did><unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="aa70b9a5330f8b2e791e8382d6bcfdf4" label="mixed materials [A0000000075861]" type="box">19</container><container id="cdfaec51723682b50edc5f7f1184e26e" parent="aa70b9a5330f8b2e791e8382d6bcfdf4" type="folder">19-20</container></did><accessrestrict id="e7cb03a6203eb58d2833529692c66d60"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="dfc2de9cdb5bf3a8437e564fa717ffbd" level="file"><did><unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="74813909f12c9b53ee747932523e8c01" label="mixed materials [A0000000075862]" type="box">20</container><container id="14b2bd42eeabbba67e2f5c3629c9f65d" parent="74813909f12c9b53ee747932523e8c01" type="folder">1-2</container></did><accessrestrict id="d913972842d3a79acf9b906df7f951e7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="95d8be151e4ef26242db019df375f791" level="file"><did><unittitle>TML, 39-94 - Drugs for hypertension</unittitle><unitdate type="inclusive">1997 November 1</unitdate><container altrender="Record Storage Box (Paige)" id="5f5d03c21cc490ccfc7f0f425c8a2980" label="mixed materials [A0000000075862]" type="box">20</container><container id="2c0c778a7aa25a42af692c497d0c7d68" parent="5f5d03c21cc490ccfc7f0f425c8a2980" type="folder">3-5</container></did><accessrestrict id="2db96bdb2ad3f2367bdf1559b5ea1133"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f8696aa81da52173ff18b97bd7eb4067" level="file"><did><unittitle>TML, 39-19 - Adapalene for acne</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="28fe3f2884419a403356329bd648a7f0" label="mixed materials [A0000000075862]" type="box">20</container><container id="b725c117e395bc1337fcc6fadc5b13db" parent="28fe3f2884419a403356329bd648a7f0" type="folder">6-7</container></did><accessrestrict id="cefd2ab82f2cd38f2cef5b4253fea1fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="d3c8f38c2b75ab98def9cb12e7933ba3" level="file"><did><unittitle>TML, 39-29 - Atorvastatin - a new lipid-lowering drug</unittitle><unitdate type="inclusive">1997 March 28</unitdate><container altrender="Record Storage Box (Paige)" id="e8e59f8c4e3d22a147b4abc8082ec859" label="mixed materials [A0000000075862]" type="box">20</container><container id="ba1d7f949c0c3b44a2a0fe83353d3113" parent="e8e59f8c4e3d22a147b4abc8082ec859" type="folder">8-9</container></did><accessrestrict id="f50e6cdc96d78aa80586f8c46bb4b44f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b2a72d06fe2be2cec8bad5a6a0fda27b" level="file"><did><unittitle>TML, 39-45 - Azelastine nasal spray for allergic rhinitis</unittitle><unitdate type="inclusive">1997 May 9</unitdate><container altrender="Record Storage Box (Paige)" id="555a8cdda03c8a06e93c4fa4ddc79a9d" label="mixed materials [A0000000075862]" type="box">20</container><container id="f3012b631d3325fbfed41f57f02bba10" parent="555a8cdda03c8a06e93c4fa4ddc79a9d" type="folder">10-13</container></did><accessrestrict id="2c8bdc164c637c083bf92b35d52554fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="36e76c3b20aacff333ba5d98cfca27de" level="file"><did><unittitle>TML, 39-12 - Betaine for homocystinuria</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="287244091112c384ab0a75a998585c69" label="mixed materials [A0000000075862]" type="box">20</container><container id="b585f522df9e7eb4526eccb89c95d538" parent="287244091112c384ab0a75a998585c69" type="folder">14-15</container></did><accessrestrict id="55bd4c86ccf4811f99aac2673693e945"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e4ca902373c4579a78db0d3b8d513633" level="file"><did><unittitle>TML, 39-93 - Bromfenac for analgesia</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="72c4716f2946c6307744d76eb0c89492" label="mixed materials [A0000000075862]" type="box">20</container><container id="43133bdd6ccbc9b89b6b30840fbb5daa" parent="72c4716f2946c6307744d76eb0c89492" type="folder">16-17</container></did><accessrestrict id="18bd5ce580d159e1acce03ad34266cc9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1a9cef87a6b1f62bf27f90e19d47c4e1" level="file"><did><unittitle>TML, 39-54 - Brimonidine - an alpha2-agonist for glaucoma</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="0f37110340821b321ea5136863656255" label="mixed materials [A0000000075862]" type="box">20</container><container id="8adfb1505e024948cbc4978503d07a2d" parent="0f37110340821b321ea5136863656255" type="folder">18-19</container></did><accessrestrict id="c12a956b010223394c6ca9d2025942d6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="56fc5093674d1372e80ed218ae8bd368" level="file"><did><unittitle>TML, 39-13 - Safety of channel blockers</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="7239b13f11daf838ee06abb58c498bfd" label="mixed materials [A0000000075862]" type="box">20</container><container id="28e46645bb8a770bd7b8be023e3ea412" parent="7239b13f11daf838ee06abb58c498bfd" type="folder">20</container></did><accessrestrict id="12b089183fda270bbeecc135b190b589"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1f85013ec13e639596b728f22f1aafc4" level="file"><did><unittitle>TML, 39-13 - Safety of channel blockers</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="f602a19b6250c66fb545faa78d84e7fc" label="mixed materials [A0000000075863]" type="box">21</container><container id="8f0ddd6d70e68fa88b08fb7477e36e51" parent="f602a19b6250c66fb545faa78d84e7fc" type="folder">1-2</container></did><accessrestrict id="8a33d90a046f00da2d8b9b030020c09e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b4a11be555144c67db801913b3a95361" level="file"><did><unittitle>TML, 39-58 - Cabergoline for hyperprolactinemia</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="afa7b9bcd5bddddd7e621cca55c384b9" label="mixed materials [A0000000075863]" type="box">21</container><container id="981a7462572baf2e8c6ef689b3501db6" parent="afa7b9bcd5bddddd7e621cca55c384b9" type="folder">3-6</container></did><accessrestrict id="300ca74e312c726f3bc6c5c2409ffa88"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="8fa954deb6dc2ce7385244a3d8abc5a9" level="file"><did><unittitle>TML - Dovonex</unittitle><unitdate type="inclusive">1993</unitdate><container altrender="Record Storage Box (Paige)" id="3d0d60ca1a4a078869a7e124601b3cc9" label="mixed materials [A0000000075863]" type="box">21</container><container id="179cb86d359c6b85bef3106284700b19" parent="3d0d60ca1a4a078869a7e124601b3cc9" type="folder">7</container></did><accessrestrict id="7ed0890a439df753466be5a70bc31770"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c70f3345ad4c90f6af9d560ffb1f3777" level="file"><did><unittitle>TML, 39-108 - Olopatadine for allergic conjunctivitis</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="6ff44be839950512e730feab3a745d30" label="mixed materials [A0000000075863]" type="box">21</container><container id="7a551544f93d06e377b0326528e0a8e3" parent="6ff44be839950512e730feab3a745d30" type="folder">8-9</container></did><accessrestrict id="7e05d25159387c3bcb0a7a1a1a57fbe9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="0f25168045c3874b852fc2566864c22b" level="file"><did><unittitle>TML, 37-1 - Drugs for asthma</unittitle><unitdate type="inclusive">1996 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="87253935730b55729f602dabdc9e26f4" label="mixed materials [A0000000075863]" type="box">21</container><container id="800f1e8f4a3af7a7726c29e2dcfe3133" parent="87253935730b55729f602dabdc9e26f4" type="folder">10-14</container></did><accessrestrict id="5124cbd46d2a439f4f59c00468b6016b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="dbe0049fdc51d967d42b54af228c58ae" level="file"><did><unittitle>TML, 39-32 - Intra-transurethral Alprostadil for impotence</unittitle><unitdate type="inclusive">1997 March 28</unitdate><container altrender="Record Storage Box (Paige)" id="28e59e9b5b2a0b3104835230f19a11f5" label="mixed materials [A0000000075863]" type="box">21</container><container id="47d1af26d63b594e240755a0b63420ce" parent="28e59e9b5b2a0b3104835230f19a11f5" type="folder">15-16</container></did><accessrestrict id="108454fd852ec91b5893f1a78b4694b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3fff697896297fb5b3e546b99c7bb615" level="file"><did><unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="2a0c68ce899e0199c7aff732796166e6" label="mixed materials [A0000000075863]" type="box">21</container><container id="cd356598e74ae3d56698771609061b7a" parent="2a0c68ce899e0199c7aff732796166e6" type="folder">17-21</container></did><accessrestrict id="6e01c10d6e482faec33ca1e6f744b4e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="ac009d8a6eba90db98f499f6852dd496" level="file"><did><unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="0a979f015125f7b24e18d56c05861e85" label="mixed materials [A0000000075864]" type="box">22</container><container id="f05a60995d000ad1a069b3a3d7f85135" parent="0a979f015125f7b24e18d56c05861e85" type="folder">1-3</container></did><accessrestrict id="1cdb7a1ff11f6e216e339e64f20c58a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="364c7d8d424593144cdef790c4e94d75" level="file"><did><unittitle>TML, 39-111 - AIDS - Drugs for HIV infection</unittitle><unitdate type="inclusive">1997 December 12</unitdate><container altrender="Record Storage Box (Paige)" id="5140350d63da33f165e5e0493ace808f" label="mixed materials [A0000000075864]" type="box">22</container><container id="be301e63940afd2cc48ad8d5b2bcc5f5" parent="5140350d63da33f165e5e0493ace808f" type="folder">4-9</container></did><accessrestrict id="a96e0ada70322de7df279993ca3ff3a5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fe5bfd483d4da9cb09abcd8d8e9114e4" level="file"><did><unittitle>TML, 39-97 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1997 October 24</unitdate><container altrender="Record Storage Box (Paige)" id="cfc7f3301058d1b39f67e179800b4ac0" label="mixed materials [A0000000075864]" type="box">22</container><container id="ffb028e2206ff9547602fbcd39b6fb0d" parent="cfc7f3301058d1b39f67e179800b4ac0" type="folder">10-15</container></did><accessrestrict id="ce3e85fc72e05bedc7f21da6973965b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6568c1026445dec6f8e364671c21bd39" level="file"><did><unittitle>TML, 39-120 - Anagrelide for essential thrombocythemia</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="d4d3b5844ce4722ccc48f689b0ad9345" label="mixed materials [A0000000075864]" type="box">22</container><container id="692a5daccfa7b9c8c17ca94b16d6305e" parent="d4d3b5844ce4722ccc48f689b0ad9345" type="folder">16-18</container></did><accessrestrict id="8df589a9af326009da84ebecd5cf8932"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b0b4f71d2ecf84b337ced4a504f89306" level="file"><did><unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="fe16dd7a5abc7f299137941dcd68003d" label="mixed materials [A0000000075864]" type="box">22</container><container id="bb3b3fbee55a3c547a7f853155fead16" parent="fe16dd7a5abc7f299137941dcd68003d" type="folder">19</container></did><accessrestrict id="8df622f363be5b50961c92589e209dc4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b1ac2f651904161cd98b8d42f99e3aa1" level="file"><did><unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="ca2fa9ed9d5096b1987db83a8b7d3c69" label="mixed materials [A0000000075865]" type="box">23</container><container id="16088ef86d1c8b010f4a00a523cb8215" parent="ca2fa9ed9d5096b1987db83a8b7d3c69" type="folder">1-4</container></did><accessrestrict id="181d3a4b218653d1790e4861871f62dd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="edca2ebba2d38b14ec07a5b9c16a0276" level="file"><did><unittitle>TML, 39-89 - Carvedilol for heart failure</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="f5eb5f520cf423b70f765051ee7e519e" label="mixed materials [A0000000075865]" type="box">23</container><container id="663e59b7bb5cd08426f1bee5370011bb" parent="f5eb5f520cf423b70f765051ee7e519e" type="folder">5-9</container></did><accessrestrict id="f5705dc19e306f206ec780b8d160e15c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3f1ba5c10401cadfc440c87da71224cb" level="file"><did><unittitle>TML, 39-57 - Topical penciclovir for herpes labialis</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="661cacb3a9ffd06dc029ebc2a7a3edc7" label="mixed materials [A0000000075865]" type="box">23</container><container id="6ca18be173bf32d79878bf810b5311c5" parent="661cacb3a9ffd06dc029ebc2a7a3edc7" type="folder">10-11</container></did><accessrestrict id="053d8eeeb8327c9a50460b4a07f88f4f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6311bd1ab3c17838b525980881eb7804" level="file"><did><unittitle>TML, 38-17 - Drugs for migraine</unittitle><unitdate type="inclusive">1995 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="1b352555ce780fc903a902b57a2b07f0" label="mixed materials [A0000000075865]" type="box">23</container><container id="01f3634fd6eeddb4d83ea88ca15a13b8" parent="1b352555ce780fc903a902b57a2b07f0" type="folder">12-16</container></did><accessrestrict id="3d255045a576ae1c355c7f2fcc48b4a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="d46efc5621917384073357b190321659" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="b86c838d38d351b5a10990222996eaf1" label="mixed materials [A0000000075865]" type="box">23</container><container id="5fcdd6635cbfaf741fd1b95370718486" parent="b86c838d38d351b5a10990222996eaf1" type="folder">17-21</container></did><accessrestrict id="663777121320adda427992b307d1db2f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fa4a7928ccfffaadb72cf4771e4d8edc" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="604e19d9310a4b60e7f618c6d1d940c9" label="mixed materials [A0000000075866]" type="box">24</container><container id="458fb12c5c8ea83fed1ef517e2dda537" parent="604e19d9310a4b60e7f618c6d1d940c9" type="folder">1</container></did><accessrestrict id="702b01fd73a7deda0a72869d6f566a47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="318ae2efe1275c93a47e9ae522f706ea" level="file"><did><unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="9949b028752424aa17077337d263ba2f" label="mixed materials [A0000000075866]" type="box">24</container><container id="7408330e2fc7ea7296cf66ba24c9fe35" parent="9949b028752424aa17077337d263ba2f" type="folder">2-3</container></did><accessrestrict id="f2ea2b6f0f794d84b25ea1befb0a8255"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b4b3b22e307f4ce6c5d2eb8f6d664d9c" level="file"><did><unittitle>TML, 38-5 - Olanzapine for schizophrenia</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="693537a139f9e65495d2c03ac125eee4" label="mixed materials [A0000000075866]" type="box">24</container><container id="9e504e612fda3761764443c4551ec9e0" parent="693537a139f9e65495d2c03ac125eee4" type="folder">4-6</container></did><accessrestrict id="54d3d516459a5d0fc04e78b00339b8f9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b5cf0dfe90fdcc6067f140e30b6809d1" level="file"><did><unittitle>TML, 38-113 - Mirtazapine - a new anti-depressant</unittitle><unitdate type="inclusive">1996 December 20</unitdate><container altrender="Record Storage Box (Paige)" id="5cd6603c4ea0776994208636aa8b366e" label="mixed materials [A0000000075866]" type="box">24</container><container id="e96f6b8da486ddd23b90d05b6cf421e3" parent="5cd6603c4ea0776994208636aa8b366e" type="folder">7-9</container></did><accessrestrict id="6a61863bdf42f359838de02eb3140260"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c2e1fc197d7490d826da206b516a38a5" level="file"><did><unittitle>TML, 40-5 - Drugs of Choice - Rheumatoid Arthritis</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="45c3317d17f3859127e1ffc403cb96bf" label="mixed materials [A0000000075866]" type="box">24</container><container id="5504d90017e247286831d27a9d49f4f0" parent="45c3317d17f3859127e1ffc403cb96bf" type="folder">10-16</container></did><accessrestrict id="5d151812a70ad7aab1e31b15864a8198"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fc12244326436c163ce3062f2ee5441e" level="file"><did><unittitle>TML, 40-59 - Clopidogrel for reduction of artherosclerotic events</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="0e82f20c6fa714ecf948004237c4b7ad" label="mixed materials [A0000000075867]" type="box">25</container><container id="e2dd67ef184fc31cd852b8e8c4d51801" parent="0e82f20c6fa714ecf948004237c4b7ad" type="folder">1-3</container></did><accessrestrict id="010c90cf26351f4881154a4f6ad41ad3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b00d90227ff22e5ebe7df4b968c6ec73" level="file"><did><unittitle>TML, 40-113 - Citalopram for depression</unittitle><unitdate type="inclusive">1998 December 4</unitdate><container altrender="Record Storage Box (Paige)" id="ddd719915c79d6d9d56f14033ffe990e" label="mixed materials [A0000000075867]" type="box">25</container><container id="76a5705a062f43601541eb2b5e99bb1e" parent="ddd719915c79d6d9d56f14033ffe990e" type="folder">4-8</container></did><accessrestrict id="e132e378e63282bf8014cd21bd84bf26"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="85788caeb20c27238d916bb497645405" level="file"><did><unittitle>TML, 40-52 - Anthrax vaccine</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="e5e37e799e052b11f871ec38f8ef41dc" label="mixed materials [A0000000075867]" type="box">25</container><container id="25405a4822bc31954b9f2c71d4b8cc99" parent="e5e37e799e052b11f871ec38f8ef41dc" type="folder">9-10</container></did><accessrestrict id="0a33ad6cdce119b325c656b5c6f11151"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7481cf56a926bcaa665f596bebcba058" level="file"><did><unittitle>TML, 40-63 - Ginkgo Biloba for dementia</unittitle><unitdate type="inclusive">1998 June 19</unitdate><container altrender="Record Storage Box (Paige)" id="be8781e39c16a3754cca4e00b9f23f0b" label="mixed materials [A0000000075867]" type="box">25</container><container id="108c1a59d1007604d00552efe20dcffb" parent="be8781e39c16a3754cca4e00b9f23f0b" type="folder">11-13</container></did><accessrestrict id="16e326bcc4bc4a1b019667382b3e42a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="276f7a6dda26470f835e467b2e300373" level="file"><did><unittitle>TML, Sildenafil - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="8d656347ec8e91aad507949cb2d3a653" label="mixed materials [A0000000075867]" type="box">25</container><container id="44755d6f25f46030e685f9bb3fbc315b" parent="8d656347ec8e91aad507949cb2d3a653" type="folder">14-16</container></did><accessrestrict id="c072f69e2c5f4579df7b9a32a2d6638a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8d9d5a14ea3c38a9bcf53eea15278788" level="file"><did><unittitle>TML, 40-69 - Hyaluronan injections for osteoarthritis of the knee</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="4f7e54d5aeba899c345bb761504d51e3" label="mixed materials [A0000000075867]" type="box">25</container><container id="4964f6a336d1483785588d43d63f8dd9" parent="4f7e54d5aeba899c345bb761504d51e3" type="folder">17-19</container></did><accessrestrict id="548bd13d1ee4dd091a7071fb17973086"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e605d151c50d15b7436fa8b95fabcc04" level="file"><did><unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="908700ee82f6dbb128f6dec888d7a0c0" label="mixed materials [A0000000075867]" type="box">25</container><container id="90cb299b07bab0890ea6f6561284da94" parent="908700ee82f6dbb128f6dec888d7a0c0" type="folder">20-21</container></did><accessrestrict id="72272d08b8d2095400f484d84b5c8623"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a2c45fce823914fd5f240eb8ce64a6d3" level="file"><did><unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="bdb01dc04b1983d2fb5b96772b9dbdbb" label="mixed materials [A0000000075868]" type="box">26</container><container id="5de463bbcee696a7ffa40d30beba54a4" parent="bdb01dc04b1983d2fb5b96772b9dbdbb" type="folder">1</container></did><accessrestrict id="e61fbc122231a69d11de05471824b4f7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="58fc0933c16d75f16f20c226741f40fc" level="file"><did><unittitle>TML, 40-21 - Drugs that cause psychiatric symptoms</unittitle><unitdate type="inclusive">1998 February 13</unitdate><container altrender="Record Storage Box (Paige)" id="339540bbdc130f4d63184168ae157e10" label="mixed materials [A0000000075868]" type="box">26</container><container id="590717d276e20ebcbf8f83293013284b" parent="339540bbdc130f4d63184168ae157e10" type="folder">2-5</container></did><accessrestrict id="cd18c294101a7fb036bca53986751b48"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f466040faafb3cd515b6f7e5924186a3" level="file"><did><unittitle>TML, 40-47 - Advice for Travelers</unittitle><unitdate type="inclusive">1998 April 24</unitdate><container altrender="Record Storage Box (Paige)" id="e22929613070ebc554b452b093c3f913" label="mixed materials [A0000000075868]" type="box">26</container><container id="42cc26bef006f8910db4b8509fbb7271" parent="e22929613070ebc554b452b093c3f913" type="folder">6-9</container></did><accessrestrict id="d3ea0598c816f490bd7b26c48572450a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="d9d7051c247d055cb3a4caa57119bc34" level="file"><did><unittitle>TML, 40-68 - Fenofibrate</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="aac1ca20eb4cfb522e508584dc639174" label="mixed materials [A0000000075868]" type="box">26</container><container id="57b75d04a8a8a5278fc7cf109b5e7cbc" parent="aac1ca20eb4cfb522e508584dc639174" type="folder">10-13</container></did><accessrestrict id="a905e6ecf288f2137eb025ea245ec0aa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="0902f98f4048374d057a60de2d1b7855" level="file"><did><unittitle>TML, 40-30 - Trovafloxacin</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="5a8046db888eb428304990d250343ae0" label="mixed materials [A0000000075868]" type="box">26</container><container id="a7b6c6801caa6f768affe6e6c0d0844c" parent="5a8046db888eb428304990d250343ae0" type="folder">14-16</container></did><accessrestrict id="d64cfc2f0c18fe44c79492b16479dde8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="40a127b41aba4ab1210aebb60355f7eb" level="file"><did><unittitle>TML - Tuberculosis - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="a57420e6716bcaa7027db4765287dca0" label="mixed materials [A0000000075868]" type="box">26</container><container id="5ac49494ee3812f1f115135356f8f096" parent="a57420e6716bcaa7027db4765287dca0" type="folder">17-18</container></did><accessrestrict id="aa2e94224c5f71c8078141e7e709d476"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="2821241f88ab33b4108c2fb8ef546a03" level="file"><did><unittitle>TML - Tuberculosis - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="624824be6bc6aa6d1c104e365abd7c5c" label="mixed materials [A0000000075869]" type="box">27</container><container id="b3b14631d09cba9830279490b894bdf6" parent="624824be6bc6aa6d1c104e365abd7c5c" type="folder">1-2</container></did><accessrestrict id="0fedc35030a79ffd7934a9d9c5acbe14"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a5e3fba9d86330d4c75e3f31b4844108" level="file"><did><unittitle>TML, 40-51 - Sildenafil - An oral drug for impotence</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="8afe4ed16f45fc851ffa27e4033af806" label="mixed materials [A0000000075869]" type="box">27</container><container id="744a166260b5b337f9e65ca5dcfcac94" parent="8afe4ed16f45fc851ffa27e4033af806" type="folder">3-4</container></did><accessrestrict id="c2a74a29c84ba08cf5bbb6cb60889b41"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="41484f1614916c304d00c6a0e2776c25" level="file"><did><unittitle>TML, 40-67 - Sucralose - a new artificial sweetner</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="e26252d7b550991f51bf13a869ab3a1d" label="mixed materials [A0000000075869]" type="box">27</container><container id="4a2f60d99b781e75a26ada8216cb3186" parent="e26252d7b550991f51bf13a869ab3a1d" type="folder">5-7</container></did><accessrestrict id="9e54423aecee12c7635588555d8c357f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="18a33071dfc9246e7c9a4f9970fc624f" level="file"><did><unittitle>TML, 40-17 - Grepafloxacin - a new fluoroquinolone</unittitle><unitdate type="inclusive">1998 January 30</unitdate><container altrender="Record Storage Box (Paige)" id="cf80fc964057af3a7c0e164a56451b09" label="mixed materials [A0000000075869]" type="box">27</container><container id="bce207f2c3225077cc00e8cfba442ef2" parent="cf80fc964057af3a7c0e164a56451b09" type="folder">8-9</container></did><accessrestrict id="bc7dcf48bb1a978d5d8891678f65f0b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="95bd003fd739d4b3a6ffdfb96fae1bc6" level="file"><did><unittitle>TML, 40-55 - Repaglinide for type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="c66b0785962b8826efc0ecb4f27abfad" label="mixed materials [A0000000075869]" type="box">27</container><container id="a24441733c3846cf2a104b2cbb812024" parent="c66b0785962b8826efc0ecb4f27abfad" type="folder">10-12</container></did><accessrestrict id="ea7f89c9aaeab7997ab0ab65a3fbabdf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c689105113c5b23ebb896f340bf02ea0" level="file"><did><unittitle>TML, 40-62 - Crystal Ear hearing aid</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="55cf38d8b846a7864be5bac9de23c693" label="mixed materials [A0000000075869]" type="box">27</container><container id="78a002ff9488dd0c2c3277d2860cc73f" parent="55cf38d8b846a7864be5bac9de23c693" type="folder">13</container></did><accessrestrict id="dc4b7b184944400de9cfe92635a05ead"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="705d7bf07e8ff402ef32c0df389a3828" level="file"><did><unittitle>TML, 40-89 - Antiplatelet</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="bf14b935799bc50f5144c3741b9d88e0" label="mixed materials [A0000000075869]" type="box">27</container><container id="220929f705b1064a2f182c63d0cf99f1" parent="bf14b935799bc50f5144c3741b9d88e0" type="folder">14-16</container></did><accessrestrict id="ae0c798c535816e3564f3b350306c0eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="cc4045365330c91030e2afc2941ff362" level="file"><did><unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="39f95fcd8c4ce98cb338dbad1d0f68cb" label="mixed materials [A0000000075869]" type="box">27</container><container id="3e3fbeb1a21f812d9bc6d017cb8e152d" parent="39f95fcd8c4ce98cb338dbad1d0f68cb" type="folder">17-19</container></did><accessrestrict id="d3830363a0deac040fb1a2187fcc43a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="74cd9f3df4304220a489f3cd523e97f4" level="file"><did><unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="4c31c715917edcf7128652d191a3ddf1" label="mixed materials [A0000000075870]" type="box">28</container><container id="6387c76402626cf66fd44e4adfb01997" parent="4c31c715917edcf7128652d191a3ddf1" type="folder">1</container></did><accessrestrict id="78f65a64160f8c684e6ad4a73eb82afd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8f7886d013678b0f444c0e7ce3af676b" level="file"><did><unittitle>TML, 40-65 - Rituximab for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">1998 June 19</unitdate><container altrender="Record Storage Box (Paige)" id="e4eee5ea2b9863c5a36a0f47d50a578c" label="mixed materials [A0000000075870]" type="box">28</container><container id="6d162aa9277a3488ca032b7e1ede97bd" parent="e4eee5ea2b9863c5a36a0f47d50a578c" type="folder">2</container></did><accessrestrict id="8e2b80b72a52938a5c321da498c8b722"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="236c02b396ea229adb1f079d93029f01" level="file"><did><unittitle>TML, 40-32 - Sibutramine for obesity</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="f5302f71ad7b894150abc883f1b22be5" label="mixed materials [A0000000075870]" type="box">28</container><container id="23f440fae4c04a258b6a94a8a2591a79" parent="f5302f71ad7b894150abc883f1b22be5" type="folder">3-5</container></did><accessrestrict id="83216716b614ac8cc38fcaa01b43355e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="34d5d1374a9121f748a24968ebe6c128" level="file"><did><unittitle>TML, 40-27 - Zolmitriptan for migraine</unittitle><unitdate type="inclusive">1998 February 27</unitdate><container altrender="Record Storage Box (Paige)" id="50b2606ea49b54f0afed3a416f6923ed" label="mixed materials [A0000000075870]" type="box">28</container><container id="705423c1d6e9eb5522f15735c04c2529" parent="50b2606ea49b54f0afed3a416f6923ed" type="folder">6-8</container></did><accessrestrict id="9f78fcde35549e85ae6f6ddddad23091"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f1f292c6e674c3d7e6f2610c2dbf9aec" level="file"><did><unittitle>TML, 40-73 - Becaplermin - Platelet-derived growth factor for diabetic ulcers</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="37d9ffb7c3485f5be5ada04eafc182e5" label="mixed materials [A0000000075870]" type="box">28</container><container id="ce80a55e6bbe1196da258c8cbec96f5f" parent="37d9ffb7c3485f5be5ada04eafc182e5" type="folder">9</container></did><accessrestrict id="a90cd7de6fbf79e2a9a41d8e6d5f1884"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fae1826f224dc5554dd9d77d43d63320" level="file"><did><unittitle>TML, 40-19 - Arbutamine for stress testing</unittitle><unitdate type="inclusive">1998 January 2</unitdate><container altrender="Record Storage Box (Paige)" id="7aca5a18f3652e003013a0844999765d" label="mixed materials [A0000000075870]" type="box">28</container><container id="18bfec345427781344a21a0089b6a916" parent="7aca5a18f3652e003013a0844999765d" type="folder">10-11</container></did><accessrestrict id="3cf800c016782dc93e3a36b622f7b36c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b4e4ab750a7b095f09a475bb6f5bb4c1" level="file"><did><unittitle>TML, 40-75 - Vitamin supplements</unittitle><unitdate type="inclusive">1998 July 31</unitdate><container altrender="Record Storage Box (Paige)" id="d9c2394c3ff496d8925f0acd350ab572" label="mixed materials [A0000000075870]" type="box">28</container><container id="37d6d540fde91c038bbf5790fc7fb8c4" parent="d9c2394c3ff496d8925f0acd350ab572" type="folder">12-16</container></did><accessrestrict id="59259d5d91da3a2acb6cb86529f69bd9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="06914f95afdacb00ca224c63b35cc3e5" level="file"><did><unittitle>TML, 40-92 - Gliadel wafers for treatment of brain tumors</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="306d75b8c0767678ba494f1f1e68b193" label="mixed materials [A0000000075870]" type="box">28</container><container id="19a49651705f023b92ad83f37ae8b0f6" parent="306d75b8c0767678ba494f1f1e68b193" type="folder">17-18</container></did><accessrestrict id="e29a7c4b92a2feed9fd0b7e0a0bb8f72"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f35a3fcbf2b099a50baf329b7d2a8f36" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="24b7c0718a253505f3f3f98f4f75f5f0" label="mixed materials [A0000000075870]" type="box">28</container><container id="d2159b4d779a63192db46c746dd6c717" parent="24b7c0718a253505f3f3f98f4f75f5f0" type="folder">19</container></did><accessrestrict id="0093f9f9cae39c07366f1e9c0c119fa4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="bc19dc00f1b6834157cb02e6fcfef4a4" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="7862f47a8a9c2a47a5d4944e94a00ae6" label="mixed materials [A0000000075871]" type="box">29</container><container id="077a091ab144e8e7fa51feee6182c2e0" parent="7862f47a8a9c2a47a5d4944e94a00ae6" type="folder">1-5</container></did><accessrestrict id="530223b01deda9e053da32d105382b18"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="559cb584a41d6690a7e856498ab89795" level="file"><did><unittitle>TML, 40-106 - Trastuzumab for metastatic breast cancer</unittitle><unitdate type="inclusive">1998 November 6</unitdate><container altrender="Record Storage Box (Paige)" id="d6e7cc8b4216b15bafde15c274ac2614" label="mixed materials [A0000000075871]" type="box">29</container><container id="d519c267c49815c35fe4b8c3b4a9e3f8" parent="d6e7cc8b4216b15bafde15c274ac2614" type="folder">6-7</container></did><accessrestrict id="cf7ce77fd85e6bc2a2e126d922cb2364"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="ece2250f2916521ae284b1830da4848e" level="file"><did><unittitle>TML, 40-114 - Three new drugs for HIV infection</unittitle><unitdate type="inclusive">1998 December 4</unitdate><container altrender="Record Storage Box (Paige)" id="645a2bafdd57d8363b6d560c28d9d9e9" label="mixed materials [A0000000075871]" type="box">29</container><container id="40ac0a8a9df91276733577720945ead8" parent="645a2bafdd57d8363b6d560c28d9d9e9" type="folder">8-11</container></did><accessrestrict id="4e7f5d2236f53f8ccc2b28a5bf8873c1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7dd5458e0da29270a7d0b887632c23ac" level="file"><did><unittitle>TML, Sexually Trasmitted Diseases - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="dd7ffb89f4823aafc37dd64799191a58" label="mixed materials [A0000000075871]" type="box">29</container><container id="1e0b17465cec6967606a2bdf56e8a993" parent="dd7ffb89f4823aafc37dd64799191a58" type="folder">12-14</container></did><accessrestrict id="0b261ea329af56d20325ac31bcf03cbe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6e5b03bb37f1b1e46c63603fddb7f5a0" level="file"><did><unittitle>TML, 40-53 - Dolasetron</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="e0c7ee6e5a525ebad34cea70957ee60e" label="mixed materials [A0000000075871]" type="box">29</container><container id="ff51f8927ff547715095cf3bafbf5fef" parent="e0c7ee6e5a525ebad34cea70957ee60e" type="folder">15-18</container></did><accessrestrict id="2f191b313a6f595b28c9d77fec25b021"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b33fb65d9a2e71bddfa4f269d47aeef6" level="file"><did><unittitle>TML, 40-18 - Irbesartan for hypertension</unittitle><unitdate type="inclusive">1998 January 30</unitdate><container altrender="Record Storage Box (Paige)" id="56b18acf60c454d132dd9f7186b4bde9" label="mixed materials [A0000000075872]" type="box">30</container><container id="80880280975afa7f951bab941195c50a" parent="56b18acf60c454d132dd9f7186b4bde9" type="folder">1-4</container></did><accessrestrict id="5fe32f0354336c745f49eaad8ec99c60"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6332598d843148b2b6fcca7483c23ff2" level="file"><did><unittitle>TML, 40-33 - The Choice of Antibacterial Drugs</unittitle><unitdate type="inclusive">1998 March 27</unitdate><container altrender="Record Storage Box (Paige)" id="ef3430bd71740a0052714bc564dabb80" label="mixed materials [A0000000075872]" type="box">30</container><container id="e574f67cc84a292e0ffdb49050919462" parent="ef3430bd71740a0052714bc564dabb80" type="folder">5-8</container></did><accessrestrict id="4de55d18dd59d1c77f9f4fdd38e7a4d2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6062e376e8011b03bf27092730e8219d" level="file"><did><unittitle>TML, 40-93 - New monoclonal antibodies to prevent transplant rejection</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="ac2811c18372b3795bffa2a2b3a7b89b" label="mixed materials [A0000000075872]" type="box">30</container><container id="877c96e7a961bba8030172863d46a294" parent="ac2811c18372b3795bffa2a2b3a7b89b" type="folder">9-12</container></did><accessrestrict id="a10e4c82bc99d39cee6a7ddd1ca31b10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="de828b3fc932777396bebd27f5fab7dd" level="file"><did><unittitle>TML, 40-117 - Choice of lipid-lowering drugs</unittitle><unitdate type="inclusive">1998 December 18</unitdate><container altrender="Record Storage Box (Paige)" id="642541ba49e766c3fb70cf018c995fad" label="mixed materials [A0000000075872]" type="box">30</container><container id="a1b84a0ce31463356b40428527811f6d" parent="642541ba49e766c3fb70cf018c995fad" type="folder">13-16</container></did><accessrestrict id="ec87238d62e4af8195602bcb6756e8f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="0bba41a40cc25a8da0e7a635fb7e3df8" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="1adedaf1b4e0cb6bfa112e1b90671a64" label="mixed materials [A0000000075872]" type="box">30</container><container id="77448e6d4e8534cf2e4ec973b2606e45" parent="1adedaf1b4e0cb6bfa112e1b90671a64" type="folder">17-19</container></did><accessrestrict id="e69b8784cca126a51aa694fe76fa93ef"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="13029629c9a2c8c4645ba910bddc0ec5" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="36cfca08d13218e941d2e1c055bd68e1" label="mixed materials [A0000000075873]" type="box">31</container><container id="3d742841acc6f17ef2e36ed1e0a79819" parent="36cfca08d13218e941d2e1c055bd68e1" type="folder">1-3</container></did><accessrestrict id="efd535a28d84b26cb3f39bdbca07f951"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c768307fb6b27100b14034cebd5227a9" level="file"><did><unittitle>TML, 40-43 - Toremifene and Letrozole for advance breast cancer</unittitle><unitdate type="inclusive">1998 April 10</unitdate><container altrender="Record Storage Box (Paige)" id="0b6e12b081b643198ce4799ccfcf55e1" label="mixed materials [A0000000075873]" type="box">31</container><container id="d1f32cda1dc3dbf10b6b5529eee074a5" parent="0b6e12b081b643198ce4799ccfcf55e1" type="folder">4-8</container></did><accessrestrict id="4fead382cbe8272480e24c54bdac4aa5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="edbc39d29ce93f5d2d89c1070b90a888" level="file"><did><unittitle>TML, 40-95 - Brinzolamide for glaucoma</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="460baa60cedde26651a736b0cc024435" label="mixed materials [A0000000075873]" type="box">31</container><container id="603756f58e89bc3fa735dc7c4c482f13" parent="460baa60cedde26651a736b0cc024435" type="folder">9-10</container></did><accessrestrict id="4761d1070aff6ae3d4f74655713baaa7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6d7c66707bdf53045a7ff953d6e108d3" level="file"><did><unittitle>TML, 40-45 - Tigabine for epilepsy</unittitle><unitdate type="inclusive">1998 April 10</unitdate><container altrender="Record Storage Box (Paige)" id="fc3e641f64d74cd13efb0e9a7ad7d164" label="mixed materials [A0000000075873]" type="box">31</container><container id="a79e365d9ad2da5021132b7182e1159f" parent="fc3e641f64d74cd13efb0e9a7ad7d164" type="folder">11-13</container></did><accessrestrict id="94fdedf900cf20f12d378b25deedc2ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a07a54028f90ac0076d2802b57942911" level="file"><did><unittitle>TML, 40-64 - A new rabies vaccine</unittitle><unitdate type="inclusive">1998 June 14</unitdate><container altrender="Record Storage Box (Paige)" id="b5c777f45fd55e232361c991c73c3fd6" label="mixed materials [A0000000075873]" type="box">31</container><container id="c07736bb4a169ffd2da38f8fed528eed" parent="b5c777f45fd55e232361c991c73c3fd6" type="folder">14-15</container></did><accessrestrict id="47ed997eea8759fcee2c1c993e8bbb47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3bd95f95656aa72b9a953a7b60fc1ff8" level="file"><did><unittitle>TML, 40-29 - Raloxifene for postmenopausal osteoporosis</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="c476b78d84f127d22229ad8bb4bb325f" label="mixed materials [A0000000075873]" type="box">31</container><container id="51e03d2961b828576c86847b414bf8cc" parent="c476b78d84f127d22229ad8bb4bb325f" type="folder">16-18</container></did><accessrestrict id="072da8fc19d0e0c642d2808e0b9452ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fa4c88d1fa307e4c1c36721c687359e5" level="file"><did><unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="85a8ed32568c0704c4a50b50a603e033" label="mixed materials [A0000000075873]" type="box">31</container><container id="a3278097b29d1b9510791c8632dae4c3" parent="85a8ed32568c0704c4a50b50a603e033" type="folder">19</container></did><accessrestrict id="4326873ad2b2259141a757cbab189cb2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b31307f7682d799e34699487a403a926" level="file"><did><unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="cc8e4585dcac43a47b5af046449c7730" label="mixed materials [A0000000075874]" type="box">32</container><container id="c16bd2d69c147647fab614dae4aa2ddd" parent="cc8e4585dcac43a47b5af046449c7730" type="folder">1-2</container></did><accessrestrict id="2802926a9875868eb77bbf4162293dea"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c0f605353f7f9186d9e181b0e5a7b35c" level="file"><did><unittitle>TML, 40-15 - Budesonide turbuhaler for asthma</unittitle><unitdate type="inclusive">1998 January 16</unitdate><container altrender="Record Storage Box (Paige)" id="7e9d90aa54c7fa8f4c57f509d8bb2574" label="mixed materials [A0000000075874]" type="box">32</container><container id="526d62a4a2ab81d25d184582e2110706" parent="7e9d90aa54c7fa8f4c57f509d8bb2574" type="folder">3-8</container></did><accessrestrict id="63c818b79b8463447ba0a35c3ed08e0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fc1c9413add7682bf34765d07e37871c" level="file"><did><unittitle>TML - Cholesterol-Lowering - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="b8dcb5fa821ba14dba6e804649f5b4ca" label="mixed materials [A0000000075874]" type="box">32</container><container id="08a79b9ced64891c0f32ca610beb2439" parent="b8dcb5fa821ba14dba6e804649f5b4ca" type="folder">9-10</container></did><accessrestrict id="263b366a38ae16d96e1447c8e1c8953b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="9212aaed4209e15330e340d1c8675d23" level="file"><did><unittitle>TML - Parasitic Infections - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="cd3e29ff97fdf940ebca6f3f66673115" label="mixed materials [A0000000075874]" type="box">32</container><container id="e4711ac448f45be7768ea0cd6bde11cf" parent="cd3e29ff97fdf940ebca6f3f66673115" type="folder">11-14</container></did><accessrestrict id="5db4f9b0242f10ed336d20896e08899c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="367ee47d6747fc683d4571ad991fcb28" level="file"><did><unittitle>TML - Malaria - Drugs for parastic infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="a664e38d8cf990aa4199dc65bd9e8545" label="mixed materials [A0000000075874]" type="box">32</container><container id="84bb5c9981b6e45141f94be164f562b9" parent="a664e38d8cf990aa4199dc65bd9e8545" type="folder">15-16</container></did><accessrestrict id="e3f66807c02c01517706efbf9eeaff5f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="d64c5c233f60d11993a1dd5cef9c5ec4" level="file"><did><unittitle>TML - Antimicrobial drugs - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="2474935f2c8f7249fd3c07a400bb309d" label="mixed materials [A0000000075874]" type="box">32</container><container id="16ee736ad16aec587ea0960fe19284db" parent="2474935f2c8f7249fd3c07a400bb309d" type="folder">17</container></did><accessrestrict id="f6a6fff3786ff1d521cdf342567849ee"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3d41d005cf4c13e14913cd67a32a5047" level="file"><did><unittitle>TML - Antimicrobial drugs - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="d6351eb8b496bda51cc91ebe56c3ef32" label="mixed materials [A0000000075875]" type="box">33</container><container id="39ea18ce1e907620fccefff8432d5142" parent="d6351eb8b496bda51cc91ebe56c3ef32" type="folder">1-2</container></did><accessrestrict id="8075ff059f0d4d931fa3535cefb097fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a70dd9355ee98a30aebc26b8daacffc8" level="file"><did><unittitle>TML - Psychiatric Symptoms - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="accc70376bcbf1505e77fa0fa2559efc" label="mixed materials [A0000000075875]" type="box">33</container><container id="134262f6ec52d84359b5fa9141eb9c61" parent="accc70376bcbf1505e77fa0fa2559efc" type="folder">3</container></did><accessrestrict id="9dfab18fed33b99b2f9c6ca42c51a487"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="878b0cb8e4fc058b68a1ed9db09469eb" level="file"><did><unittitle>TML, 40-109 - Candesartan</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="f2a9f22ff9af391688e26a23e5ce4073" label="mixed materials [A0000000075875]" type="box">33</container><container id="667d9d305bd2a636b8ec39162609b39f" parent="f2a9f22ff9af391688e26a23e5ce4073" type="folder">4-6</container></did><accessrestrict id="ba7cc6a8281cf2cb771c412c8f89cd3f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e61911867cf616602aa72255f38dc9ba" level="file"><did><unittitle>TML, 40-77 - Interleukin-11</unittitle><unitdate type="inclusive">1998 July 31</unitdate><container altrender="Record Storage Box (Paige)" id="068c2bca333fa14ce955441fe2a80bfe" label="mixed materials [A0000000075875]" type="box">33</container><container id="0984de4caabe8b1e831b57b16e077f93" parent="068c2bca333fa14ce955441fe2a80bfe" type="folder">7-9</container></did><accessrestrict id="4f66d0ee0cc0c75d98d5ce57dfee6a86"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="4f7233bf7c77fcfc22d806ea70169968" level="file"><did><unittitle>TML, 40-85 - Cefdinir</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="54983ae7c66cadcc354713ee1fea7e75" label="mixed materials [A0000000075875]" type="box">33</container><container id="a21731c78bd149d5f9aa4592c48103e8" parent="54983ae7c66cadcc354713ee1fea7e75" type="folder">10-12</container></did><accessrestrict id="028c35e32d1addf3672d48cb03ad70d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="910ff3d576f61dcba1783abe6210dff1" level="file"><did><unittitle>TML, 40-79 - Drugs for pain</unittitle><unitdate type="inclusive">1998 August 14</unitdate><container altrender="Record Storage Box (Paige)" id="15ee2ee9da481678dab2f5240f777713" label="mixed materials [A0000000075875]" type="box">33</container><container id="2e1d5ceac9698dfefb1279b2c5e86d97" parent="15ee2ee9da481678dab2f5240f777713" type="folder">13-17</container></did><accessrestrict id="72993e3876c2683037ab6df23f908193"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="960c1722fd9da508635b32ac38c60f80" level="file"><did><unittitle>TML, 40-87 - Risedronate</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="7633bee930dae823b4f2bec3e2f7a5fc" label="mixed materials [A0000000075875]" type="box">33</container><container id="f4d9b18f6c050d778de004b1796f712d" parent="7633bee930dae823b4f2bec3e2f7a5fc" type="folder">18-19</container></did><accessrestrict id="c3d8c6875a01ba6968c3fea93fe65185"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8e8879c55ee8242081f7f64851b4db08" level="file"><did><unittitle>TML, 40-87 - Risedronate</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="68e75f4f775cad6db318ab03c5a366e3" label="mixed materials [A0000000075876]" type="box">34</container><container id="97b01b42f8f10181976de056ee7a94d5" parent="68e75f4f775cad6db318ab03c5a366e3" type="folder">1-2</container></did><accessrestrict id="54d5c0c828c3316a8382b3f15461804c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="5d664f33dcd2cabbe962a4227379c390" level="file"><did><unittitle>TML, 40-94 - Lepirudin for heparin-induced thrombocytopenia</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="ac91e04fd754edaddcdaba09c0cf456e" label="mixed materials [A0000000075876]" type="box">34</container><container id="c7369994a34ab2fb65e3a06e3aa8fc48" parent="ac91e04fd754edaddcdaba09c0cf456e" type="folder">3-4</container></did><accessrestrict id="df311ee9e0d78fb33b148774389da7c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3d76a36572332e4c480702f762cc9918" level="file"><did><unittitle>TML, 40-25 - Propecia and Rogaine Extra Stength for Alopecia</unittitle><unitdate type="inclusive">1998 February 27</unitdate><container altrender="Record Storage Box (Paige)" id="603adf161bd751cbd09fa28f9d0b811d" label="mixed materials [A0000000075876]" type="box">34</container><container id="6465aebcfbcc00c9908ffcd854b5d8de" parent="603adf161bd751cbd09fa28f9d0b811d" type="folder">5-8</container></did><accessrestrict id="c3ab3185c9cf9153482322e821491aa5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="affe7599f3c787d823e95823bfc0cbfc" level="file"><did><unittitle>TML, 40-106 - Capecitabine for metastatic breast cancer</unittitle><unitdate type="inclusive">1998 November</unitdate><container altrender="Record Storage Box (Paige)" id="4549d846c864406e65fada52e277312a" label="mixed materials [A0000000075876]" type="box">34</container><container id="e48bc81a0ee55139103792cb96bf2f23" parent="4549d846c864406e65fada52e277312a" type="folder">9-10</container></did><accessrestrict id="544789c77c743995f3e1041b8e18aab6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="2e2e66929019d8531954a7ad095700fb" level="file"><did><unittitle>TML, 40-13 - Cerivastatin for hypercholesterolemia</unittitle><unitdate type="inclusive">1998 January 16</unitdate><container altrender="Record Storage Box (Paige)" id="62e3cd56ce2b59152c4e2877adbd8326" label="mixed materials [A0000000075876]" type="box">34</container><container id="7ba64b800c06a5c2a30c8c0f544a03df" parent="62e3cd56ce2b59152c4e2877adbd8326" type="folder">11-13</container></did><accessrestrict id="c00a8622a08054369fa43b3f435559cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="4043d39a1cb0cf7a9edea397c7574337" level="file"><did><unittitle>TML, 40-101 - Tolterodine for overactive bladder</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="0c09c6251f6bde4450d2162472b65645" label="mixed materials [A0000000075876]" type="box">34</container><container id="434a4a0407975813baf643dbc8974307" parent="0c09c6251f6bde4450d2162472b65645" type="folder">14-16</container></did><accessrestrict id="5ed653620eb193653bb7be17c3823301"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e5341af61e6a0539c242e29242b615c6" level="file"><did><unittitle>TML, 40-102 - An Emergency Contraceptive Kit</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="6c64a65f420a6d85c5cae4bcd2136e17" label="mixed materials [A0000000075876]" type="box">34</container><container id="3eb72768731c04d719197905f78f7dbb" parent="6c64a65f420a6d85c5cae4bcd2136e17" type="folder">17-18</container></did><accessrestrict id="5f3dbedbdfcd288cd297f8d578fd4ced"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3f39fb343e118836671bfce7c8c9e0be" level="file"><did><unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="b499388c478c470e2eb33e1d9bb13435" label="mixed materials [A0000000075876]" type="box">34</container><container id="fe68b72b06ff4acf81e6d1b042e7ec7d" parent="b499388c478c470e2eb33e1d9bb13435" type="folder">19</container></did><accessrestrict id="a3bdebd3c863cd5e8915acd5b9e97a95"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e43a7710b28863a0de4803cfd4c0b542" level="file"><did><unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="4f9b63f3b66d6c13a8282fcb8eaa3c06" label="mixed materials [A0000000075877]" type="box">35</container><container id="0b5c4a9d8957769182bba87d6e23d9ee" parent="4f9b63f3b66d6c13a8282fcb8eaa3c06" type="folder">1-2</container></did><accessrestrict id="4b8fa308ff1db3b9b6869466f7f0fe98"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f487b7ea1e7909af55b4d7eeee8db68c" level="file"><did><unittitle>TML, 40-103 - Thalidomide</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="57c31931f81320f3b146b4372a19c6b0" label="mixed materials [A0000000075877]" type="box">35</container><container id="48c13e0e4607c59c94a898bcad954b4f" parent="57c31931f81320f3b146b4372a19c6b0" type="folder">3-6</container></did><accessrestrict id="afd021cfb4388a63de5e218998fd47c7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="31cfa0b79a02b7866aa0dc7e48743280" level="file"><did><unittitle>TML, 40-97 - New Triptans and other drugs for migraine</unittitle><unitdate type="inclusive">1998 October 9</unitdate><container altrender="Record Storage Box (Paige)" id="0a2b45621f52b1fa6965b11fc6ac5c61" label="mixed materials [A0000000075877]" type="box">35</container><container id="3d75ea2f825b33027642a4486f150f6e" parent="0a2b45621f52b1fa6965b11fc6ac5c61" type="folder">7-12</container></did><accessrestrict id="43083e8c7ccdb0aa74b842657cd508ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f35138cee47bea646beb32b2995d4598" level="file"><did><unittitle>TML, 40-91 - Influenza vaccine, 1998-1999</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="71d70f94c1a146c3faa3b749a17f610c" label="mixed materials [A0000000075877]" type="box">35</container><container id="aa458ab5f591c0e7fdeef5a34d01d0a4" parent="71d70f94c1a146c3faa3b749a17f610c" type="folder">13</container></did><accessrestrict id="a29dd57181aa1c5e6c3a1e5d3b488af7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7c2b7e050833f74d66d0b600d186eae5" level="file"><did><unittitle>TML, 40-105 - Creatine and Androstenedione - two "dietary supplements"</unittitle><unitdate type="inclusive">1998 November 6</unitdate><container altrender="Record Storage Box (Paige)" id="091d4a423e35d114803ab0f704dbb587" label="mixed materials [A0000000075877]" type="box">35</container><container id="85ae218b9293b44065cbe856012bf372" parent="091d4a423e35d114803ab0f704dbb587" type="folder">14-16</container></did><accessrestrict id="bcbeeba99d41f442379b4633e1dc7778"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a4342729d9ef2567742167972402009f" level="file"><did><unittitle>TML, 39-107 - St. John's Wort</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="83dbcebdaad276b6211500254d8f8ef3" label="mixed materials [A0000000075877]" type="box">35</container><container id="214ac23b7f4328cfe3bf3fb66bd70c6b" parent="83dbcebdaad276b6211500254d8f8ef3" type="folder">17-18</container></did><accessrestrict id="f27838dbfd9cecfa9e71bf77f07fe682"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="ddfb397d4b944785854d8ea719c202bd" level="file"><did><unittitle>TML, 41-73 - Malathion for treatment of head lice</unittitle><unitdate type="inclusive">1999 August 13</unitdate><container altrender="Record Storage Box (Paige)" id="e729f18280e963aafadd504c3b1af095" label="mixed materials [A0000000075878]" type="box">36</container><container id="d84c99df829abd24dffe52a1da47ee46" parent="e729f18280e963aafadd504c3b1af095" type="folder">1-2</container></did><accessrestrict id="854b0f58396665c4e2d4a0465f949fd7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="35b97709b422b46ecdc94c987c5952ec" level="file"><did><unittitle>TML, 41-39 - Advice for travelers</unittitle><unitdate type="inclusive">1999 April 23</unitdate><container altrender="Record Storage Box (Paige)" id="77cf8113b77131655112c13a1f00307b" label="mixed materials [A0000000075878]" type="box">36</container><container id="6275e58056bc7e39f994aae669830b2c" parent="77cf8113b77131655112c13a1f00307b" type="folder">3-4</container></did><accessrestrict id="04ad6f830bf72709637049c7b301499d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="f916a9e5c338ff7fc1707311815267f1" level="file"><did><unittitle>TML, 41-30 - Modafinil for narcolepsy</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="6da5704be6d826ae99fff475f67db7d4" label="mixed materials [A0000000075878]" type="box">36</container><container id="0f0c88a7efec5db86dc860084108964c" parent="6da5704be6d826ae99fff475f67db7d4" type="folder">5-7</container></did><accessrestrict id="113f676d893d247079b5e4ff614aec1e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="2fc16ae414cf9dd501de68ee706014d5" level="file"><did><unittitle>TML, 41-51 - Levalbuterol for asthma</unittitle><unitdate type="inclusive">1999 June 4</unitdate><container altrender="Record Storage Box (Paige)" id="daf8155394ea91a280f5f9d3208081b3" label="mixed materials [A0000000075878]" type="box">36</container><container id="8ebe77a7f62f6a8be07d890f921478cb" parent="daf8155394ea91a280f5f9d3208081b3" type="folder">8-10</container></did><accessrestrict id="17d7935132e18e8bac890aeefcb5960f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="3922b9c381c0b19cb3d63cbe803305a6" level="file"><did><unittitle>TML, 41-16 - Mometasone furoate nasal spray for allergic rhinitis</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="1acb170292a6245a780641cca4e3e98f" label="mixed materials [A0000000075878]" type="box">36</container><container id="8a54f11498f73db78fa6e6c74d4904f1" parent="1acb170292a6245a780641cca4e3e98f" type="folder">11-12</container></did><accessrestrict id="481e161096febedcc11b1ed837e0109b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="4d4ebb415f82a62d6c6b5091a9afeb7a" level="file"><did><unittitle>TML, 41-50 - Vaccine for rotavirus</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="6a26ad1468e6633e78724992139c9b1f" label="mixed materials [A0000000075878]" type="box">36</container><container id="b6ac4dfacd7f9a6034cc9218bfba70c6" parent="6a26ad1468e6633e78724992139c9b1f" type="folder">13-14</container></did><accessrestrict id="b72eb586cf031b15f2ce8b6037f013b2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="65d972dc57e884b250ec76744f2d84f9" level="file"><did><unittitle>TML, 41-91 - Two neuraminidase inhibitors for treatment of influenza</unittitle><unitdate type="inclusive">1999 October 8</unitdate><container altrender="Record Storage Box (Paige)" id="0c253bd987815846ba491d4119778175" label="mixed materials [A0000000075878]" type="box">36</container><container id="3169dfcfd0b93895d3588549fe631c17" parent="0c253bd987815846ba491d4119778175" type="folder">15-17</container></did><accessrestrict id="6e3fe48fdf68db20082fc8bad62e904f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="26fd68ebafc0d8085fe92d2eb77fcbf6" level="file"><did><unittitle>TML, 41-93 - Zaleplon for insomnia</unittitle><unitdate type="inclusive">1999 October 8</unitdate><container altrender="Record Storage Box (Paige)" id="ad28cdc2915aeb73cc855b469a60e579" label="mixed materials [A0000000075879]" type="box">37</container><container id="4cb4457a6e4448f4b934195ee74d511a" parent="ad28cdc2915aeb73cc855b469a60e579" type="folder">1-4</container></did><accessrestrict id="b25acf713bbbe8621cf294856e16ba28"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ec877eb8397cacf7d82d77f65b127412" level="file"><did><unittitle>TML, 41-1 - Tamoxife for the prevention of breast cancer</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="e739b495e0078f03d5c20c255ce54ae4" label="mixed materials [A0000000075879]" type="box">37</container><container id="4c2dcbc73a624d23756750ee90008714" parent="e739b495e0078f03d5c20c255ce54ae4" type="folder">5-6</container></did><accessrestrict id="5090105f2f60079c4d3f971adf860516"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="94ff8cec3e58b5c4d7bd8582a705f051" level="file"><did><unittitle>TML, 41-123 - Temozolomide</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="af3080f4160f88107b91eaea76367e71" label="mixed materials [A0000000075879]" type="box">37</container><container id="e5f07bdb5f4dbafded581c2debd41ce0" parent="af3080f4160f88107b91eaea76367e71" type="folder">7-8</container></did><accessrestrict id="7a64776358d5df180bb0a5ddbff0bef7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a4b43b9f4b92e02c161ee56d03e178c9" level="file"><did><unittitle>TML, 41-53 - Interferon plus ribavirin for chronic hepatitis C</unittitle><unitdate type="inclusive">1999 June 4</unitdate><container altrender="Record Storage Box (Paige)" id="12f434d0d05af4f4203144b6579288ba" label="mixed materials [A0000000075879]" type="box">37</container><container id="a8c5775829e0473ca5b9fb7dd92982fc" parent="12f434d0d05af4f4203144b6579288ba" type="folder">9-11</container></did><accessrestrict id="af177345fcae67c9d255185c0a10e870"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="024012e8b7f7de531d716961ead029ce" level="file"><did><unittitle>TML, 41-49 - Miglitol for Type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="48b1ea853227111fc76077fc596f4143" label="mixed materials [A0000000075879]" type="box">37</container><container id="9edd61ce63b074388db7800b767b3363" parent="48b1ea853227111fc76077fc596f4143" type="folder">12-13</container></did><accessrestrict id="d6f81a58c2dc3eaf1f79b5dc23f9a66b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a9621527ed50246d7a862b61f10afb79" level="file"><did><unittitle>TML, 41-110 - Rabeprazole</unittitle><unitdate type="inclusive">1999 November 9</unitdate><container altrender="Record Storage Box (Paige)" id="6863d03a7b3a407b20e84acbfe80d978" label="mixed materials [A0000000075879]" type="box">37</container><container id="1d4dc32cf221a256cc02d8297c6577a1" parent="6863d03a7b3a407b20e84acbfe80d978" type="folder">14-15</container></did><accessrestrict id="fa2239be1fca64f3de4ed0688d43b5a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="fcec222c26512f8ebe8b672bf459fbe9" level="file"><did><unittitle>TML, 41-21 - Rifapentine for tuberculosis</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="6a292fa848e5937f7b7a04a85d8927e6" label="mixed materials [A0000000075879]" type="box">37</container><container id="8c404bbaf5d76f23ff3bf036246d6eca" parent="6a292fa848e5937f7b7a04a85d8927e6" type="folder">16-17</container></did><accessrestrict id="5eabb94693fe31a0f053df4c9645327d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="c2530250616ca691ba7d71e8d92ca5e1" level="file"><did><unittitle>TML, 41-109 - Quinupristin (Dalfopristin)</unittitle><unitdate type="inclusive">1999 November 19</unitdate><container altrender="Record Storage Box (Paige)" id="f0108214cc8511057693984effc228c7" label="mixed materials [A0000000075879]" type="box">37</container><container id="302c90103983050ad027b1d033ea8fa7" parent="f0108214cc8511057693984effc228c7" type="folder">18-19</container></did><accessrestrict id="96db099c24d150d666b7ebe07b50d611"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e80acff708763c79ba27fdf7b90311e5" level="file"><did><unittitle>TML, 41-71 - Rosiglitazone for Type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1999 August 13</unitdate><container altrender="Record Storage Box (Paige)" id="9832cb792262c14ad929acbf3dd228fc" label="mixed materials [A0000000075880]" type="box">38</container><container id="c70647ccf5e26079abe99d1cd73ebd96" parent="9832cb792262c14ad929acbf3dd228fc" type="folder">1-3</container></did><accessrestrict id="165ec4ab5ea0c075fdbea5fe2e192f3d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="703b499487840917db1eeb7a3bbf97c3" level="file"><did><unittitle>TML - Drugs of Choice - Rheumatoid Arthritis</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="b0515f4e1ee19cc8ed546fdadb6af6f0" label="mixed materials [A0000000075880]" type="box">38</container><container id="1f60fd4f59fcd0c7c727a255c5d056b4" parent="b0515f4e1ee19cc8ed546fdadb6af6f0" type="folder">4-7</container></did><accessrestrict id="15f525d3017c59fe2b80a8ae96ac839d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="d1121bbf04acf6873bc6f6be66e80e1c" level="file"><did><unittitle>TML, 41-59 - Rofecoxib for osteoarthritis and pain</unittitle><unitdate type="inclusive">1999 July 2</unitdate><container altrender="Record Storage Box (Paige)" id="69b49b17433bd7162b60a5b2f1e5e6da" label="mixed materials [A0000000075880]" type="box">38</container><container id="65f687840b18724e3750ec6de6be1ee6" parent="69b49b17433bd7162b60a5b2f1e5e6da" type="folder">8-10</container></did><accessrestrict id="11221f9e1bc9230aebbe4b8afe4c8c85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="755deaec93a3a8f46413cdb9d38a9847" level="file"><did><unittitle>TML, 41-84 - Pneumococcal vaccine</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="8aac9124d0ce1e7cac8c7d17d24940d3" label="mixed materials [A0000000075880]" type="box">38</container><container id="aed1f73d2dec47a8ce61adbee5c35d66" parent="8aac9124d0ce1e7cac8c7d17d24940d3" type="folder">11-13</container></did><accessrestrict id="ad40d9598ad03e97e0de7ff5b12324c2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0ee2e8ec8ef4a025a102da4125d330c6" level="file"><did><unittitle>TML, 41-20 - Homeopathic products</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="05ad18591ba1b1d13e7ed0edf2eec91a" label="mixed materials [A0000000075880]" type="box">38</container><container id="773edd914b093c64abdc9a2f6aacb790" parent="05ad18591ba1b1d13e7ed0edf2eec91a" type="folder">14-16</container></did><accessrestrict id="1d27c989e3d0f4c9ca2d59fcac0ed578"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0f8ace5b9ab967ce17459254fb17ca75" level="file"><did><unittitle>TML, 41-55 - Orlistat for obesity</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="be5f7433d11048f9d3f9648203125e1d" label="mixed materials [A0000000075880]" type="box">38</container><container id="02ef0373190c598997245ca3e27cd0d1" parent="be5f7433d11048f9d3f9648203125e1d" type="folder">17</container></did><accessrestrict id="3afad4f5d733d9716d22ba16c44983fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="b2928e0b146edbf6a03684604b2f6230" level="file"><did><unittitle>TML, 41-69 - Prosorba column for rheumatoid arthritis</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="354af9de954be6e14d27447bb88ebf31" label="mixed materials [A0000000075880]" type="box">38</container><container id="9f2bcdff0d170530b9f64149c57b9d78" parent="354af9de954be6e14d27447bb88ebf31" type="folder">18</container></did><accessrestrict id="f89d8a299f3aa1cb78fdeda3584f26e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e394fdb910a180949b33fcfe30e8b17c" level="file"><did><unittitle>TML, 41-23 - Drugs for hypertension</unittitle><unitdate type="inclusive">1999 March 12</unitdate><container altrender="Record Storage Box (Paige)" id="72df7715304a9b3f80553f70d3c94028" label="mixed materials [A0000000075881]" type="box">39</container><container id="9e5d3a70bac6e83be4c93dcd78b4e56f" parent="72df7715304a9b3f80553f70d3c94028" type="folder">1-6</container></did><accessrestrict id="a85ce10fe729a0b9b0f29f163788bcd8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="1a3e95e6f5eb2cbf5b0cdb530d4df8b2" level="file"><did><unittitle>TML, 41-113 - Drugs for non-HIV viral infection</unittitle><unitdate type="inclusive">1999 December 3</unitdate><container altrender="Record Storage Box (Paige)" id="33622d6a3e02f542e10fa8071e2d0461" label="mixed materials [A0000000075881]" type="box">39</container><container id="926ab137e04532a37c6323838c9d3a23" parent="33622d6a3e02f542e10fa8071e2d0461" type="folder">7-10</container></did><accessrestrict id="ddc058cf574899e5d0347e37efa9598e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e42d2f63edb58feb20931053061b1339" level="file"><did><unittitle>TML, 41-112 - Pioglitazone (Actos)</unittitle><unitdate type="inclusive">1999 November 19</unitdate><container altrender="Record Storage Box (Paige)" id="eb50fc46ea851385d87904b9f48a6709" label="mixed materials [A0000000075881]" type="box">39</container><container id="4632cc2f8bfff95b8891b2a6fdee75ed" parent="eb50fc46ea851385d87904b9f48a6709" type="folder">11</container></did><accessrestrict id="2bf75590065032d73df0e0fa13732a7d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="28427104a307e9895b1500110c4ba78c" level="file"><did><unittitle>TML, 41-43 - Suncreens - Are they safe and effective</unittitle><unitdate type="inclusive">1999 May 7</unitdate><container altrender="Record Storage Box (Paige)" id="505542a5193ae71f0710f7175b786360" label="mixed materials [A0000000075881]" type="box">39</container><container id="0f3c395365f99e0efee1e84c52bdfe5b" parent="505542a5193ae71f0710f7175b786360" type="folder">12-16</container></did><accessrestrict id="d50144a362c7ab5f8c046503c10ecf2a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a4c7b991a97b85bed8305af27776e491" level="file"><did><unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="3635424f883a580bb16106a8df5fd73c" label="mixed materials [A0000000075881]" type="box">39</container><container id="6dd06a64cafd82ff49941ea9942b60ee" parent="3635424f883a580bb16106a8df5fd73c" type="folder">17-18</container></did><accessrestrict id="9b77ea87c2f2795c19e71f426864b471"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="efd202ef6564adfebc4106108c9561f2" level="file"><did><unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="99230f325bb71e07d7c556690a5214e1" label="mixed materials [A0000000075882]" type="box">40</container><container id="88dfed11687f35abcc5f4678d6f33b2b" parent="99230f325bb71e07d7c556690a5214e1" type="folder">1-2</container></did><accessrestrict id="6304e26af10a0e94e7ef043fee53ad70"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="5422bbde47d91ace2df22b5b7527a0e6" level="file"><did><unittitle>TML, 41-105 - A new ACE inhibitorand two new angiotensin receptor blockers for hypertension</unittitle><unitdate type="inclusive">1999 November 5</unitdate><container altrender="Record Storage Box (Paige)" id="4b2b3f0bcf0aee0a0c082927466be05c" label="mixed materials [A0000000075882]" type="box">40</container><container id="47111d1d74e04c495ff92c15859e6c69" parent="4b2b3f0bcf0aee0a0c082927466be05c" type="folder">3-6</container></did><accessrestrict id="e16a540da639162df21cb6fa8cf623e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="087aeda452bdc8c1f70b599b752d152a" level="file"><did><unittitle>TML, 41-67 - A new conjugated estrogen</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="937107205148eb61f0e5f18b7085094a" label="mixed materials [A0000000075882]" type="box">40</container><container id="a8caab1fc9a403fe7a0ea5f127dc86b8" parent="937107205148eb61f0e5f18b7085094a" type="folder">7-8</container></did><accessrestrict id="3dd21eec3f06c65a80aa71eae6b88575"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e1ba3784eccce1db97752b63119a9737" level="file"><did><unittitle>TML, 41-15 - Drugs and vaccines against biological warfare</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="124f8cfe8318a5aa491f5079a14b1097" label="mixed materials [A0000000075882]" type="box">40</container><container id="8144c646129c740d8edd921cf251d276" parent="124f8cfe8318a5aa491f5079a14b1097" type="folder">9</container></did><accessrestrict id="a078c6c919634b8920e26478d73bef6a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ee9f72d21997962aa5e1d76e60f28954" level="file"><did><unittitle>TML, 41-68 - Laser hair removal</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="86fc34f18205735c3fa58c12242b480a" label="mixed materials [A0000000075882]" type="box">40</container><container id="3a9e48aa454c4f332aff2049719819bc" parent="86fc34f18205735c3fa58c12242b480a" type="folder">10-11</container></did><accessrestrict id="0797b526bde059f59517ea165bdcb518"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0f4d6a53975d9232738144f364667da0" level="file"><did><unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="e1b880d6355c8a88bc95efc4c286c194" label="mixed materials [A0000000075882]" type="box">40</container><container id="e1f28154827ce64c8e224508175002a3" parent="e1b880d6355c8a88bc95efc4c286c194" type="folder">12-16</container></did><accessrestrict id="ca7184a59b6ddfe5ef00a19434c19c48"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="5db523527161519d86f176dd07137b4b" level="file"><did><unittitle>TML, 41-5 - Drugs for Asthma</unittitle><unitdate type="inclusive">1999 January 15</unitdate><container altrender="Record Storage Box (Paige)" id="68fe88aba9fde5e8bd3c07d864f80062" label="mixed materials [A0000000075883]" type="box">41</container><container id="7f8c6605a546ca61c1886ee049ccd56b" parent="68fe88aba9fde5e8bd3c07d864f80062" type="folder">1-5</container></did><accessrestrict id="24b467056399b27bd316ca395f5c8a5e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="3c1f55d592280bce047dbd773f816697" level="file"><did><unittitle>TML, 41-12 - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">1999 January 29</unitdate><container altrender="Record Storage Box (Paige)" id="033393b994497ee01dcf066f4df98c8d" label="mixed materials [A0000000075883]" type="box">41</container><container id="6d8d093bd018bf87d64fc2460e74fa97" parent="033393b994497ee01dcf066f4df98c8d" type="folder">6-8</container></did><accessrestrict id="a82b9541fad7707df8ff8e0ecec045a1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a5ef95fdd53a4ad00be13d575b720a90" level="file"><did><unittitle>TML, 41-32 - Valrubicin for bladder cancer</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="c88c3907d341984b3db8631a0bffdb69" label="mixed materials [A0000000075883]" type="box">41</container><container id="d43c8a1cc91a5200d37a8087617b2275" parent="c88c3907d341984b3db8631a0bffdb69" type="folder">9</container></did><accessrestrict id="1246d47b99a5b28275ca7ac909e04e17"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="c9b5394af1307b91512bebaa47987a03" level="file"><did><unittitle>TML, 41-19 - Infliximab (Remicade) for Crohn's disease</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="042e62490a331f39647cd3232a70d8b3" label="mixed materials [A0000000075883]" type="box">41</container><container id="500f8270767110692d0ba2f1c860e018" parent="042e62490a331f39647cd3232a70d8b3" type="folder">10-11</container></did><accessrestrict id="bceed6a85bb227d8a5c9b54693104fa7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="9431f5004a39b8a0d9a05be98633933b" level="file"><did><unittitle>TML, 41-82 - Influenza vaccine, 1999-2000</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="ba79f6902969d52883a3318c0c3701d2" label="mixed materials [A0000000075883]" type="box">41</container><container id="3e0cfd0d7dd8591f8508df7e0eb7e9e2" parent="ba79f6902969d52883a3318c0c3701d2" type="folder">12-13</container></did><accessrestrict id="cab250b6e8f335e1e9356ce49870aa0f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="aa75d744d2b7b8eae4e0c83305434171" level="file"><did><unittitle>TML, 41-81 - Spironolactone for heart failure</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="c9b2dc77613ad2c4e9e183a718922955" label="mixed materials [A0000000075883]" type="box">41</container><container id="009894b2fc03e2325d7169dcdb4c1bc5" parent="c9b2dc77613ad2c4e9e183a718922955" type="folder">14-15</container></did><accessrestrict id="4baffc7980c89aadb8cef585c345f731"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="12a411c26719cadf670414ea9db35b3a" level="file"><did><unittitle>TML, 41-2 - Growth-hormone-releasing factor for growth hormone deficiency</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="e7e069fa86b07e6b3c91f24abec4a2bf" label="mixed materials [A0000000075883]" type="box">41</container><container id="8ff0b50f354b439f1293338b58c61a24" parent="e7e069fa86b07e6b3c91f24abec4a2bf" type="folder">16-18</container></did><accessrestrict id="f46608e112550ebc9f422dd17a55e3b3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="50fdbec047db8cdec50f09ae8f09ce33" level="file"><did><unittitle>TML, 41-18 - Saw Palmetto for benign prostatic hyperplasia</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="c48e1833f72f6623dafc78ac81e60ee3" label="mixed materials [A0000000075884]" type="box">42</container><container id="7025fb45a7e2d0fd0f0bbf758639c4cd" parent="c48e1833f72f6623dafc78ac81e60ee3" type="folder">1-3</container></did><accessrestrict id="ebda9b553416d292abf3337874edf243"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="12974761e15d5b5a631f8a1708a1d0e6" level="file"><did><unittitle>TML, 41-107 - SAMe for depression</unittitle><unitdate type="inclusive">1999 November 5</unitdate><container altrender="Record Storage Box (Paige)" id="e0ae25a4c14adcf624303789cf046a28" label="mixed materials [A0000000075884]" type="box">42</container><container id="ed70fa6d03d18be33362b2a04b2c62ba" parent="e0ae25a4c14adcf624303789cf046a28" type="folder">4-7</container></did><accessrestrict id="9f6ccc892b5225ac4e542904aba616bf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="2891c6463578c91c35a01dfbc0867c34" level="file"><did><unittitle>TML, 41-3 - Palivizumab (Synagis) for prevention of RSV infection</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="33345ee6e8d117fda8f58d9f9e69f01f" label="mixed materials [A0000000075884]" type="box">42</container><container id="d7cbdef10d5653e32b61a0adb3cfa397" parent="33345ee6e8d117fda8f58d9f9e69f01f" type="folder">8-9</container></did><accessrestrict id="b084224a8b4665a510e8da9d5962cae8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="aa2d0e7ffb5da88f1ad0bda04c4f91da" level="file"><did><unittitle>TML, 41:47 - Generic Drugs</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="2d89d7716eba93d2f531e61648b8cc3c" label="mixed materials [A0000000075884]" type="box">42</container><container id="31a7530e98769b7fae1add25a5e2dbe9" parent="2d89d7716eba93d2f531e61648b8cc3c" type="folder">10-15</container></did><accessrestrict id="d25ac57dbed224f7c437f5c406d80bfb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="d463206ca7312a03520c55b4035d6d7c" level="file"><did><unittitle>TML, 41-64 - Amprenavir - a new HIV protease inhibitor</unittitle><unitdate type="inclusive">1999 July 16</unitdate><container altrender="Record Storage Box (Paige)" id="102096de2a278857dd1befb08d733b6e" label="mixed materials [A0000000075884]" type="box">42</container><container id="87998caa195ee233b62c17e1c72595d8" parent="102096de2a278857dd1befb08d733b6e" type="folder">16-17</container></did><accessrestrict id="bebb6703e7e1148e21f6bff4883b5f0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="dacba7e70abbc68ca64fcd4963a6f95a" level="file"><did><unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1999 August 27</unitdate><container altrender="Record Storage Box (Paige)" id="7581e193a9678d5c3d0d96cd633379a9" label="mixed materials [A0000000075884]" type="box">42</container><container id="f0209fea3c63e497502efa05016240b9" parent="7581e193a9678d5c3d0d96cd633379a9" type="folder">18</container></did><accessrestrict id="a555f10f258ebdc237376c5bf299600d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="813dc879c0e4261b5ae728f45f81e536" level="file"><did><unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1999 August 27</unitdate><container altrender="Record Storage Box (Paige)" id="4e5c45854f40be75db941f828e47961a" label="mixed materials [A0000000075885]" type="box">43</container><container id="d4259f43ab7c772111d9bd3e61cf4355" parent="4e5c45854f40be75db941f828e47961a" type="folder">1-3</container></did><accessrestrict id="64327b946a10f94bc40f30737c8f1cd2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="bdc50b4955f16ee4564f9a2f1ecc15ee" level="file"><did><unittitle>TML, 41-95 - The Choice of antibacterial drugs</unittitle><unitdate type="inclusive">1999 October 22</unitdate><container altrender="Record Storage Box (Paige)" id="20ecdd00f605189374c792a7a2cbe332" label="mixed materials [A0000000075885]" type="box">43</container><container id="16b8d5c747fb953ad75960ab2aff29e6" parent="20ecdd00f605189374c792a7a2cbe332" type="folder">4-8</container></did><accessrestrict id="6b1bb72d82bf5bc8c23cfe7d730b6597"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="9edd35ab1f22644cf6c65fedb0f5fd9d" level="file"><did><unittitle>TML, 41-63 - Cosmetic use of botulinum toxin</unittitle><unitdate type="inclusive">1999 July 16</unitdate><container altrender="Record Storage Box (Paige)" id="aa377685c3d3f947b6ffe2d6ca156a57" label="mixed materials [A0000000075885]" type="box">43</container><container id="cb2848bfca3ba669db6333feac882d04" parent="aa377685c3d3f947b6ffe2d6ca156a57" type="folder">9-12</container></did><accessrestrict id="dfa20e59cc18902aef49d7b5c22d5eb5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="cadd4aba2aafedf04d2457bcd20ecb68" level="file"><did><unittitle>TML, 41-29 - Lyme disease vaccine</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="55103545eec3e001469e87c919a07b2a" label="mixed materials [A0000000075885]" type="box">43</container><container id="03e4959e08849be55ff60ce4754c5b73" parent="55103545eec3e001469e87c919a07b2a" type="folder">13-16</container></did><accessrestrict id="ebb5315c0e462b0e2629b5dcb90203c8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="bb27af27ca7507bfd777f78da0d17147" level="file"><did><unittitle>TML, 41-121 - Rapid diagnostic tests for influenza</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="14f93eb2267a5b318496d1b7c9dc5c8b" label="mixed materials [A0000000075885]" type="box">43</container><container id="d13bc23161f7e9aeed368d70cdb8f4d3" parent="14f93eb2267a5b318496d1b7c9dc5c8b" type="folder">17-18</container></did><accessrestrict id="86662934e660af89d7aeaa4e4d013446"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="cf44b51a4bbfd2f5063743b63c4a93e3" level="file"><did><unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">1999 September 24</unitdate><container altrender="Record Storage Box (Paige)" id="9d2c1d833399a1722a514b34d457ff8b" label="mixed materials [A0000000075885]" type="box">43</container><container id="39dcad23d3f3eccde087e55a560dc655" parent="9d2c1d833399a1722a514b34d457ff8b" type="folder">19</container></did><accessrestrict id="53ace92e24d776a3c07d0e679ac418eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="98fd7e915d5c04bccf9bfee05be98149" level="file"><did><unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">1999 September 24</unitdate><container altrender="Record Storage Box (Paige)" id="9eb305b95da564998f9d0eaf6175ae48" label="mixed materials [A0000000075886]" type="box">44</container><container id="92f9d063e1497e10a41d15131ff7d38e" parent="9eb305b95da564998f9d0eaf6175ae48" type="folder">1-3</container></did><accessrestrict id="4fa538c8b0c22de3e0eea7db981ae287"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="47b865bf089a172b75b4d43ce7a1e447" level="file"><did><unittitle>TML, 41-33 - Depression and anxiety</unittitle><unitdate type="inclusive">1999 April 9</unitdate><container altrender="Record Storage Box (Paige)" id="decb822310d4cf55354d530cc6535286" label="mixed materials [A0000000075886]" type="box">44</container><container id="31ece298bf0ca672a63ebb4cb2ce7961" parent="decb822310d4cf55354d530cc6535286" type="folder">4-13</container></did><accessrestrict id="b0f422d658f31862e120da53fa05b6f9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="71225c0666898a85e784b2cb281888c6" level="file"><did><unittitle>TML, 41-122 - Corneal surgery for correction of refractive errors</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="516cbc251b74cbda59314b20a5b71f43" label="mixed materials [A0000000075886]" type="box">44</container><container id="1fe8a27c5187822632bb49ce32fa093e" parent="516cbc251b74cbda59314b20a5b71f43" type="folder">14-16</container></did><accessrestrict id="383c5c203f77ebf4dd9e3dfe67c24cf7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="45f2b2be0a5f877794d8dab41d1e2c89" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="1ce43aa7f9dabf676a1f5cb9ee7bfd1f" label="mixed materials [A0000000075886]" type="box">44</container><container id="8c1a6b90463c4b8f6f53060fbfc2d2fa" parent="1ce43aa7f9dabf676a1f5cb9ee7bfd1f" type="folder">17-18</container></did><accessrestrict id="149a9e74e2c2eb4d35105c1043e77fd1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="59f39d33e558df2c7a53b2df2d17a4ae" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="a849f9ad815ca20892ff44ce46732edf" label="mixed materials [A0000000075887]" type="box">45</container><container id="45d3d3dd482cde9e8acc53db065bb43a" parent="a849f9ad815ca20892ff44ce46732edf" type="folder">1-3</container></did><accessrestrict id="6cab2eae0fd66d97ea7c349b2f4718db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="8d82b612550e56f5febd997b649248f6" level="file"><did><unittitle>TML - Drugs for Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="4ccd8f29413a1b8d924337ca76a2cd82" label="mixed materials [A0000000075887]" type="box">45</container><container id="a3080b893823138c1cf836cbfeb6bc13" parent="4ccd8f29413a1b8d924337ca76a2cd82" type="folder">4-9</container></did><accessrestrict id="9ea5dcafb096eb9d1dba6ab8571932c7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="729c9bb0e1660ceb032fe6da8350333c" level="file"><did><unittitle>TML - Drugs of Choice for cancer chemotherapy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="daca5165fb468aaa2758ae2837265cab" label="mixed materials [A0000000075887]" type="box">45</container><container id="22cc51ee4cdeb3cf3e8b74fed78a71c3" parent="daca5165fb468aaa2758ae2837265cab" type="folder">10-16</container></did><accessrestrict id="5ad67e35d3361f03756bfe78c6e60019"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="737148b055ba101acbd8ee7df7c07e4c" level="file"><did><unittitle>TML, 41-44 - Cilostazol for intermittent claudication</unittitle><unitdate type="inclusive">1999 May 7</unitdate><container altrender="Record Storage Box (Paige)" id="19b969d091ec581ff8c7aaaf1c0d0174" label="mixed materials [A0000000075887]" type="box">45</container><container id="1aac2eb0a6f2f4eba20c922222d52aae" parent="19b969d091ec581ff8c7aaaf1c0d0174" type="folder">17-20</container></did><accessrestrict id="91985532c77a98b2be6619b3829a2c87"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="6e0f28a2b5a8cac84be32ec338816dac" level="file"><did><unittitle>TML, 41-11 - Celecoxib for arthritis</unittitle><unitdate type="inclusive">1999 January 29</unitdate><container altrender="Letter Document Box" id="d60c834dbd8315aac0bd68dd39cd7c99" label="mixed materials [A0000000075888]" type="box">46</container><container id="73cb64e1e8042ef3bb81a1dfe5f11875" parent="d60c834dbd8315aac0bd68dd39cd7c99" type="folder">1-4</container></did><accessrestrict id="5220646ffa341e43aaef650d57ef5cbb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="47ee2aa0e1414311aab659a0b7791d48" level="file"><did><unittitle>TML, 41-61 - Drug interactions</unittitle><unitdate type="inclusive">1999 July 2</unitdate><container altrender="Letter Document Box" id="d21b880ac737e6bd8b667d7aa85d2b7c" label="mixed materials [A0000000075945]" type="box">103</container><container id="c56761335003fe93f0d30dde15c166df" parent="d21b880ac737e6bd8b667d7aa85d2b7c" type="folder">1-4</container></did><accessrestrict id="2310dca3aaada449df04e476753e097f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ca7a582ccc3762635c6b2b1ab49c2e38" level="file"><did><unittitle>TML, 42-51 - Ciclopirox (Penlac) nail lacquer for onychomysis</unittitle><unitdate type="inclusive">2000 June 12</unitdate><container altrender="Record Storage Box (Paige)" id="dda74aefda7ff0fd0b613fc4b9144750" label="mixed materials [A0000000075889]" type="box">47</container><container id="cc61c70eab66ab8528bc3e66da19a7fc" parent="dda74aefda7ff0fd0b613fc4b9144750" type="folder">1-2</container></did><accessrestrict id="9580c594e1986354a883d0b4d0b71bc3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="4b13f0ecb976a0758dff29129231c5ab" level="file"><did><unittitle>TML, 42-70 - Cevimeline (Evoxac) for dry mouth</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="cd9af405a14591d9c44a7787c7b43a9a" label="mixed materials [A0000000075889]" type="box">47</container><container id="cf7591d4f53612ac84b9d41cb8bc3b12" parent="cd9af405a14591d9c44a7787c7b43a9a" type="folder">3</container></did><accessrestrict id="ab5ca835a64facd8b0328a6bddeaa9db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="65fedbec948e0fc83c65d93e86ad6afd" level="file"><did><unittitle>TML, 42-13 - Sirolimus (Rapamune) for transplant rejection</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="efc00a607bf27b78521cb64de4acc935" label="mixed materials [A0000000075889]" type="box">47</container><container id="1c6d3ea6f06eb3a94c328e1a4aad67af" parent="efc00a607bf27b78521cb64de4acc935" type="folder">4-6</container></did><accessrestrict id="7082abcbc2a52e308ef67322853d8731"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="43b3f1afcb8ce7fdcc73ea538a9dcaef" level="file"><did><unittitle>TML, 42-56 - Drug interactions with St. John's Wort</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="55cd042547ff7473ef6309a18e435e4f" label="mixed materials [A0000000075889]" type="box">47</container><container id="bdd8ace28b52a4fce7a12b4d41545ebd" parent="55cd042547ff7473ef6309a18e435e4f" type="folder">7-9</container></did><accessrestrict id="fc05579a4affa53f15f6bf7701c8c36c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="13d9761c756a2fe7adb0ccd2bd89e5c3" level="file"><did><unittitle>TML, 42-27 - Curosurf</unittitle><unitdate type="inclusive">2000 March 20</unitdate><container altrender="Record Storage Box (Paige)" id="ff1515ea8491815a7108a4bb9a205438" label="mixed materials [A0000000075889]" type="box">47</container><container id="d3de6d976a84b9aa30f62d33c74e77bf" parent="ff1515ea8491815a7108a4bb9a205438" type="folder">10-12</container></did><accessrestrict id="a42091b45287859d025abbb92f4814dc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c1fd925b81d971c06ec273ef08f3cb74" level="file"><did><unittitle>TML, 42-81 - Photodynamic therapy with veterfporfin (Visudyne) for macular degeneration</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="62d9be01cb217532c482db250f866a2a" label="mixed materials [A0000000075889]" type="box">47</container><container id="37cd057665959244df9790f0a1040207" parent="62d9be01cb217532c482db250f866a2a" type="folder">13-15</container></did><accessrestrict id="25831287c40dd007e7ad4f179aa90da2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="259c3ccf591bab51ffdaba3a9994e765" level="file"><did><unittitle>TML, 42-57 - Drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">2000 July 10</unitdate><container altrender="Record Storage Box (Paige)" id="f4c0a47d1eacd47699e4ef9049da5625" label="mixed materials [A0000000075889]" type="box">47</container><container id="bd247a46715c0035b64bec3ba0de159f" parent="f4c0a47d1eacd47699e4ef9049da5625" type="folder">16-20</container></did><accessrestrict id="162cb0e7647f4a98954f5445c257c882"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="62b6871b865b6d75c47266161b21cb21" level="file"><did><unittitle>TML, 42-113 - Phenylpropanolamine</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="f55821f5b6a62f50da70ebd70d9a7797" label="mixed materials [A0000000075890]" type="box">48</container><container id="4f583e34b60f8ae1be1a6005f3ca56db" parent="f55821f5b6a62f50da70ebd70d9a7797" type="folder">1</container></did><accessrestrict id="3a8380c96fc7714fa7d33e8fc9eda5f1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7e8cf0d2095db89bdcf602dcfa388b37" level="file"><did><unittitle>TML, 42-94 - Zonisamide (Zonegran) for epilepsy</unittitle><unitdate type="inclusive">2000 August 1</unitdate><container altrender="Record Storage Box (Paige)" id="a515a0f9ce5159b0d6512768bf466a52" label="mixed materials [A0000000075890]" type="box">48</container><container id="191526bc1e2e00d41a1d266ea568d36d" parent="a515a0f9ce5159b0d6512768bf466a52" type="folder">2-4</container></did><accessrestrict id="af9a344f43755a6c943435e3e709888a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="505b60f40ff960c724ff856e304ce951" level="file"><did><unittitle>TML, 42-10 - Emergency Contraception - Plan B</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="e00d42e109035d550f50a6e966d07505" label="mixed materials [A0000000075890]" type="box">48</container><container id="5a9fb66d4cb5f78eced43acb9dad227c" parent="e00d42e109035d550f50a6e966d07505" type="folder">5</container></did><accessrestrict id="3cd71612bf2f98b55022fa5ad125e9e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="86b41328d3a3f3bd0b39258221d169af" level="file"><did><unittitle>TML, 42-42 - Oral contraceptives</unittitle><unitdate type="inclusive">2000 May 15</unitdate><container altrender="Record Storage Box (Paige)" id="0234e8d2328ad87464f9c0734c2846dd" label="mixed materials [A0000000075890]" type="box">48</container><container id="a0ad50c0067b28241d964deb979bb4a8" parent="0234e8d2328ad87464f9c0734c2846dd" type="folder">6-11</container></did><accessrestrict id="362a441b3fc8d8a82b31585a57ea0665"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="5af9d8711bf691d44ab3b1e5bb256681" level="file"><did><unittitle>TML, 42-17 - Phytoestrogens</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="24ec3ff367d2ed543206a2e4ed706604" label="mixed materials [A0000000075890]" type="box">48</container><container id="c33c133f84b82c84c9401bfa943af677" parent="24ec3ff367d2ed543206a2e4ed706604" type="folder">12-14</container></did><accessrestrict id="b6923da0f1e80e36ed724d7930240ab0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="408be2b8c6034a613b1211f2ecf9b661" level="file"><did><unittitle>TML, 42-29 - Calcium citrate vs Calcium carbonate calcium supplements</unittitle><unitdate type="inclusive">2000 April 3</unitdate><container altrender="Record Storage Box (Paige)" id="b733194e6f3562a23490889e19a63125" label="mixed materials [A0000000075890]" type="box">48</container><container id="d4bd6407cc8b5bb586f398272d12fec5" parent="b733194e6f3562a23490889e19a63125" type="folder">15-16</container></did><accessrestrict id="f012aa712ae69a791944518eafe15ae9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3335c85c5f584c0623918d305860bba9" level="file"><did><unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="8181b53772f8943870505e225ea22b6a" label="mixed materials [A0000000075890]" type="box">48</container><container id="7b482022e49490b293453b8a19f322ed" parent="8181b53772f8943870505e225ea22b6a" type="folder">17-18</container></did><accessrestrict id="55427e8bb48ad2b8315333c1ff339476"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c6d41dc2321b4992a2ce79264290f903" level="file"><did><unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="91e3d5434de47118f3932dbe670161b5" label="mixed materials [A0000000075891]" type="box">49</container><container id="61400de7687a605ab74c617e41234b56" parent="91e3d5434de47118f3932dbe670161b5" type="folder">1</container></did><accessrestrict id="a4945089c03fcb0a219bdaccf387431a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="1ff03efd208b21a2efb1beeeca59fbe2" level="file"><did><unittitle>TML, 42-41 - Dofetilide for atrial fibrillation</unittitle><unitdate type="inclusive">2000 May 15</unitdate><container altrender="Record Storage Box (Paige)" id="dbc50bbaeb272ce7f42177c55254fae7" label="mixed materials [A0000000075891]" type="box">49</container><container id="baf34eab9f39d1f13c7b7527f2be1b87" parent="dbc50bbaeb272ce7f42177c55254fae7" type="folder">2-4</container></did><accessrestrict id="f05aa84b2f28b6ffb33fe96ec43cd992"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="97e9932d34799dd8520be9e13f8a01ce" level="file"><did><unittitle>TML, 40-102 - Colesevelam (Welchol) for hypercholesterolemia</unittitle><unitdate type="inclusive">2000 October 30</unitdate><container altrender="Record Storage Box (Paige)" id="4f64a829d724a49d2e56eed15e68bbef" label="mixed materials [A0000000075891]" type="box">49</container><container id="78c15c06184c917fd200681e4f99c108" parent="4f64a829d724a49d2e56eed15e68bbef" type="folder">5</container></did><accessrestrict id="349dee1a0f2981a7afaffa486ad92400"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b1e989f44b7978ab2b1aaaf201f34aeb" level="file"><did><unittitle>TML, 42-108 - Docosanal cream (Abreva) for recurrent herpes labialis</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="00bb5923e73ac29096476e53170c4951" label="mixed materials [A0000000075891]" type="box">49</container><container id="6d04ebd13556f63a3dfdd48759215979" parent="00bb5923e73ac29096476e53170c4951" type="folder">6</container></did><accessrestrict id="086b94bfdd5ebcae1564c66a07d71bf4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="e0e61fb5a1e14299b5769bb3645966af" level="file"><did><unittitle>TML, 42-106 - Temecteplase (TNKASE) for thrombolysis</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="828966e5cef0401799a23a5703c16dd7" label="mixed materials [A0000000075891]" type="box">49</container><container id="0b00f41c11606ba47fc84bc8260908a6" parent="828966e5cef0401799a23a5703c16dd7" type="folder">7-10</container></did><accessrestrict id="6881f1eb6305a22e4485bcca7bf92f20"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3d342507f2c128f34587c4f458c47ae3" level="file"><did><unittitle>TML, 42-113 - Valproate and other anticonvulsants for psychiatric disorders</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="2e1b4be87b8e088ccda850affb9e59ac" label="mixed materials [A0000000075891]" type="box">49</container><container id="0ca453cddaf14cba0b810690b934a1f8" parent="2e1b4be87b8e088ccda850affb9e59ac" type="folder">11-14</container></did><accessrestrict id="175706ce1b1be1373cdbf4234daea11e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="89f1be4de95ddec6822bda7f0e83b385" level="file"><did><unittitle>TML, 42-8 - Prevention of malaria</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="e41441e99856b428dddaabcfde6045c0" label="mixed materials [A0000000075891]" type="box">49</container><container id="d5a179f52446829420f83ed892ab992c" parent="e41441e99856b428dddaabcfde6045c0" type="folder">15</container></did><accessrestrict id="9af6ac60aa40dc6005ce4edb57dc6970"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="da557a8aeefe93b11b7b65ef3275ee26" level="file"><did><unittitle>TML, 42-37 - Lyme disease</unittitle><unitdate type="inclusive">2000 May 1</unitdate><container altrender="Record Storage Box (Paige)" id="5057af3ef705f957428ec7a5cba9cc32" label="mixed materials [A0000000075891]" type="box">49</container><container id="5ce58dbe2189b0dad6cce816c33e10ef" parent="5057af3ef705f957428ec7a5cba9cc32" type="folder">16-18</container></did><accessrestrict id="50f594b6d9dec7b83b3b83386b475dcd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b9d25758af7747ace6aaf80757aac85f" level="file"><did><unittitle>TML, 42-18 - Aspirin for primary prevention of cardiovascular disease</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="b66cf4a897e4cd242797d1439e205e5a" label="mixed materials [A0000000075891]" type="box">49</container><container id="edbd40735f9659858eb88c6dcfba983e" parent="b66cf4a897e4cd242797d1439e205e5a" type="folder">19-20</container></did><accessrestrict id="bd7e6d6a5d2765181060a6c4e5bc8024"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8827ef8acb277df2d477589d43015ed3" level="file"><did><unittitle>TML, 42-73 - Drugs for pain</unittitle><unitdate type="inclusive">2000 August 21</unitdate><container altrender="Record Storage Box (Paige)" id="3393a7ae8c84031428e158a90101044f" label="mixed materials [A0000000075892]" type="box">50</container><container id="3fbe2b4a9ddf0d582ff0a7213e9cd6b3" parent="3393a7ae8c84031428e158a90101044f" type="folder">1-6</container></did><accessrestrict id="45351d67ab671d76012768894632e65f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7ca68fc3cc569b193dc410a094f9a61f" level="file"><did><unittitle>TML, 42-19 - Drugs for Asthma</unittitle><unitdate type="inclusive">2000 March 6</unitdate><container altrender="Record Storage Box (Paige)" id="76b7ef2448cc65c1baa800cd34a344bc" label="mixed materials [A0000000075892]" type="box">50</container><container id="12ba9e6d42bf15cdca21240157b1be86" parent="76b7ef2448cc65c1baa800cd34a344bc" type="folder">7-10</container></did><accessrestrict id="843840cc3a1f4f944dcd68fb679ac778"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="11f2fac87764b93bfe43bd87321c6e78" level="file"><did><unittitle>TML, 42-49 - Androgel</unittitle><unitdate type="inclusive">2000 June 1</unitdate><container altrender="Record Storage Box (Paige)" id="5f8e676c1b4e97c8e28fa57659195b04" label="mixed materials [A0000000075892]" type="box">50</container><container id="083b9cf06e95a7cf370c486f2d0ee49b" parent="5f8e676c1b4e97c8e28fa57659195b04" type="folder">11-13</container></did><accessrestrict id="373b10f2aaf453294914d4fe78b9487f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f519c54c8f624fc16003fa1c04fa88f0" level="file"><did><unittitle>TML, 42-97 - Drugs for prevention and treatment of postmenopausal osteoporosis</unittitle><unitdate type="inclusive">2000 October 16</unitdate><container altrender="Record Storage Box (Paige)" id="3c04c78d794f390865354465f66da576" label="mixed materials [A0000000075892]" type="box">50</container><container id="ea9a432f9606d96cfc39b12ad197dec1" parent="3c04c78d794f390865354465f66da576" type="folder">14-18</container></did><accessrestrict id="f6c66097c55fc7906c4f0813a2f589d8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="da9eaff7a676c3ce93fb52a83c4df992" level="file"><did><unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="eedf66020b56b190eb614c18b1c97f38" label="mixed materials [A0000000075892]" type="box">50</container><container id="303fe884b08705d37de14bc88a628d65" parent="eedf66020b56b190eb614c18b1c97f38" type="folder">19-20</container></did><accessrestrict id="0b717ab0083f68384631636b834fec64"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f307fe5a6bafa6083a914965f47c224f" level="file"><did><unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="d989c73cf93db9784e049ca0e65265f5" label="mixed materials [A0000000075893]" type="box">51</container><container id="2e3229ed008907e216de50845abb16cc" parent="d989c73cf93db9784e049ca0e65265f5" type="folder">1</container></did><accessrestrict id="dc26934d88198182e177b592f4868a43"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0d88056c01b79b6a4d890ffb52ef26d7" level="file"><did><unittitle>TML, 42-31 - Bexrotene</unittitle><unitdate type="inclusive">2000 April 3</unitdate><container altrender="Record Storage Box (Paige)" id="b6bdf6768b3e7df30aa7147e987eeb2b" label="mixed materials [A0000000075893]" type="box">51</container><container id="b96428df8d82d0eb588d3a832af5baed" parent="b6bdf6768b3e7df30aa7147e987eeb2b" type="folder">2-4</container></did><accessrestrict id="9a8c86a85c6d5ea077e55d9b7597d55f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="78aad480d71976b1ac63856f8414b2de" level="file"><did><unittitle>TML, 42-116 - Portable Defibrillators</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="bfc3f7d5e75b96b1198ee0c63f597f9c" label="mixed materials [A0000000075893]" type="box">51</container><container id="360f78b056a140e07651c9c139712eeb" parent="bfc3f7d5e75b96b1198ee0c63f597f9c" type="folder">5-6</container></did><accessrestrict id="da50ccc68a37dbb555145dfbcf8f1e7c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8856ac6d297ba039f5f59b8393406463" level="file"><did><unittitle>TML, 42-111 - Drugs that may cause cognitive disorders in the elderly</unittitle><unitdate type="inclusive">2000 November 27</unitdate><container altrender="Record Storage Box (Paige)" id="58120f193e3e55fed828dca3223b506d" label="mixed materials [A0000000075893]" type="box">51</container><container id="b910be527ee7e4dbd56a82c974884d9c" parent="58120f193e3e55fed828dca3223b506d" type="folder">7-10</container></did><accessrestrict id="2247b3013b5d4bd66554d265282ec46f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="d791d0f324ea7d0ebc4dcab430fc3a36" level="file"><did><unittitle>TML, 42-36 - Substituting for troglitazone (Rezulin)</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="39e4e889325111ab948013eb19777bd8" label="mixed materials [A0000000075893]" type="box">51</container><container id="35a6c4ff615d5e4ef3555a05b437fcd5" parent="39e4e889325111ab948013eb19777bd8" type="folder">11</container></did><accessrestrict id="35757c84324de4837de836a4d664e4bd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="390553fd7a4eea2f5cbee5002f2322bc" level="file"><did><unittitle>TML, 42-109 - Atovaquone - Proguanil (Malarone) for malaria</unittitle><unitdate type="inclusive">2000 November 27</unitdate><container altrender="Record Storage Box (Paige)" id="68ef586f6f839c07c3e1573ee55a6bcc" label="mixed materials [A0000000075893]" type="box">51</container><container id="d59f327fe966350a6e75ef7b1594e8ea" parent="68ef586f6f839c07c3e1573ee55a6bcc" type="folder">12-15</container></did><accessrestrict id="717bd1e1f90c70ff656382467cc26f89"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="102174d0143d0b7b46d5dbdfb6ee2e6c" level="file"><did><unittitle>TML, 42-39 - Ketotifen and Pemirlostat - New drugs for allergic conjunctivitis</unittitle><unitdate type="inclusive">2000 May 1</unitdate><container altrender="Record Storage Box (Paige)" id="f547528ea55e3d79c5fa812b0f5686f0" label="mixed materials [A0000000075893]" type="box">51</container><container id="887ac62e90a01c7378113d1a67d6eb02" parent="f547528ea55e3d79c5fa812b0f5686f0" type="folder">16-17</container></did><accessrestrict id="c0dedfa65ff00b42eaec283e7dbe5ee3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="968dfa06d929ab040463fb621fb94e15" level="file"><did><unittitle>TML - HAT - Systemic antifungal</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="296a7ab0e69522ca5681d003a0be4f36" label="mixed materials [A0000000075893]" type="box">51</container><container id="9318cd9ba69e5c0cfe0e8426c28ca322" parent="296a7ab0e69522ca5681d003a0be4f36" type="folder">18-19</container></did><accessrestrict id="a7608b2e6d21017e82cac99f4c300d04"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ffb773729eccb5c024461cb32728a1f5" level="file"><did><unittitle>TML - HAT - Systemic antifungal</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="232dbd242afecb48224a2fb984334fa3" label="mixed materials [A0000000075894]" type="box">52</container><container id="a4de2179429e399363e7241d8b7539b2" parent="232dbd242afecb48224a2fb984334fa3" type="folder">1-2</container></did><accessrestrict id="fc274c9d6d48168ac3a11ea6067869e0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b5adf750afaa8fb0be9aa2061a43e3b8" level="file"><did><unittitle>TML, 42-96 - Eflornithine cream for facial hair reduction</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="e824c6165b95707cc914f624c9b752fb" label="mixed materials [A0000000075894]" type="box">52</container><container id="9dc7017602374c1824656d3eb0ca3cb7" parent="e824c6165b95707cc914f624c9b752fb" type="folder">3</container></did><accessrestrict id="97998d665049bfafbdf7f044ef962ac2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c88b481d9cf92fe516e086aa696f2759" level="file"><did><unittitle>TML, 42-67 - Gemtuzumab for relapsed acute myeloid leukemia</unittitle><unitdate type="inclusive">2000 July 24</unitdate><container altrender="Record Storage Box (Paige)" id="bb61b90084857b5198276dee0109c8ba" label="mixed materials [A0000000075894]" type="box">52</container><container id="8afe7654f3b982b11564611f0fb63e03" parent="bb61b90084857b5198276dee0109c8ba" type="folder">4-5</container></did><accessrestrict id="8158423ad1861ed096a1f762bea5ed19"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="d316d036d1c1c8b5e65cc5a3309c50cf" level="file"><did><unittitle>TML, 42-52 - Atkin's diet</unittitle><unitdate type="inclusive">2000 June 12</unitdate><container altrender="Record Storage Box (Paige)" id="4c9c5637ffe851950108f03b774d9c5b" label="mixed materials [A0000000075894]" type="box">52</container><container id="2f01d63b535abde46d15d99fd4725ade" parent="4c9c5637ffe851950108f03b774d9c5b" type="folder">6-8</container></did><accessrestrict id="0024c5f9b90643b42da0ff940f490484"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f039186b802088d6736b63d8692ff877" level="file"><did><unittitle>TML, 42-71 - Hypnotic drugs</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="c61a0b199c2651a7e246b169688237d7" label="mixed materials [A0000000075894]" type="box">52</container><container id="8247994f41460a28042a4f40938c047b" parent="c61a0b199c2651a7e246b169688237d7" type="folder">9-12</container></did><accessrestrict id="66081d4df14137512de48118dd485bfc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ddaac639270ba0e3369ea6c5bef18c02" level="file"><did><unittitle>TML, 42-79 - Influenza update 2000-2001</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="fee5c959e9d82bd99902eb6617ffe8cc" label="mixed materials [A0000000075894]" type="box">52</container><container id="760356872a89e08e377c803671dbdc68" parent="fee5c959e9d82bd99902eb6617ffe8cc" type="folder">13-14</container></did><accessrestrict id="2370a9ec5de5c8b19f6823b89c720366"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3b89f483901c2a204aeb8a707d5f619e" level="file"><did><unittitle>TML, 42-35 - Exemestane for advanced breast cancer</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="d087a65c0a3cfe62c8cab51f20bb549a" label="mixed materials [A0000000075894]" type="box">52</container><container id="ba872706c8c91d2ab82272b01d233165" parent="d087a65c0a3cfe62c8cab51f20bb549a" type="folder">15-17</container></did><accessrestrict id="908ae2bf04aa596e7e5c1b4a0b435a1a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="5b4d37f27c36f2cf78b12c02f16d9dd0" level="file"><did><unittitle>TML, 42-12 - Epirubicin for adjuvant therapy in node-positive breast cancer</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="8f22faa0c39d6b2ba3fbbdd01fa25d07" label="mixed materials [A0000000075894]" type="box">52</container><container id="47d53344e422a6170132fb4142b73170" parent="8f22faa0c39d6b2ba3fbbdd01fa25d07" type="folder">18-20</container></did><accessrestrict id="231c8f3761cd29bf8b9da59c1db76773"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ea21c93279b7213ac4ebcf26ac90ac01" level="file"><did><unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="6edf3d68bceec338499aa974a936b11d" label="mixed materials [A0000000075894]" type="box">52</container><container id="9f6f2a2e972a82637076594052ec3f3b" parent="6edf3d68bceec338499aa974a936b11d" type="folder">21</container></did><accessrestrict id="ecde6f626cda50967973b161a20fcc74"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0670855c3da978011ef91e63b94b8614" level="file"><did><unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="df3893fc915ed8a73ea6e02bfa768d5a" label="mixed materials [A0000000075895]" type="box">53</container><container id="beb636bb0f939911c066917ea0019a9f" parent="df3893fc915ed8a73ea6e02bfa768d5a" type="folder">1-2</container></did><accessrestrict id="b1545fba52ccf81c38c8688169dab34a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b9f3b0c3756751d471fc83952e9cdb9e" level="file"><did><unittitle>TML - HAT - Adverse Effects</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="15f3e536574d9ede9dcf043287ed53c7" label="mixed materials [A0000000075895]" type="box">53</container><container id="1c4f98f313ee30c93f48895a274ade0d" parent="15f3e536574d9ede9dcf043287ed53c7" type="folder">3-4</container></did><accessrestrict id="f035a5812a9a5ba9f187b537f909316a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0f64e1cb70a81058fe2a570f1ccb8c4a" level="file"><did><unittitle>TML - Perinopril - A new ACE inhibitor for hypertension</unittitle><unitdate type="inclusive">2000 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="4036d38371b161fc859702c4268b9c93" label="mixed materials [A0000000075895]" type="box">53</container><container id="9a15025b0067a486467cdbf4e686b2f3" parent="4036d38371b161fc859702c4268b9c93" type="folder">5-8</container></did><accessrestrict id="8e19dab12d3196a7486bcf0f13a7475f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="9370ffe6e8855002d778fc797c644238" level="file"><did><unittitle>TML, 42-65 - Pantoprazole (Protonix)</unittitle><unitdate type="inclusive">2000 July 24</unitdate><container altrender="Record Storage Box (Paige)" id="d9def74a842ca28c353807865a9d2431" label="mixed materials [A0000000075895]" type="box">53</container><container id="788ea662453dc0233f7fbd0a124ddf00" parent="d9def74a842ca28c353807865a9d2431" type="folder">9-12</container></did><accessrestrict id="a1015b3acc8c847466def1105f15644b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="354614b4cdeb7c25dce7323acfe3837f" level="file"><did><unittitle>TML, 42-15 - Gatifloxacin and Moxifloxacin - Two new fluoroquinolones</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="177365a184a714eafdaf0cc77f7e9e47" label="mixed materials [A0000000075895]" type="box">53</container><container id="278c7d97f8d505b2d4ea301e17a6951a" parent="177365a184a714eafdaf0cc77f7e9e47" type="folder">13-18</container></did><accessrestrict id="5bf74d558644f64e23255ce061463c78"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ee26dc57604d2e8beb15f5282094c199" level="file"><did><unittitle>TML, HAT - Antimicrobial Dosage</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="111022e16dd83ea85586024300a38452" label="mixed materials [A0000000075895]" type="box">53</container><container id="f60085cf19e8d8a1919bcd05e4bec219" parent="111022e16dd83ea85586024300a38452" type="folder">19</container></did><accessrestrict id="11c3455a2f2e87c2b16773aa9e6aea7c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="a088080df443869d26625b88cfb8357c" level="file"><did><unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="cf7452fde615db4a74a5ba4e20d573f3" label="mixed materials [A0000000075895]" type="box">53</container><container id="226de12ce7f2c5a764a0893954ed5cf3" parent="cf7452fde615db4a74a5ba4e20d573f3" type="folder">20</container></did><accessrestrict id="204852f90f3648c6b6e5e6274cb652ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="4786db2a3aa9c724f7f60dcf4fcf9164" level="file"><did><unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="c584cd13805d131411e0efe746f47fda" label="mixed materials [A0000000075896]" type="box">54</container><container id="6e1408364000a83ba48b7741b3184ac5" parent="c584cd13805d131411e0efe746f47fda" type="folder">1-2</container></did><accessrestrict id="19470d2540faf3143d53c5e0f0f04553"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ff8898d4bdb05f23855cdb33eaefc878" level="file"><did><unittitle>TML, 42-53 - Alosetron (Lotronex) for irritable bowel syndrome</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="67b6eff37839e26735a0dd97c141f219" label="mixed materials [A0000000075896]" type="box">54</container><container id="152d30c198e702b4ed6d9658028df9a8" parent="67b6eff37839e26735a0dd97c141f219" type="folder">3-4</container></did><accessrestrict id="a92fba8d7b374bd5ed2b6377d7f5dfcf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c83dbfe7a53fd4d335c81b6902eff92d" level="file"><did><unittitle>TML, 42-25 - Conjugated pneumococcal vaccine for infants and children</unittitle><unitdate type="inclusive">2000 March 20</unitdate><container altrender="Record Storage Box (Paige)" id="fd23be42b2a9c52bed38ca664bc24572" label="mixed materials [A0000000075896]" type="box">54</container><container id="3b653607a697a76e117efe1a6341184a" parent="fd23be42b2a9c52bed38ca664bc24572" type="folder">5-7</container></did><accessrestrict id="aee461894cb0482b20c2792522b46e12"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0c6944c64d3e895d17a92cb7a840b2cc" level="file"><did><unittitle>TML, 42-69 - Meningococcal vaccine - College students</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="efb68ab5875471f52c5437940ae0a91c" label="mixed materials [A0000000075896]" type="box">54</container><container id="7f6915d21f1b7c324fadc1073d5b9a1f" parent="efb68ab5875471f52c5437940ae0a91c" type="folder">8-9</container></did><accessrestrict id="df37cebc2f1268161ba89264e0aa24c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f8521e46162fc0e16135537e8fe60e0e" level="file"><did><unittitle>TML, 42-80 - A new long-acting methylphenidate</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="19575e59e4eb008a852563f81d999268" label="mixed materials [A0000000075896]" type="box">54</container><container id="c2b45c6624649692404f088a38cffd51" parent="19575e59e4eb008a852563f81d999268" type="folder">10-11</container></did><accessrestrict id="a4aa4fa7be7331aba5f8a5db5ecf9418"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="77d873ab9fa6653d75e07ecd29388474" level="file"><did><unittitle>TML, 42-17 - Entacapone for Parkinson's disease</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="0af97af1580f69d02da9634d48e5b84a" label="mixed materials [A0000000075896]" type="box">54</container><container id="428b87bb3223599be07255ea3f726808" parent="0af97af1580f69d02da9634d48e5b84a" type="folder">12-14</container></did><accessrestrict id="c4cc72e54e77645b47ebceda334dae90"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="2c3c36361f7d26d6245b10967d53cba6" level="file"><did><unittitle>TML, 42-45 - Linezolid (Zyvox)</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="716a9a80bd4e8da106ed84bf9b63efab" label="mixed materials [A0000000075896]" type="box">54</container><container id="39ccbf6266a985acf3f07fa1a8e8c759" parent="716a9a80bd4e8da106ed84bf9b63efab" type="folder">15-18</container></did><accessrestrict id="134bd94a116d4a00868b6be7c821b669"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f3db800fbd8c30fd18c0ce7421c0675c" level="file"><did><unittitle>TML, 42-1 - Drugs for HIV</unittitle><unitdate type="inclusive">2000 January 10</unitdate><container altrender="Record Storage Box (Paige)" id="4df4d3065600a6dfd1450da1b46429ae" label="mixed materials [A0000000075896]" type="box">54</container><container id="6057bb5b2143abd230d43ecf0bf85ced" parent="4df4d3065600a6dfd1450da1b46429ae" type="folder">19-21</container></did><accessrestrict id="6357a8604ec2f14301f33a46a3a3ee64"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c29c016865d236b6f578b647c46a6676" level="file"><did><unittitle>TML, 42-1 - Drugs for HIV</unittitle><unitdate type="inclusive">2000 January 10</unitdate><container altrender="Record Storage Box (Paige)" id="b8a21ad7031be029dac164517ea868f5" label="mixed materials [A0000000075897]" type="box">55</container><container id="34fc664237abe882551e09a30f45f221" parent="b8a21ad7031be029dac164517ea868f5" type="folder">1-2</container></did><accessrestrict id="8e3afc9c0897bcf7957059afb787d613"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0ef84e9be7c32e14ccb4cf39bfd45359" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="a366dc1a1239454db72af080757fbc49" label="mixed materials [A0000000075897]" type="box">55</container><container id="70f31731693e6e3a3feb22a3d99d8fcd" parent="a366dc1a1239454db72af080757fbc49" type="folder">3-6</container></did><accessrestrict id="9bb37702887fbb2a3b6b04978a2797eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="cc6bb16d28e33a08e3172f055c9bc2b1" level="file"><did><unittitle>TML, 42-11 - Aggrenox - A combination of antiplatelet drugs for stroke prevention</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="e724b019984da5ccfc0463e6ec804c6c" label="mixed materials [A0000000075897]" type="box">55</container><container id="bccaf9f6d43e1b22191ab6ac538ebd38" parent="e724b019984da5ccfc0463e6ec804c6c" type="folder">7-8</container></did><accessrestrict id="b6c3f76765c91d59d07d1942830fb182"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7fc91d920ef13c04bcd488ff67fb27eb" level="file"><did><unittitle>TML - 42-54 - Beta Blockers for heart failure</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="a6be00369661e0fb4ef64eea474cc6a0" label="mixed materials [A0000000075897]" type="box">55</container><container id="91c5a6b280c5ad53102d1a6f8cc70475" parent="a6be00369661e0fb4ef64eea474cc6a0" type="folder">9-13</container></did><accessrestrict id="ddd4e956f4e4703f485c6e09538b3de5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="2659d96c29ea4c72cecf071a3ffe82cf" level="file"><did><unittitle>TML, 42-83 - Drugs of Choice - Cancer chemotherapy</unittitle><unitdate type="inclusive">2000 September 18</unitdate><container altrender="Record Storage Box (Paige)" id="dc92001e95411790aa5287f7df264b64" label="mixed materials [A0000000075897]" type="box">55</container><container id="52464984b80cf88df355eca978492b84" parent="dc92001e95411790aa5287f7df264b64" type="folder">14-18</container></did><accessrestrict id="fdc72de4846ddb965722a850fb816e7f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="85452dc178e1dadec0332fe42563215d" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Tuberculosis</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="87903e3df625fbbbe68d3a13e80590cd" label="mixed materials [A0000000075898]" type="box">56</container><container id="82564eba6a0e7912385c56573c4cac8d" parent="87903e3df625fbbbe68d3a13e80590cd" type="folder">1-4</container></did><accessrestrict id="f9bcd6fc9775a8cd44d753ed67359607"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="9c48a5236a35ed8f3ce7136401b6da9e" level="file"><did><unittitle>TML, 42-101 - Mifepristone (RU 486)</unittitle><unitdate type="inclusive">2000 October 30</unitdate><container altrender="Record Storage Box (Paige)" id="5bc80087d56f0d93ba54353682689685" label="mixed materials [A0000000075898]" type="box">56</container><container id="eca311a00c0658234e094940b4298fa3" parent="5bc80087d56f0d93ba54353682689685" type="folder">5-8</container></did><accessrestrict id="512097af868e6310c2ef7aa3a3ab7af5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="41cb55e32ff2281af228fcf98e48db43" level="file"><did><unittitle>TML - Osteoporosis - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="441dc556cbf7133226252550586584f3" label="mixed materials [A0000000075898]" type="box">56</container><container id="2dfefe61d7d0b96ae03109ad3b53fddc" parent="441dc556cbf7133226252550586584f3" type="folder">9-12</container></did><accessrestrict id="a1eb04973eb4447d22f3324b1056f9bf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="669d4a856fe8af2c5b04130d94fa8d3e" level="file"><did><unittitle>TML - Asthma - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="988b33c78bca715632fefedf21010d24" label="mixed materials [A0000000075898]" type="box">56</container><container id="7a2b8a77531ace41a72af8d6979a5b64" parent="988b33c78bca715632fefedf21010d24" type="folder">13-16</container></did><accessrestrict id="38e2af006895a52bd2de3eb894293ec3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0ec6c4e753e63df5926b6bb8dc0ec41d" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="9932e644e079f0fa8a1a056db5d7961c" label="mixed materials [A0000000075898]" type="box">56</container><container id="9ac571837f8602110e66da1a234244db" parent="9932e644e079f0fa8a1a056db5d7961c" type="folder">17-20</container></did><accessrestrict id="d8d94d63528159d44953c7215892b5f2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="1716a9979d5479baf368216eb3017f50" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Box" id="f8a6adfd216a785e237c265c7d9dffba" label="mixed materials [A0000000075899]" type="box">57</container><container id="1da463363c5f4ff53d371ac1fed84cfa" parent="f8a6adfd216a785e237c265c7d9dffba" type="folder">1-4</container></did><accessrestrict id="7be18115960dc69ccd463738ce3438d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="296856f8c0a6139989dec83e2967a3f6" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Box" id="09ecd0f53454416950b3658ceb523045" label="mixed materials [A0000000075899]" type="box">57</container><container id="6b711d5fae2112068f88298b33136465" parent="09ecd0f53454416950b3658ceb523045" type="folder">5</container></did><accessrestrict id="44a20fdcc0c5ee5bc8f27d1eb7439095"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="41a4f1b5ec21dcacfcb1590a26be0255" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Box" id="be29ffb34b3d119a3744b99de13e3bfb" label="mixed materials [A0000000075900]" type="box">58</container><container id="4d689deeecf0eae86b9666b5ed2a0512" parent="be29ffb34b3d119a3744b99de13e3bfb" type="folder">1-3</container></did><accessrestrict id="aae3719b7a851cb67c17470197b044d1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8d745390980b9c7fe7639600ac855496" level="file"><did><unittitle>TML, 43-92 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">2001 October 29</unitdate><container altrender="Record Storage Box (Paige)" id="8f3f44d0865e63b3ca7f719a3d647dcd" label="mixed materials [A0000000075901]" type="box">59</container><container id="25cbbf07f438efaff2ac4d52125b75d5" parent="8f3f44d0865e63b3ca7f719a3d647dcd" type="folder">1-3</container></did><accessrestrict id="08c08b71a5f549bb03c9e539391bf0c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c8e27cfe3b70673df671446dc0f171dd" level="file"><did><unittitle>TML, 43-43 - Choice of Lipid-lowering drugs</unittitle><unitdate type="inclusive">2001 May 28</unitdate><container altrender="Record Storage Box (Paige)" id="c72ad535d86cc06f9614196fbc757123" label="mixed materials [A0000000075901]" type="box">59</container><container id="6d247bc2080823ab3bc68a52d1611b14" parent="c72ad535d86cc06f9614196fbc757123" type="folder">4-10</container></did><accessrestrict id="12c485e70ce77057b564f5f005de3180"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b12b140d39cce8b86f62018ce31197dd" level="file"><did><unittitle>TML, 43-1 - Lopinavir - Ritonavir - A protease-inhibitor combination</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="2d286dbf1e2938f46f1987c9e30c55c5" label="mixed materials [A0000000075901]" type="box">59</container><container id="4b76d98b4c25a667272f6c7e533bfd80" parent="2d286dbf1e2938f46f1987c9e30c55c5" type="folder">11-13</container></did><accessrestrict id="cb4f314cadf4551b7cb834b70eadf1cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f3e4fd1faa4faa99ba52ed68b8dde6c9" level="file"><did><unittitle>TML, 43-87 - Drugs and vaccines against biological warfare</unittitle><unitdate type="inclusive">2001 October 19</unitdate><container altrender="Record Storage Box (Paige)" id="5c5df2ebe17f729d8e56922fa1e18122" label="mixed materials [A0000000075901]" type="box">59</container><container id="0791df268fff26cdf6376b0cf52e73bb" parent="5c5df2ebe17f729d8e56922fa1e18122" type="folder">14-17</container></did><accessrestrict id="19d192e97e549e2b446276124a3eb6b6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f8fecc1cfd922fa2df867ba43e2d95e6" level="file"><did><unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="a61b6859736a428fceab181a7d05bf59" label="mixed materials [A0000000075901]" type="box">59</container><container id="dba2abaa4dc6a9e46cb3257ce02ac541" parent="a61b6859736a428fceab181a7d05bf59" type="folder">18</container></did><accessrestrict id="bf0a0b9053f30a04f40935cc85ba1264"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3283e79cbed2dd24ba8423865f0e23c0" level="file"><did><unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="b413b73854fcc2f67fca0ce0c9f70c43" label="mixed materials [A0000000075902]" type="box">60</container><container id="a75a5773a7f55e200871d046c291db84" parent="b413b73854fcc2f67fca0ce0c9f70c43" type="folder">1</container></did><accessrestrict id="f2c531fe46fbd0a55fbf3a371d0cfb12"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b08aa5d6ed86fd5fceee0126fd84fd06" level="file"><did><unittitle>TML, 43-9 - Beta-Blockers</unittitle><unitdate type="inclusive">2001 February 5</unitdate><container altrender="Record Storage Box (Paige)" id="4f7b9d0df7c2f044966138a93ebca1d1" label="mixed materials [A0000000075902]" type="box">60</container><container id="646013b39e75573cc0b310a20683da16" parent="4f7b9d0df7c2f044966138a93ebca1d1" type="folder">2-6</container></did><accessrestrict id="6048933eb3a55f5f2d6a90721d4dd65f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="efb930d3872ae9d77c1298a07d7d5921" level="file"><did><unittitle>TML, 43-62 - Balsalazide (Colazal) for ulcerative colitis</unittitle><unitdate type="inclusive">2001 July</unitdate><container altrender="Record Storage Box (Paige)" id="8ed59d36ad05f96627cd99b37b0529f1" label="mixed materials [A0000000075902]" type="box">60</container><container id="f77d4f00f97d476cb515ead4a7034fec" parent="8ed59d36ad05f96627cd99b37b0529f1" type="folder">7-9</container></did><accessrestrict id="a454b4aa29b54507db7a4b31bd4c8d5f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b522bd1a5159bd2d2194d2263cc22904" level="file"><did><unittitle>TML, 43-11 - Argatroban for treatment of heparin-induced thrombocytopenia</unittitle><unitdate type="inclusive">2001 February 5</unitdate><container altrender="Record Storage Box (Paige)" id="18426d7c8f405ea1c4dc33f6b57bd1e4" label="mixed materials [A0000000075902]" type="box">60</container><container id="ecc4b062f5b4f47d3cb6a7dfe82a890a" parent="18426d7c8f405ea1c4dc33f6b57bd1e4" type="folder">10-12</container></did><accessrestrict id="a20e6edf2b912e65b1924e6cbfaf7256"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="46514d81205269c17a4b19d49a573235" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="3759b33c67a52278494e79b49872fe23" label="mixed materials [A0000000075902]" type="box">60</container><container id="e0988c942e65c4e6c6889cb6bc3970a7" parent="3759b33c67a52278494e79b49872fe23" type="folder">13-15</container></did><accessrestrict id="0ac715d063832982eec2283c964a4110"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6dc4850ed3f15e6085336df184251532" level="file"><did><unittitle>TML - Drugs of Choice - Osteoporosis</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="94ebaee0398c8d91ffd645b7e0a8e16a" label="mixed materials [A0000000075902]" type="box">60</container><container id="6851ec020e03730a0035d811376ec1f7" parent="94ebaee0398c8d91ffd645b7e0a8e16a" type="folder">16</container></did><accessrestrict id="a5d61d385919f6ecefd5058c2bf3e8d5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="02fc378d7f3b4b93e45c3eef89379858" level="file"><did><unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle><unitdate type="inclusive">2001 August 20</unitdate><container altrender="Record Storage Box (Paige)" id="aba2d088606871158b9d11b6b6c54e6f" label="mixed materials [A0000000075902]" type="box">60</container><container id="86c64ddb2d790e1c186bc81b90f2829d" parent="aba2d088606871158b9d11b6b6c54e6f" type="folder">17-18</container></did><accessrestrict id="a1e5c73ef6115e61a317948cb85a9927"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2c6bff42d1f14c6a829324e9782c498a" level="file"><did><unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle><unitdate type="inclusive">2001 August 20</unitdate><container altrender="Record Storage Box (Paige)" id="a9a92997de7ed1d13bbdc3aa0bbc7fd1" label="mixed materials [A0000000075903]" type="box">61</container><container id="3e71b829e947ada3a07a938ce06bc3d2" parent="a9a92997de7ed1d13bbdc3aa0bbc7fd1" type="folder">1-3</container></did><accessrestrict id="5b52a18cd7491854824957b6528aa161"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6bf6928a0695a21bf35c621f43a5b338" level="file"><did><unittitle>TML - Antimicrobial prophylaxis and Endocarditis - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="e2c6148acdd41d55936c058521784425" label="mixed materials [A0000000075903]" type="box">61</container><container id="82375f524773c38f2467e640b82e96bf" parent="e2c6148acdd41d55936c058521784425" type="folder">4-6</container></did><accessrestrict id="7c855f662c00758a77e6169900e656ac"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e83ae1dbb9d2dcd79b2efc11e8415787" level="file"><did><unittitle>TML - AIDS - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="714df85bdd2347bb5160e9b49e80ffef" label="mixed materials [A0000000075903]" type="box">61</container><container id="bf141ecf81c4f77d0f053f9ca9c877ba" parent="714df85bdd2347bb5160e9b49e80ffef" type="folder">7-11</container></did><accessrestrict id="6f3b8da68a968edcf7612c6c7ab0d96d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c6e64d3eb72280cbc65604fd0d1ef63b" level="file"><did><unittitle>TML, 43-91 - Post Exposure Anthrax prophylaxis</unittitle><unitdate type="inclusive">2001 October 29</unitdate><container altrender="Record Storage Box (Paige)" id="79f26148356f93c93f325ca62d3baf12" label="mixed materials [A0000000075903]" type="box">61</container><container id="8a8ae9d1f3333fb873295c54bfb07a41" parent="79f26148356f93c93f325ca62d3baf12" type="folder">12-13</container></did><accessrestrict id="c107fed35cdd31085f732308990ad842"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="41aa0763a7e36f6ce380706ce01181e3" level="file"><did><unittitle>TML, 43-54 - PEG-Intron for chronic Hepatitis C</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="9e39cb537902e10a4bb8799ecf781116" label="mixed materials [A0000000075903]" type="box">61</container><container id="e96acef0123a371d8973a9c1e79620a3" parent="9e39cb537902e10a4bb8799ecf781116" type="folder">14-16</container></did><accessrestrict id="10b78f31b326647359759629918503ac"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="21f79f7c6b4acd8a596b33dacb48841b" level="file"><did><unittitle>TML, 43-110 - Insulin Glargine - a new long-acting insulin</unittitle><unitdate type="inclusive">2001 August 6</unitdate><container altrender="Record Storage Box (Paige)" id="426dd9170cdca91ae8fe186107d42b3e" label="mixed materials [A0000000075903]" type="box">61</container><container id="b0bef1a6dd88423abdb909cb914b98a1" parent="426dd9170cdca91ae8fe186107d42b3e" type="folder">17-19</container></did><accessrestrict id="ce544613fec94a632b764ccaa6155e27"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2eed515acb400c24339036029a7a8f49" level="file"><did><unittitle>TML, 43-29 - Nateglinide for Type 2 diabetes</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="fcd1083484acaf8b015f4507eb22a0c5" label="mixed materials [A0000000075904]" type="box">62</container><container id="915739023105446fa071841bc645ca7f" parent="fcd1083484acaf8b015f4507eb22a0c5" type="folder">1-3</container></did><accessrestrict id="7bf007b3c2f616cf82e76b675923a0ae"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ccba2cedcccf56cdefa0e205fc19e877" level="file"><did><unittitle>TML - Drugs of Choice - Cancer</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="fe0f3bb75631b03afed50a5aa8e22430" label="mixed materials [A0000000075904]" type="box">62</container><container id="ada4cd1c5671985bcdf371835442b758" parent="fe0f3bb75631b03afed50a5aa8e22430" type="folder">4-5</container></did><accessrestrict id="d687a473729a78247a1c380123065159"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8b4de852b3dcabc7ad6e003cb57745bf" level="file"><did><unittitle>TML, 43-100 - Nesiritide for decompensated congestive heart failure</unittitle><unitdate type="inclusive">2001 November 12</unitdate><container altrender="Record Storage Box (Paige)" id="d1a11deeadc5f65d3899a904d1dfb215" label="mixed materials [A0000000075904]" type="box">62</container><container id="2bb9d915aad2423f57dceaa6172f2fb1" parent="d1a11deeadc5f65d3899a904d1dfb215" type="folder">6-9</container></did><accessrestrict id="60722a1253dc5c989a1fb84363bf8347"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ae81e26ee03016b7e8a19efe2323b2b6" level="file"><did><unittitle>TML, 43-35 - Non-Sedating Antihistamines</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="d87d1028f22739dd252e930cdd553ca6" label="mixed materials [A0000000075904]" type="box">62</container><container id="772c5fa0a760372b1cc92fc24cb8526b" parent="d87d1028f22739dd252e930cdd553ca6" type="folder">10-13</container></did><accessrestrict id="e3c9df3f442f047a5b6b393b36042f5b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ebbf6e65860c02f436f6ca0982c14e3e" level="file"><did><unittitle>TML, 43-17 - Drugs for hypertension</unittitle><unitdate type="inclusive">2001 March 5</unitdate><container altrender="Record Storage Box (Paige)" id="11b9796b5e61a375646699a9787d3979" label="mixed materials [A0000000075904]" type="box">62</container><container id="5447380b6b37902a324949094e81c3c5" parent="11b9796b5e61a375646699a9787d3979" type="folder">14-18</container></did><accessrestrict id="3e2fa8d34c5d3f85b91b8b755235d673"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="dc20397e0f8fc97006ecdf0d5f679b73" level="file"><did><unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="6a1b6fefa147cd7764545e5dd0565353" label="mixed materials [A0000000075904]" type="box">62</container><container id="481dc8d2b278e95e224333adf5a5d45f" parent="6a1b6fefa147cd7764545e5dd0565353" type="folder">19</container></did><accessrestrict id="bedf8436e8ecc88cef43b4466703321f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2a3e11c7291578855058677f583ba4cc" level="file"><did><unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="b6996a47553d49a294ba0e3b5d62860d" label="mixed materials [A0000000075905]" type="box">63</container><container id="c6362a282bb944c516aecfc482d92549" parent="b6996a47553d49a294ba0e3b5d62860d" type="folder">1-2</container></did><accessrestrict id="1faf2fbe4c747499b17f777c7da8d367"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="7aeba34ec44547fe9581d43a0fc4043e" level="file"><did><unittitle>TML, 43-6 - Nebulized Budesonide for Asthma in children</unittitle><unitdate type="inclusive">2001 January 27</unitdate><container altrender="Record Storage Box (Paige)" id="3c8b2f28413be682e5d12a303526527c" label="mixed materials [A0000000075905]" type="box">63</container><container id="9addb9824da12eb2409bbe312e8f12c5" parent="3c8b2f28413be682e5d12a303526527c" type="folder">3-7</container></did><accessrestrict id="d1f83bcd9d1dba630ab83fe624589365"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9011b2319d9d385461bdca83ff03a269" level="file"><did><unittitle>TML, 42-2 - Cool Click - a needle-free device for growth hormone delivery</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="19ffc40eaf583ba953adfbeb6a0ee965" label="mixed materials [A0000000075905]" type="box">63</container><container id="83964268518715b8ed9b3ac8d0902c73" parent="19ffc40eaf583ba953adfbeb6a0ee965" type="folder">8-10</container></did><accessrestrict id="d1142cfc576dc71445c5513786f60e47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="43f128e719abd7716a8b552dab41b4ca" level="file"><did><unittitle>TML, 43-84 - Cord Blood Banks</unittitle><unitdate type="inclusive">2001 October 1</unitdate><container altrender="Record Storage Box (Paige)" id="edc0b22286dc1d843bf0257e83410b3d" label="mixed materials [A0000000075905]" type="box">63</container><container id="09164e72b0b996dbe5a8150c228606f3" parent="edc0b22286dc1d843bf0257e83410b3d" type="folder">11-14</container></did><accessrestrict id="d355e32a24f6cffb35162f5a565f8aad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2ca4ec46f32a50a21f55760304d5080b" level="file"><did><unittitle>TML, 43-59 - Initital treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="17d583dbd0f0191a6adeacc226d66232" label="mixed materials [A0000000075905]" type="box">63</container><container id="6ee8f5ca74ed41a9cfbbac96da69675b" parent="17d583dbd0f0191a6adeacc226d66232" type="folder">15-16</container></did><accessrestrict id="12449f363aa33b967622999d1c656f25"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f4881e412a79293a02fce06ab7ada62d" level="file"><did><unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="3153d58963f70c175e012cc82c0de4f7" label="mixed materials [A0000000075905]" type="box">63</container><container id="9f136ecb4bc796087810efcb02292fbf" parent="3153d58963f70c175e012cc82c0de4f7" type="folder">17-20</container></did><accessrestrict id="762520a711ae5cf2f881c37d75c585e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="076a7f8b55c4644de3dc62c6db843a72" level="file"><did><unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="0bf80c1dd7192ea9e65cf84728ae9d3c" label="mixed materials [A0000000075906]" type="box">64</container><container id="30833bb12b808514bdc663c11582cbe8" parent="0bf80c1dd7192ea9e65cf84728ae9d3c" type="folder">1-2</container></did><accessrestrict id="0e6e931602cabb1fe060a758f1e09d3e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="98d5e522f0e12ef676f68b6296b375c4" level="file"><did><unittitle>TML, 43-61 - Lung Cancer screening</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="a261a7753d91728d13d468875e8a6fee" label="mixed materials [A0000000075906]" type="box">64</container><container id="d9fb0496fe5930c6ac6d18da6f3ce05c" parent="a261a7753d91728d13d468875e8a6fee" type="folder">3-5</container></did><accessrestrict id="1fa9376a18b8cabf3a1ced8db4bc6995"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="bbfbf04fd92af083cfe5f2803138df54" level="file"><did><unittitle>TML, 43-7 - Mirena</unittitle><unitdate type="inclusive">2001 January 22</unitdate><container altrender="Record Storage Box (Paige)" id="3f6321fbf606f1ad2206b85ce0df3555" label="mixed materials [A0000000075906]" type="box">64</container><container id="d7a7bc6aa111a27e4685059727c9935e" parent="3f6321fbf606f1ad2206b85ce0df3555" type="folder">6-8</container></did><accessrestrict id="6eb2c131de0d820a3d57bfd6b90300e6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3b86dfd5896dc8ed385111ad16cbd218" level="file"><did><unittitle>TML, 43-109 - Darbopoetin (Aranesp) - a long acting erythropoietin</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="f0ad9b3501263a611f85e3b9b10063f0" label="mixed materials [A0000000075906]" type="box">64</container><container id="6d9e1ef76930d1a3b8908c2d410c502a" parent="f0ad9b3501263a611f85e3b9b10063f0" type="folder">9-10</container></did><accessrestrict id="f505d3982f99b3e642ccbf40fbd75883"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="0f9927bdf850374dd901cc030c68dc7c" level="file"><did><unittitle>TML - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">2001 April 6</unitdate><container altrender="Record Storage Box (Paige)" id="7ca51b78399459937ebb714b108302b1" label="mixed materials [A0000000075906]" type="box">64</container><container id="7836144b10b311cd55f98ec8ec9a4ce6" parent="7ca51b78399459937ebb714b108302b1" type="folder">11-14</container></did><accessrestrict id="6be4b2a90096d23f4c7270994aa74f17"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="97fc093a6a8e4909bb2c604168b0b754" level="file"><did><unittitle>TML, 43-58 - Caspofungin (Candidas) for aspergillosis</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="37f3c931859e1b217db68b7de31f4b35" label="mixed materials [A0000000075906]" type="box">64</container><container id="00029552358f7e39d0e99047f6d44b3d" parent="37f3c931859e1b217db68b7de31f4b35" type="folder">15-18</container></did><accessrestrict id="f836855e02f4d6fe9f63b628886a4c85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6da20ff4a72dc0604ae511c5634291e7" level="file"><did><unittitle>TML, 43-55 - A new snake antivenin</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="56cd43199b68297c5648009b1b988908" label="mixed materials [A0000000075906]" type="box">64</container><container id="7e0183010148c5a78464aa48bd8e284c" parent="56cd43199b68297c5648009b1b988908" type="folder">19-20</container></did><accessrestrict id="f08173f37c2607c4d273372be7fedab1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ede8d569017eb650ffb86947aa817ebe" level="file"><did><unittitle>TML, 43-110 - Zometa (Zoledronic Acid) for injection</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="05cf83887c8016f4d6e9b5d0b740d796" label="mixed materials [A0000000075907]" type="box">65</container><container id="6d60d5241ccf43d3a51df9a49371110a" parent="05cf83887c8016f4d6e9b5d0b740d796" type="folder">1-3</container></did><accessrestrict id="3a54c329c0d6d0bc229bdd0616332d9d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a2f1959db87c3ed2aeb2a70eafd0d767" level="file"><did><unittitle>TML, 43-51 - Ziprasidone (Geodon) for schizophrenia</unittitle><unitdate type="inclusive">2001 June 11</unitdate><container altrender="Record Storage Box (Paige)" id="9e9e3fc90d8413fc0f56774c4079450f" label="mixed materials [A0000000075907]" type="box">65</container><container id="bc2ee12b456889251dea3dbd5590d6c1" parent="9e9e3fc90d8413fc0f56774c4079450f" type="folder">4-7</container></did><accessrestrict id="810ad5d825ba01f69c55af09b52e33af"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8068f52546b65b321ac2f5fa6a731f4c" level="file"><did><unittitle>TML, - Drugs for depression and anxiety</unittitle><unitdate type="inclusive">2001 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="9322a3b9992c9b2d9f38e681b2d3e340" label="mixed materials [A0000000075907]" type="box">65</container><container id="35336feb476dbc8fd9746df69c28b332" parent="9322a3b9992c9b2d9f38e681b2d3e340" type="folder">8-10</container></did><accessrestrict id="67940cb71724cb07bb1c047808a223cf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="55a8ca16b598343eb87537a2d296ecd1" level="file"><did><unittitle>TML, 43-15 - PC-Spes</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="6b28acf6d02bbc9cae505cb0b826b22b" label="mixed materials [A0000000075907]" type="box">65</container><container id="860985632bc8062c47833512ea86089b" parent="6b28acf6d02bbc9cae505cb0b826b22b" type="folder">11-12</container></did><accessrestrict id="75c2794ebd1f11660bcef03019daccd2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ebe0e5315e3cdfa6495aed9cdada44d6" level="file"><did><unittitle>TML, 43-83 - Metadate (Extended-Release Methylphenidate)</unittitle><unitdate type="inclusive">2001 October 1</unitdate><container altrender="Record Storage Box (Paige)" id="192100e599e6b757fcd1e706afa3e831" label="mixed materials [A0000000075907]" type="box">65</container><container id="fceabb42b4123c7a91a31905334c94f4" parent="192100e599e6b757fcd1e706afa3e831" type="folder">13-16</container></did><accessrestrict id="07f8b933648e23ed47138c1bef096df8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="833ebff3fb7c7c45c0c064414304d04f" level="file"><did><unittitle>TML, 43-49 - Gleevec (STI-571) for chronic myeloid leukemia</unittitle><unitdate type="inclusive">2001 June 11</unitdate><container altrender="Record Storage Box (Paige)" id="51d18925e37ae0335fc5347332d90a2c" label="mixed materials [A0000000075907]" type="box">65</container><container id="dfa7825413731432a302ccf814dae0a8" parent="51d18925e37ae0335fc5347332d90a2c" type="folder">17-18</container></did><accessrestrict id="8a48c9bb323707808cd2699c098b90df"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e579c81ba72fe1f002ea554c42ec0eb7" level="file"><did><unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="7d0e84687bfd4fb302d99980cc90de8a" label="mixed materials [A0000000075907]" type="box">65</container><container id="9bdf9b358a2d14842b9f8ca737dc864b" parent="7d0e84687bfd4fb302d99980cc90de8a" type="folder">19</container></did><accessrestrict id="5b72b0c715fd854e87ba957e71353a88"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2c8e55774a1bb77e5eb47e4cd5592dca" level="file"><did><unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="530b305f4e3b6f86d32a7caa15b03f59" label="mixed materials [A0000000075908]" type="box">66</container><container id="62968a559cbd329976b44bb493031ea1" parent="530b305f4e3b6f86d32a7caa15b03f59" type="folder">1</container></did><accessrestrict id="45e2eef135b65b2a4bc8bfac6895eae6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a3e98844edbadfd1126f96dcee9fa072" level="file"><did><unittitle>TML, 43-89 - Insulin Aspart - a new rapid-acting insulin</unittitle><unitdate type="inclusive">2001 October 15</unitdate><container altrender="Record Storage Box (Paige)" id="27afaafea4354ce85168d932d59d685d" label="mixed materials [A0000000075908]" type="box">66</container><container id="a47e7c06e0a6a84515bcc81d580037b1" parent="27afaafea4354ce85168d932d59d685d" type="folder">2-3</container></did><accessrestrict id="95db9e419544c222951aae12dd139e45"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2330e815d4bdfd9c12c459306864dcca" level="file"><did><unittitle>TML, 43-103 - Drugs for HIV infection</unittitle><unitdate type="inclusive">2001 November 26</unitdate><container altrender="Record Storage Box (Paige)" id="4232387bb80dbdf5658eb2ef21232e90" label="mixed materials [A0000000075908]" type="box">66</container><container id="847ed2b99ddf9d08c22933d886bcc11d" parent="4232387bb80dbdf5658eb2ef21232e90" type="folder">4-7</container></did><accessrestrict id="ba5d1519c239af0bb83357cd9431cc00"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c9e718e37292bcb43f7c0f24dd8175bb" level="file"><did><unittitle>TML, 43-26 - Once-a-Week Alendronate (Fosamaz)</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="ae0512dd485daf0b46315db01c4354d9" label="mixed materials [A0000000075908]" type="box">66</container><container id="126e5bb1a0708b162b5df886097991ec" parent="ae0512dd485daf0b46315db01c4354d9" type="folder">8</container></did><accessrestrict id="3aaad115d37c1f7c6a8b419cea0284e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ce9f44342b0f523de0bfcb639e0134e8" level="file"><did><unittitle>TML - Drugs of Choice - Migraine - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="a4b6525badfc8ee9887d4adc2b0d2ea1" label="mixed materials [A0000000075908]" type="box">66</container><container id="cdd4b74ea80c284a443a7f80ef428172" parent="a4b6525badfc8ee9887d4adc2b0d2ea1" type="folder">9-10</container></did><accessrestrict id="9d4ad8765f4f79883181f256eb7f9879"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8c50daa78ebe0875cf14c75e503ea1c1" level="file"><did><unittitle>TML, Drugs of Choice - Pain</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="3138246c859a0a4d9d7fc5a60889f50e" label="mixed materials [A0000000075908]" type="box">66</container><container id="8299a6f5c7e2340d7c579b9785a1f631" parent="3138246c859a0a4d9d7fc5a60889f50e" type="folder">11</container></did><accessrestrict id="3b2728fff814b6aa47a93b6386e34381"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="468e734f765a9be3853dd86c21c17c5d" level="file"><did><unittitle>TML, 43-25 - Direct-to-Consumer advertisements for Glucophage XR</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="3d0be769f566f9d6ccd2ae737fff88d0" label="mixed materials [A0000000075908]" type="box">66</container><container id="f343b361f7813b7bbbee530f05147e69" parent="3d0be769f566f9d6ccd2ae737fff88d0" type="folder">12</container></did><accessrestrict id="82bce5eadd0f640bbbd014ce96f624b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d63b61dd440fbe48748ed3adaaa153a3" level="file"><did><unittitle>TML, 43-13 - Palivizumab update</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="8fea1fdfe4eff482c3f5562a568bd63d" label="mixed materials [A0000000075908]" type="box">66</container><container id="30141974f946b3fc11d1e3061fa98202" parent="8fea1fdfe4eff482c3f5562a568bd63d" type="folder">13-14</container></did><accessrestrict id="a7dd4884d34880dfc26867a2d2428bf1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="07c5a88addbecee925056539789a95ce" level="file"><did><unittitle>TML, 43-14 - Tinzaparin for treatment of deep vein thrombosis</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="302c308d46316cdb032d349bd2d124d2" label="mixed materials [A0000000075908]" type="box">66</container><container id="6026f3c7f94c8ff6bce24e6c724b9309" parent="302c308d46316cdb032d349bd2d124d2" type="folder">15-17</container></did><accessrestrict id="e9948bb5cd6966ff6405e6dc4196d47e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3c99102c3cbe6573776800745f8ae469" level="file"><did><unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="674d24cb0ea73f6c6c9365822cec7c5c" label="mixed materials [A0000000075908]" type="box">66</container><container id="d97e9b1a7897c19c96b317092b60a95f" parent="674d24cb0ea73f6c6c9365822cec7c5c" type="folder">18-20</container></did><accessrestrict id="0e83e8dd8e86709df7f972ac81515598"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c6baca4f86fe997597684780a50afb04" level="file"><did><unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="769208f17ad5eae8531f59057f01bc0d" label="mixed materials [A0000000075909]" type="box">67</container><container id="fb66740f493fe91f5bbf439ae4d69600" parent="769208f17ad5eae8531f59057f01bc0d" type="folder">1</container></did><accessrestrict id="a04d9293e94b60a9e39c9b4189abc925"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="21563c371ed6d15964e3cc6b122e8325" level="file"><did><unittitle>TML, 43-31 - Advair "Diskus" - A combination of fluticasone and salmeterol for asthma</unittitle><unitdate type="inclusive">2001 April 6</unitdate><container altrender="Record Storage Box (Paige)" id="b7a9d2115bb022657446a94172a4940c" label="mixed materials [A0000000075909]" type="box">67</container><container id="611fab10447f84958cc58889491f2cda" parent="b7a9d2115bb022657446a94172a4940c" type="folder">2-5</container></did><accessrestrict id="591f5ce0464ac805e58c930e1f206114"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a56fc8ba008f5ec96cb059f94525d216" level="file"><did><unittitle>TML, 43-5 - Fluoxetine (Sarafem) for premenstrual dysphoric disorder</unittitle><unitdate type="inclusive">2001 January 22</unitdate><container altrender="Record Storage Box (Paige)" id="0a766575d0e2f5eb70dced8c4ad16818" label="mixed materials [A0000000075909]" type="box">67</container><container id="176a6f7ce25d2e99c63077036f178b71" parent="0a766575d0e2f5eb70dced8c4ad16818" type="folder">6-8</container></did><accessrestrict id="516c40c3c42f23a1ef834fac3280423d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="29dd0d00d8ca1ffa9497a61ade7fcac7" level="file"><did><unittitle>TML, 43-57 - Levothyroxine</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="e042521915be5f089e5c78ce1e290fb6" label="mixed materials [A0000000075909]" type="box">67</container><container id="ed68b759b5ad08a282cda721c9a331eb" parent="e042521915be5f089e5c78ce1e290fb6" type="folder">9-11</container></did><accessrestrict id="5e4d50d8e1cee2179d409a4d58ebfe39"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d2d95b76affb3a4c9b22a381ae08576d" level="file"><did><unittitle>TML, 43-28 - Detrol LA and Ditropan XL for overactive bladder</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="326532a3b83db58c0f23e896cfdde11f" label="mixed materials [A0000000075909]" type="box">67</container><container id="6d2b6c3a6e4f509a9e7a50d0285ea818" parent="326532a3b83db58c0f23e896cfdde11f" type="folder">12-13</container></did><accessrestrict id="c2a600b167a1d8ec49922e49f096e4ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="bf76f78ab4a4977fe44b60003b8f05f2" level="file"><did><unittitle>TML, 43-27 - Prozac Weekly</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="3c6e21c730d1b934670ecd70fd58592a" label="mixed materials [A0000000075909]" type="box">67</container><container id="227fb4fa326329aa2cb37794ff9f034d" parent="3c6e21c730d1b934670ecd70fd58592a" type="folder">14</container></did><accessrestrict id="154ff78d3302dfb71a0c20f63e7f510f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d6b0a2f70273ff0516f8b345cdc4f512" level="file"><did><unittitle>TML - Drugs for migraine</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="9a8c34298a69c590c88dfb38e56de92c" label="mixed materials [A0000000075909]" type="box">67</container><container id="f7557b52228551032ba8fbc3e5293732" parent="9a8c34298a69c590c88dfb38e56de92c" type="folder">15-17</container></did><accessrestrict id="81584269571599c2534c39747bee7f6e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ab3c9b20ba673d3a09626a2131dfbd70" level="file"><did><unittitle>TML - Drugs for migraine</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="9a90643df3344c208a6573397427f4f3" label="mixed materials [A0000000075910]" type="box">68</container><container id="a63a5e6724a7b6e0a56b4819a9cd3820" parent="9a90643df3344c208a6573397427f4f3" type="folder">1</container></did><accessrestrict id="33ca4d5589e42adbdeba4c14888b39e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ce9d0ae7e21eaea0c4687dae309cfee9" level="file"><did><unittitle>TML, 43-67 - Twinrix - A combination Hepatitis A and B vaccine</unittitle><unitdate type="inclusive">2001 August 6</unitdate><container altrender="Record Storage Box (Paige)" id="966fd7e8bc5939b8601f9f28c2109b4b" label="mixed materials [A0000000075910]" type="box">68</container><container id="1a1688af3805d8a6ab6bf9a7c983655d" parent="966fd7e8bc5939b8601f9f28c2109b4b" type="folder">2-4</container></did><accessrestrict id="c860c07bca67d0f682cba26ca6577767"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="50348bc86f79794dd7d3880f772dc9fb" level="file"><did><unittitle>TML, 43-81 - Influenza prevention 2001-2002</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="1ee38d6e7ac9c5a81d104b907e59f205" label="mixed materials [A0000000075910]" type="box">68</container><container id="973de66f74ec6c1f27205247d057eae4" parent="1ee38d6e7ac9c5a81d104b907e59f205" type="folder">5-8</container></did><accessrestrict id="1bbd28b63a91d7783c47a3da12aa5197"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3b16d2ad8da51e66ff96ab39df1d0aac" level="file"><did><unittitle>TML, 43-33 - Topical tacrolimus treatment for atopic dermatitis</unittitle><unitdate type="inclusive">2001 April 16</unitdate><container altrender="Record Storage Box (Paige)" id="9f931820b8d28282412b0d582067b442" label="mixed materials [A0000000075910]" type="box">68</container><container id="8b2c401fc390a1c73378e276b07a55f7" parent="9f931820b8d28282412b0d582067b442" type="folder">9-12</container></did><accessrestrict id="524857adc52fa0f183b069d3ae7050b5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="41122ea5a6e7981f0132dc387c47d526" level="file"><did><unittitle>TML, 43-42 - Glucowatch Biographer - A noninvasive glucose monitoring device</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="aa993dcf58c853632716a75fc4e0a104" label="mixed materials [A0000000075910]" type="box">68</container><container id="6dd6d920e9d13b050546175d48e3db93" parent="aa993dcf58c853632716a75fc4e0a104" type="folder">13-14</container></did><accessrestrict id="8a2f04b8e85fd19c93d31127f994912c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="1f33fb25dbc24b2e3a9cc4123daa4b4c" level="file"><did><unittitle>TML, 43-99 - Cardiovascular Safety of COX-2 Inhibitors</unittitle><unitdate type="inclusive">2001 November 12</unitdate><container altrender="Record Storage Box (Paige)" id="893a25712ff2294efa90860faf1acaa0" label="mixed materials [A0000000075910]" type="box">68</container><container id="e7f7dabc9c074dbef4dcb503a47edf0a" parent="893a25712ff2294efa90860faf1acaa0" type="folder">15-17</container></did><accessrestrict id="ed26092ce8449e46cf63b80b2a291816"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9c5905505fca4831e512fb2648100be7" level="file"><did><unittitle>TML - Drugs of Choice - Hypertension and Heart Failure</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="4bc313be127d3bb350a3d911f23b824d" label="mixed materials [A0000000075910]" type="box">68</container><container id="ee1c3891e3652ea21d1b569491b0f0d2" parent="4bc313be127d3bb350a3d911f23b824d" type="folder">18</container></did><accessrestrict id="75c6bb282a1bebd46a6a30af50403e35"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d83158c1d6d2339140e8e837daa705b4" level="file"><did><unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="8aeb2a1d4c2dbb135d43040b72db23b8" label="mixed materials [A0000000075910]" type="box">68</container><container id="491d47fa78bd34c9bac88d37cbc97870" parent="8aeb2a1d4c2dbb135d43040b72db23b8" type="folder">19-21</container></did><accessrestrict id="a70ce5ed30190ec1d7686f21b89b6372"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="45a1a372dc6189c488cbf6dbf95adb8d" level="file"><did><unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="1a5478737f5b48955f58117807d2a9d9" label="mixed materials [A0000000075911]" type="box">69</container><container id="504613e224c096bb72ea5e2f8ad69ad0" parent="1a5478737f5b48955f58117807d2a9d9" type="folder">1</container></did><accessrestrict id="a1903924a041556ee7b26f4c2b26ac5e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="4cdec89511203afd4fe2dc98bb7107a3" level="file"><did><unittitle>TML, 43-3 - Drugs for Vulvovaginal Candidiasis</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="4eb469584ae18284c7cee0e098eb80f7" label="mixed materials [A0000000075911]" type="box">69</container><container id="6555138a7a5132fba6aa3d50ab4b2c8d" parent="4eb469584ae18284c7cee0e098eb80f7" type="folder">2-4</container></did><accessrestrict id="721d15062edf16474f8c9615e7343c9b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9c93f14bdbe03244367dc9260f841c8a" level="file"><did><unittitle>TML, 43-40 - Epoetin - Erythropoietin (Procrit; Epogen) Revisited</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="a354261c0818ae53a3a5f5b101862a95" label="mixed materials [A0000000075911]" type="box">69</container><container id="55aff466935ce6fd906584d2a3069f14" parent="a354261c0818ae53a3a5f5b101862a95" type="folder">5-8</container></did><accessrestrict id="0834865471315b83cd87445af0b5d964"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8c1db8b64ee78c1dea2315fd90476615" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="68ba6cfff38b4ce775be6d234deeb029" label="mixed materials [A0000000075911]" type="box">69</container><container id="3ea0b63e450d5bff1aff6d542958fb69" parent="68ba6cfff38b4ce775be6d234deeb029" type="folder">9-12</container></did><accessrestrict id="0b08c7f91d343d75d562eb65c74f54bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="42c85fbc002a3352f01a11a7e4a6f54d" level="file"><did><unittitle>TML, 43-36 - Esomeprazole (Nexium)</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="6c5c87a148e81ca5c8634c6bec881b12" label="mixed materials [A0000000075911]" type="box">69</container><container id="ec4e615f39a8278a476014adb331b478" parent="6c5c87a148e81ca5c8634c6bec881b12" type="folder">13-14</container></did><accessrestrict id="cc2db5a946dc97445662edf403135cfe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="dde7a8f4a1c15dd762a0160728804b73" level="file"><did><unittitle>TML, 43-111 - Update on glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="b9149de927a167647a34c10a864ff6c1" label="mixed materials [A0000000075911]" type="box">69</container><container id="f6bbb051ae6e6b54c0f3392a0b9379fc" parent="b9149de927a167647a34c10a864ff6c1" type="folder">15-17</container></did><accessrestrict id="5b2a4f2cbe109ddd0b02adec46206e8d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9666394f9b7e1594ab6d9d740833bf6d" level="file"><did><unittitle>TML, 43-53 - Galantamine (Reminyl) for Alzheimer's disease</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="69b98f43329485e65d794604257fba9a" label="mixed materials [A0000000075911]" type="box">69</container><container id="4e330ec39a567b27d9cd5cedc7f70069" parent="69b98f43329485e65d794604257fba9a" type="folder">18-20</container></did><accessrestrict id="64351c947d34d22cef39ad4007296824"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9e514faa1eb026a69873e6b610137535" level="file"><did><unittitle>TML, 43-80 - Oxycodone and Oxycontin</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="8bb5d4f470cd9836020e38c7b19ce25a" label="mixed materials [A0000000075912]" type="box">70</container><container id="2b02686a5d5afb4a1d2e85a009ef3e93" parent="8bb5d4f470cd9836020e38c7b19ce25a" type="folder">1-4</container></did><accessrestrict id="71c26f172f9a9a3876c7b24d11cc0db1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9bf44e00458f50d0ecc17dc1d13c078a" level="file"><did><unittitle>TML - Drugs of Choice - Asthma - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="91bf1084b4b66cf6bb1aee3e18ab4379" label="mixed materials [A0000000075912]" type="box">70</container><container id="175139e359a775e97da8d746ed26223e" parent="91bf1084b4b66cf6bb1aee3e18ab4379" type="folder">5-7</container></did><accessrestrict id="753a55d97a80d113ee2476718a3d1661"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="0dc13b68cd4edd9b7be7bd34aad97ff0" level="file"><did><unittitle>TML - Drugs of Choice - Hypertension - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="0e1249424a9ca7d88dda07cb02d8aa29" label="mixed materials [A0000000075912]" type="box">70</container><container id="3eeeeb6525b9e42a48702bc87b5cf333" parent="0e1249424a9ca7d88dda07cb02d8aa29" type="folder">8-10</container></did><accessrestrict id="d504ebc62c5421f5e1d907042650019a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="28985057e383ceb12ff871b5d26e61da" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="d88ce10434e2b13cf2433bd3dce06c05" label="mixed materials [A0000000075912]" type="box">70</container><container id="e823e2227030b2d8be4db15cbd109bce" parent="d88ce10434e2b13cf2433bd3dce06c05" type="folder">11-13</container></did><accessrestrict id="22fbfc715602ec37fdf0114b7cb13cbe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e9eaa9b717e217af3529d05e6f9fbd9e" level="file"><did><unittitle>TML - Drugs of Choice - Arthritis - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="bfd70b524e6a326bf489e8528bcb8d9d" label="mixed materials [A0000000075912]" type="box">70</container><container id="68f8731fcc27f7ad7faffaaf4c8c1367" parent="bfd70b524e6a326bf489e8528bcb8d9d" type="folder">14-15</container></did><accessrestrict id="b5d06faa04330361ca1ca75b21c017fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a8579ee641a8d372e5b92c341780d2f0" level="file"><did><unittitle>TML - Drugs of Choice - Depression and Anxiety</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="849c682b4bf95bc5be258a5f1f3a6c54" label="mixed materials [A0000000075912]" type="box">70</container><container id="6b851b88bf81e2070a4ef1bbfe49a423" parent="849c682b4bf95bc5be258a5f1f3a6c54" type="folder">16-17</container></did><accessrestrict id="85e3914a93c77fea32c035bd079cdf38"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d1091da187ca03263e9fbe06a0c8e8b9" level="file"><did><unittitle>TML, 44-105 - Adefovir (Hespera) for chronic Hepatitis B infection</unittitle><unitdate type="inclusive">2002 December 9</unitdate><container altrender="Record Storage Box (Paige)" id="8af32178f5fd7cb018c64302036eea58" label="mixed materials [A0000000075913]" type="box">71</container><container id="4be5c9b3d9ea6ee24bf43cdcd1666472" parent="8af32178f5fd7cb018c64302036eea58" type="folder">1-4</container></did><accessrestrict id="5e9a358af553725b2b7a0e754e583db4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a52ad11ec1e3f4d9273267e959212194" level="file"><did><unittitle>TML, 44-67 - Alosetron (Lotronex) revisited</unittitle><unitdate type="inclusive">2002 August 5</unitdate><container altrender="Record Storage Box (Paige)" id="034e5da2782d750da059b9991e9d80d8" label="mixed materials [A0000000075913]" type="box">71</container><container id="4465f0d5df767e5ce56cd310af8bb619" parent="034e5da2782d750da059b9991e9d80d8" type="folder">5-8</container></did><accessrestrict id="44f937981b03e47fe5b48832e2bc3c06"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="524bcd1ef0983fc228db57fdceccbd8a" level="file"><did><unittitle>TML, 44-1 - Prevention and treatment of injury from chemical biological warfare</unittitle><unitdate type="inclusive">2002 January 7</unitdate><container altrender="Record Storage Box (Paige)" id="b2a8bc49c14c28edd0704e9df7361094" label="mixed materials [A0000000075913]" type="box">71</container><container id="1590829c10568fcfd7f69ead053f91c4" parent="b2a8bc49c14c28edd0704e9df7361094" type="folder">9-11</container></did><accessrestrict id="41a008738c8b0cf8972cf6b24432d838"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bad1e6f9e4ec0f760e77c31253787c34" level="file"><did><unittitle>TML, 44-18 - Anakinra (Kineret) for rheumatoid arthritis</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="5f424a044d5f9d4c635b940741c18bd5" label="mixed materials [A0000000075913]" type="box">71</container><container id="faeb14ccea2a11ce16bfb4463a986f63" parent="5f424a044d5f9d4c635b940741c18bd5" type="folder">12-13</container></did><accessrestrict id="5283c1dbc9ae363bd049db90b8c9f8d8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ba78803aaafb030f1962308400163490" level="file"><did><unittitle>TML, 44-19 - Almotriptan (Axert) and Frovatriptan (Friva) for migraine</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="8a011e0a8564e25e977a9ae0214e9e4e" label="mixed materials [A0000000075913]" type="box">71</container><container id="e517a7cb34024804943d7a7d95d9dce1" parent="8a011e0a8564e25e977a9ae0214e9e4e" type="folder">14-16</container></did><accessrestrict id="261eac7e701cc4253a133eadd4895b0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bb6077375b3a6ffeb4bb53556a4f4c3c" level="file"><did><unittitle>TML, 44-110 - Hemolysis from Ceftriaxone</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="b47df351ea7dc3574e84e41a41408dcf" label="mixed materials [A0000000075913]" type="box">71</container><container id="98dad67c08e15e1af335e2f4bb47df11" parent="b47df351ea7dc3574e84e41a41408dcf" type="folder">17-19</container></did><accessrestrict id="06663a53b51c9f32469146874e6a53fd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a4e45a144c74f16ab14378047e5576f1" level="file"><did><unittitle>TML, 44-6 - Budesonide (Entocort EC) for Crohn's disease</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="f7842376913851d229e9237db22e745d" label="mixed materials [A0000000075913]" type="box">71</container><container id="2ab0d3a0cdbfd16915e8db8f88a67149" parent="f7842376913851d229e9237db22e745d" type="folder">20-21</container></did><accessrestrict id="344623fd522ad204005bd4713a3a7eaa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9f13d0adec34e41920a5e68ddd64292c" level="file"><did><unittitle>TML, 44-109 - Dustateride (Avodart) for benign prostatic hyperplasia</unittitle><unitdate type="inclusive">2002 December 23</unitdate><container altrender="Record Storage Box (Paige)" id="abd29fcc548bdb6097edc8c63d758201" label="mixed materials [A0000000075914]" type="box">72</container><container id="cfaf2829db7682b03250b4f0b70f211c" parent="abd29fcc548bdb6097edc8c63d758201" type="folder">1</container></did><accessrestrict id="867284bb3e82161ed3ce13cf85bb50cf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9263ee3a396996d1f6c92f91c990e8b4" level="file"><did><unittitle>TML, 44-55 - Yasmin - an oral contraceptive with a new progestin</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="a760a9ffeb0e5c2259541c796d9f8a0c" label="mixed materials [A0000000075914]" type="box">72</container><container id="0b30cab622555eac1ef2275c688b9c4a" parent="a760a9ffeb0e5c2259541c796d9f8a0c" type="folder">2-7</container></did><accessrestrict id="c400e4bb55cfe7ea165cfb2d2dc99c6b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="fec2a29720e66cc581b066877ffa632d" level="file"><did><unittitle>TML, 44-8 - Othro Evra - A contraceptive patch</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="9cce4c4ee055e7921b9483e879bec119" label="mixed materials [A0000000075914]" type="box">72</container><container id="a8548519033896051919894ffc30a6af" parent="9cce4c4ee055e7921b9483e879bec119" type="folder">8-9</container></did><accessrestrict id="f89be5a42a6e7c9142c05161a1bb4330"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ea19cfea9c41aa789e87a27139849cc9" level="file"><did><unittitle>TML, 44-42 - Copyright violations</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="27d6631ca992de0bfaa69e4084fba1e5" label="mixed materials [A0000000075914]" type="box">72</container><container id="6ddb849629c373548f8534ab1060a776" parent="27d6631ca992de0bfaa69e4084fba1e5" type="folder">10</container></did><accessrestrict id="ec1aa5a5bbffa7071d0ee4e1725ec096"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="573b9aa7949c2b6064549d58f22d1ef4" level="file"><did><unittitle>TML, 44-89 - Generic drugs</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="d1f718b9edef40b45c205eb39a7507b3" label="mixed materials [A0000000075914]" type="box">72</container><container id="4d90ee9ab169eb9aba5b77abbc32d1f8" parent="d1f718b9edef40b45c205eb39a7507b3" type="folder">11-13</container></did><accessrestrict id="5b1243a2f3ac837601682945b4ad6a9e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="eca6e6e8880da77ade266c114c4c3ef8" level="file"><did><unittitle>TML, 44-77 - Gefitinib (Iressa) for advanced non-small cell lung cancer</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="59eb74fa732696ddd03c7c50c9f11516" label="mixed materials [A0000000075914]" type="box">72</container><container id="27a6e9e389b83e0fa861e04f9d37b087" parent="59eb74fa732696ddd03c7c50c9f11516" type="folder">14-16</container></did><accessrestrict id="e52979497dde6f1c31a59d9d3764a403"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a5125bf7e9b481c9cf3b474c751ee55e" level="file"><did><unittitle>TML, 44-103 - GHB for nacolepsy</unittitle><unitdate type="inclusive">2002 December 9</unitdate><container altrender="Record Storage Box (Paige)" id="4e7928292614d81af3f5a48fd1205511" label="mixed materials [A0000000075914]" type="box">72</container><container id="e1466eadb729e7c1375adc585b60dd5f" parent="4e7928292614d81af3f5a48fd1205511" type="folder">17-19</container></did><accessrestrict id="0fce222a44f0f4d669d6446bfe4d0948"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="5f1f43a60e3a918e61f1524dd78e1670" level="file"><did><unittitle>TML - Fungal Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="5eb75defa86ab171321f0d44133b611d" label="mixed materials [A0000000075914]" type="box">72</container><container id="fdc1f0a029de1b11c5ef39053a7f4093" parent="5eb75defa86ab171321f0d44133b611d" type="folder">20</container></did><accessrestrict id="43b31e9dd0e56b4393c587638541da8a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d0277fd8830f2d769496c88f15bb859c" level="file"><did><unittitle>TML - Fungal Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="5077f34397a22b28c2b224bb40a8fb62" label="mixed materials [A0000000075915]" type="box">73</container><container id="540ce8578527498e18403d9aed139a78" parent="5077f34397a22b28c2b224bb40a8fb62" type="folder">1</container></did><accessrestrict id="0374c695f899676ae2f0f4ab46c32079"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="38f15317a1ab04ccab7ddf87c59865ca" level="file"><did><unittitle>TML, 44-65 - Fulvestrant (Faslodex) for advanced breast cancer</unittitle><unitdate type="inclusive">2002 July 22</unitdate><container altrender="Record Storage Box (Paige)" id="2e6bee72391005153140c18ff0d67aba" label="mixed materials [A0000000075915]" type="box">73</container><container id="f63ee9f898d518ba99c512b3fb57352f" parent="2e6bee72391005153140c18ff0d67aba" type="folder">2-4</container></did><accessrestrict id="ce879f9aa1fe59c4646fb8a958d249d1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c2dd44962d67176662e4db78dd0a66d1" level="file"><did><unittitle>TML, 44-5 - Cefditoren (Spectracef) - A new oral cephalosporin</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="c22ae425fb96031dcc756d5e08e9c0c7" label="mixed materials [A0000000075915]" type="box">73</container><container id="543b52f05e170cac7d7e182b629608b3" parent="c22ae425fb96031dcc756d5e08e9c0c7" type="folder">5-7</container></did><accessrestrict id="a137a040fd97e7017313ae9a82d2fe86"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="70993f6f906adca6d28b7cec87c5cbab" level="file"><did><unittitle>TML, 44-93 - Drugs past their expiration date</unittitle><unitdate type="inclusive">2002 October 28</unitdate><container altrender="Record Storage Box (Paige)" id="46b63ce4ff0e470aaea39aef341d0ca7" label="mixed materials [A0000000075915]" type="box">73</container><container id="8149334c3cc1c6d2e7ab354899437863" parent="46b63ce4ff0e470aaea39aef341d0ca7" type="folder">8-10</container></did><accessrestrict id="e06690c5813977cdcc6c8a5a7653718f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f9bc602671296cc3d2de922401f1986e" level="file"><did><unittitle>TML, 44-83 - Escitalopram (Lexapro) for depression</unittitle><unitdate type="inclusive">2002 September 30</unitdate><container altrender="Record Storage Box (Paige)" id="e66eb3b1fe7ffc2db8257c7ee826bd00" label="mixed materials [A0000000075915]" type="box">73</container><container id="9664117c5c2afc2d99d1df55b79468e9" parent="e66eb3b1fe7ffc2db8257c7ee826bd00" type="folder">11-12</container></did><accessrestrict id="fdb13be24c2193fa8c3289e7d5ad654a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="88bf2c423e244a87d79645badbf2e9f3" level="file"><did><unittitle>TML, 44-43 - Fondaparinux (Arixtra) - a new anticoagulant</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="60d84448b21d9ea7010158bee2f4c50d" label="mixed materials [A0000000075915]" type="box">73</container><container id="b7725523ff90184fc679ca610f8907aa" parent="60d84448b21d9ea7010158bee2f4c50d" type="folder">13-15</container></did><accessrestrict id="bbbdd53df2b8ebd0612902a21d46a748"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="05b64e3022467a23598c9201bc74dfdf" level="file"><did><unittitle>TML - Cefepime</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="ff9f2b4c9543bafd9e5524fd61cd7c4d" label="mixed materials [A0000000075915]" type="box">73</container><container id="f340873636902ceff971bf4d0aefe16d" parent="ff9f2b4c9543bafd9e5524fd61cd7c4d" type="folder">16-18</container></did><accessrestrict id="394b3115bcff39760eac5c39dc81bdb6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0b79a2b45ac5a48beb03988b3255f34c" level="file"><did><unittitle>TML, 44-126 - Eratapenem - a new parenteral carbapenem</unittitle><unitdate type="inclusive">2002 March 18</unitdate><container altrender="Record Storage Box (Paige)" id="ffcb684ab2847d709f038a6596c4e076" label="mixed materials [A0000000075915]" type="box">73</container><container id="af5563bbdba4ae7d3a051fdc53f76b24" parent="ffcb684ab2847d709f038a6596c4e076" type="folder">19-21</container></did><accessrestrict id="556a688586b09ef7523a269879e4d606"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2ab8dcb85ae9ce0ddd2d1fdc51a02ee6" level="file"><did><unittitle>TML - Echinacea</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="2c71a7cff9b3ce3ed90f0771527aba45" label="mixed materials [A0000000075916]" type="box">74</container><container id="e2fce1efa544b025b9206f9ad5673d27" parent="2c71a7cff9b3ce3ed90f0771527aba45" type="folder">1-3</container></did><accessrestrict id="dc18fb2ef4fb05f2fdaba6355d199ff6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="af85bd11efe07fd729751c8c218f32d2" level="file"><did><unittitle>TML, 44-47 - Botulinum Toxin (Botox Cosmetic) for frown lines</unittitle><unitdate type="inclusive">2002 May 27</unitdate><container altrender="Record Storage Box (Paige)" id="ceb436a47500d1a5e12a3e48c4afc03b" label="mixed materials [A0000000075916]" type="box">74</container><container id="4a056bba86d28339f631dd605b6bbd03" parent="ceb436a47500d1a5e12a3e48c4afc03b" type="folder">4-6</container></did><accessrestrict id="e67c688500af00baeca0146003fa4b6f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="45aa8fe42fd0ddc4536be77350df4b57" level="file"><did><unittitle>TML - Fungal Infections - Reprints</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="bf0ab13ec5f1129223139d2e73f951e4" label="mixed materials [A0000000075916]" type="box">74</container><container id="f83c351554c8d7681f60ed1bf6c04232" parent="bf0ab13ec5f1129223139d2e73f951e4" type="folder">7</container></did><accessrestrict id="1f1099e38699970b363bae0c6975a70b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2e47b4ee1607009a90bcdea23b07a404" level="file"><did><unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="cb271b2776461e3db8f85cbb62b927ce" label="mixed materials [A0000000075916]" type="box">74</container><container id="1a689f92c90528cfd75b3d6ab53f9683" parent="cb271b2776461e3db8f85cbb62b927ce" type="folder">8-19</container></did><accessrestrict id="831283e78ef78563e6f6b9e3060a60fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f41b47c09c3e11ca72cf6fe9fcfca8b2" level="file"><did><unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="1b9c31a5b5ba087d836ca7a930998c82" label="mixed materials [A0000000075917]" type="box">75</container><container id="34a07532919b3a242f731594534f081b" parent="1b9c31a5b5ba087d836ca7a930998c82" type="folder">1-2</container></did><accessrestrict id="37075cc131616efa32d821ddec70e19a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0785dbde88fe25acb019e68e53796851" level="file"><did><unittitle>TML, 44-73 - Neotame - a new artificial sweetner</unittitle><unitdate type="inclusive">2002 August 19</unitdate><container altrender="Record Storage Box (Paige)" id="a70962ce0b5aa9baac37895fe4b68bab" label="mixed materials [A0000000075917]" type="box">75</container><container id="7e54f7203cf1d6d7b5dae76dfc3e14c6" parent="a70962ce0b5aa9baac37895fe4b68bab" type="folder">3-4</container></did><accessrestrict id="423a699022dfc41e5a19356b8ede358f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="daec721a5877ed667e3be025c5b3972b" level="file"><did><unittitle>TML, 44-95 - Valacyclovir (Valtrex) for herpes labialis</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="a5071bfc44a30c5d8dc92b8b45852f51" label="mixed materials [A0000000075917]" type="box">75</container><container id="8a57b7f9bfeab8ece4ff3aae30c167a5" parent="a5071bfc44a30c5d8dc92b8b45852f51" type="folder">5-6</container></did><accessrestrict id="65275a0edfafc2779f6f3b12b167613d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="daaa98dacc14a33f7dd8c3607f43fabe" level="file"><did><unittitle>TML - Drugs for prevention and treatment of postmenopausal osteoporosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 November 1</unitdate><container altrender="Record Storage Box (Paige)" id="ca52c48523e85b34a55db5eb15820849" label="mixed materials [A0000000075917]" type="box">75</container><container id="10b0d33ad7982d3ccce739875b761ab8" parent="ca52c48523e85b34a55db5eb15820849" type="folder">7-10</container></did><accessrestrict id="66fca14cfc643877b243d938549ef683"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="6c5c80d095e7afd1c721854326e0f8cc" level="file"><did><unittitle>TML, 44-9 - Drugs for Non-HIV viral infections</unittitle><unitdate type="inclusive">2002 February 4</unitdate><container altrender="Record Storage Box (Paige)" id="d5fb23373fbcb339028ac845690f3d8f" label="mixed materials [A0000000075917]" type="box">75</container><container id="e90c2a26f1c57f4b237aa5512a146168" parent="d5fb23373fbcb339028ac845690f3d8f" type="folder">11-17</container></did><accessrestrict id="bdf05fc38d86db9b72f37658b33c4730"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bcfed60146a9353c15a7810e066eb562" level="file"><did><unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="b6a82e612f5d6e3964747eae1fa527cc" label="mixed materials [A0000000075917]" type="box">75</container><container id="5e7ce5d4b02713ad47849ef9ea84e510" parent="b6a82e612f5d6e3964747eae1fa527cc" type="folder">18-19</container></did><accessrestrict id="3f36d4c0ac7dd42dca225464d90a4a7b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="26f9f680797154013e700d36b1ee02cc" level="file"><did><unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="f8de7ad53819987b625ea35ebf5f0665" label="mixed materials [A0000000075918]" type="box">76</container><container id="130e6a6637ae61618fbdb158e837fabf" parent="f8de7ad53819987b625ea35ebf5f0665" type="folder">1-2</container></did><accessrestrict id="538e6db36155fc336b5cd7453b267830"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="87edb03339d8ce2c8587c9b08fa0c33c" level="file"><did><unittitle>TML, 44-52 - Tazarotene (Tazorac) for acne</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="b07ccb91127e949d769b7d4737d59316" label="mixed materials [A0000000075918]" type="box">76</container><container id="a6e8f5655a2922693051f31c7078f325" parent="b07ccb91127e949d769b7d4737d59316" type="folder">3-5</container></did><accessrestrict id="009827e7a43d5b337cbe6459416c7913"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="4e2f11c3afbd278cc01889db51cc3594" level="file"><did><unittitle>TML - Safety of antimicrobials in pregnancy</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="4328587d891f8dc46f20bf13531db43b" label="mixed materials [A0000000075918]" type="box">76</container><container id="21420316eaa4603e65a3392a533a7d22" parent="4328587d891f8dc46f20bf13531db43b" type="folder">6-9</container></did><accessrestrict id="4077280e1fc84a55fa2f33342e312820"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d9af5da201c75753edd17152b98006c9" level="file"><did><unittitle>TML, 44-63 - Voriconazole</unittitle><unitdate type="inclusive">2002 July 22</unitdate><container altrender="Record Storage Box (Paige)" id="bb440a42fd5d06b6241b3c075f8db0b0" label="mixed materials [A0000000075918]" type="box">76</container><container id="2c7976b1248250f85dc5139d69ef6a5c" parent="bb440a42fd5d06b6241b3c075f8db0b0" type="folder">10-14</container></did><accessrestrict id="7f7313cf1c86daf164b8b5b1d2c47390"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f449d0ea0cb02a16dc4bb161afd0e8e1" level="file"><did><unittitle>TML - Cardiovascular drugs in the ICU - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 December</unitdate><container altrender="Record Storage Box (Paige)" id="c7fdf83c14a29170abe556557d031f0a" label="mixed materials [A0000000075918]" type="box">76</container><container id="d05a27fb88664f6ec87bd14e6e120adb" parent="c7fdf83c14a29170abe556557d031f0a" type="folder">15-20</container></did><accessrestrict id="d78727a12815fb45316cee4c1bb66369"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="4536f53d88709a34f9764f238002f522" level="file"><did><unittitle>TML, 44-51 - Triptorelin Pamoate (Trelstar)</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="6571f93e615f510a2dfc2bb1718b8f0a" label="mixed materials [A0000000075919]" type="box">77</container><container id="6bad0568d17b108858517029090f9f59" parent="6571f93e615f510a2dfc2bb1718b8f0a" type="folder">1-4</container></did><accessrestrict id="3f564956f49faf84f827624973a86572"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="8319ac1e74f3772c55f953d49d1fe802" level="file"><did><unittitle>TML - Drugs for Tuberculosis</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="6a1fa00906143f83cc01d5ad218784bd" label="mixed materials [A0000000075919]" type="box">77</container><container id="538f3d328348bdf11c9f04c9f83d959f" parent="6a1fa00906143f83cc01d5ad218784bd" type="folder">5-8</container></did><accessrestrict id="6e3e6b2b8bab0f3a6559d5327bba741c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c61123a9a767eb2a2f0665b7e710f056" level="file"><did><unittitle>TML, 44-80 - Tepostinil (Remodulin) for pulmonary arterial hypertension</unittitle><unitdate type="inclusive">2002 September 16</unitdate><container altrender="Record Storage Box (Paige)" id="c9c46e4bfdb8e6ab0f32a06aee3a7345" label="mixed materials [A0000000075919]" type="box">77</container><container id="63539bc7d55ec38ab699c42da34a997b" parent="c9c46e4bfdb8e6ab0f32a06aee3a7345" type="folder">9-11</container></did><accessrestrict id="96d0a14409c624606417824206c572f4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9c1edb72ecb57f4a5cf544ab8a33f1ca" level="file"><did><unittitle>TML, 44-59 - Drugs that may cause psychiatric symptoms</unittitle><unitdate type="inclusive">2002 July 8</unitdate><container altrender="Record Storage Box (Paige)" id="d50d6e9d4dd73e134f0e91aa2eadc722" label="mixed materials [A0000000075919]" type="box">77</container><container id="d757edfa2b45f10f91e1a1b92a019526" parent="d50d6e9d4dd73e134f0e91aa2eadc722" type="folder">12-16</container></did><accessrestrict id="049b266831555277c80bf92411b09f0b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="83c1e0a1fb9e3488cec1e298480b45b9" level="file"><did><unittitle>TML, 44-79 - Tegaserod Maleate (Zelnom) for IBS with constipation</unittitle><unitdate type="inclusive">2002 September 16</unitdate><container altrender="Record Storage Box (Paige)" id="97e596293fdc3712a90a4a290a5c546d" label="mixed materials [A0000000075919]" type="box">77</container><container id="1fc193d7e9ea262761347217d6e9c62a" parent="97e596293fdc3712a90a4a290a5c546d" type="folder">17-19</container></did><accessrestrict id="6b6e7ca2998642d620f912e4ae273e58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="702df7b3933e28f25249b7010b1efc23" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="b99c75d3426ecc9be9950954f6c569b8" label="mixed materials [A0000000075919]" type="box">77</container><container id="fb75141b88644e291edbfa11d89bc00e" parent="b99c75d3426ecc9be9950954f6c569b8" type="folder">20</container></did><accessrestrict id="21f8d786633e1a74c8baaec02b6e69c6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="fbd9f3d2b393e963f637e86d90ca6f0c" level="file"><did><unittitle>TML - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="1952fc40314860121a1e012ab1b0a6c1" label="mixed materials [A0000000075919]" type="box">77</container><container id="8f67330e51d46777a29123e5758a6ea6" parent="1952fc40314860121a1e012ab1b0a6c1" type="folder">21</container></did><accessrestrict id="8c19ab74e7734be86d15ccfc2ffd8632"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="3238875c71befee0c843bfb578b0af6f" level="file"><did><unittitle>TML - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="271d7fd2e83910663f2f165ca062eff5" label="mixed materials [A0000000075920]" type="box">78</container><container id="91e6d7b36c7033fd1c6330015ba4a19c" parent="271d7fd2e83910663f2f165ca062eff5" type="folder">1-3</container></did><accessrestrict id="f07baa851539686de763d2f786c2177e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0f73f901dbd4ead91b01d80ceed67c30" level="file"><did><unittitle>TML, 44-75 - Influenza prevention 2002-2003</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="bfa7aa12b3a72345ce065cdb375b122f" label="mixed materials [A0000000075920]" type="box">78</container><container id="7954f596e4e4ef06146f9c96fe2aea55" parent="bfa7aa12b3a72345ce065cdb375b122f" type="folder">4-6</container></did><accessrestrict id="f979eb1f784b0838d5a64de4d9ac9da1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="23ee674858aa228c8597cb11a5363b5d" level="file"><did><unittitle>TML, 44-33 - Advice for travelers</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="a53cc24625759ed6e84acf91eab2805f" label="mixed materials [A0000000075920]" type="box">78</container><container id="fc0bd3ebed8c0eb5c8307502cafccc13" parent="a53cc24625759ed6e84acf91eab2805f" type="folder">7-9</container></did><accessrestrict id="687d9c16855007cc90b89408873e9116"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c3ff86733b644974c019ea29b403f49f" level="file"><did><unittitle>TML, 44-97 - Potassium Iodine for thyroid protection in a nuclear accident or attack</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="894f55072f354f6b60fec2407a4bc6e6" label="mixed materials [A0000000075920]" type="box">78</container><container id="72616e3f29e4aecee6d0983a139a6ea9" parent="894f55072f354f6b60fec2407a4bc6e6" type="folder">10-11</container></did><accessrestrict id="ae3d1b9904d63ec7a442b7bf1ecd8dc5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="24af9a9128ef19b87942303f71c93a4b" level="file"><did><unittitle>TML, 44-91 - Acetaminophen safety</unittitle><unitdate type="inclusive">2002 October 28</unitdate><container altrender="Record Storage Box (Paige)" id="bac907e633a1bb582dd5d7311f4eb6ff" label="mixed materials [A0000000075920]" type="box">78</container><container id="107302031c92717fcfeb9e470ca302f9" parent="bac907e633a1bb582dd5d7311f4eb6ff" type="folder">12-16</container></did><accessrestrict id="7768a5d75ddf57469eb3bbdfec0f20af"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b3aae1ba9f482e9eeee3c33251fd33f7" level="file"><did><unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="b50faee36666ffdedfa325cbecfb957d" label="mixed materials [A0000000075920]" type="box">78</container><container id="9dd807a1521d99bbec359fc3a9dcff54" parent="b50faee36666ffdedfa325cbecfb957d" type="folder">17-19</container></did><accessrestrict id="afa4af3e07bce4f2fa04d79ed2a8e09b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="8104e8da1a3aff8455ce0008f38fee5a" level="file"><did><unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="e0972087ca471a287e65c9799a7a252e" label="mixed materials [A0000000075921]" type="box">79</container><container id="7f028e28d2a2f2ddfe8ad80595c0e216" parent="e0972087ca471a287e65c9799a7a252e" type="folder">1-2</container></did><accessrestrict id="aca0e4a78b7223c626fd6a43994f5d31"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="02479e2c1173076c05f34aa17007ba49" level="file"><did><unittitle>TML, 44-21 - Acute reactions of drug abuse</unittitle><unitdate type="inclusive">2002 March 4</unitdate><container altrender="Record Storage Box (Paige)" id="c05fe8d288f8e4fdf405513e13c501df" label="mixed materials [A0000000075921]" type="box">79</container><container id="7119eb192eb97172753ff215f37f32fa" parent="c05fe8d288f8e4fdf405513e13c501df" type="folder">3-6</container></did><accessrestrict id="c95f7f827b4be73752d104280c14ae0c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d1098818233489d81f3ee9a35c491fda" level="file"><did><unittitle>TML, 44-71 - Tests for drug abuse</unittitle><unitdate type="inclusive">2002 August 19</unitdate><container altrender="Record Storage Box (Paige)" id="cf0716dcf08a4d3bdb972a67f7e77803" label="mixed materials [A0000000075921]" type="box">79</container><container id="44b12951532c2877d41e2c8543ff354b" parent="cf0716dcf08a4d3bdb972a67f7e77803" type="folder">7-10</container></did><accessrestrict id="6b5deed194656d7a78e4584eaf23da1c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a2d97df9926c22348169dc85fc2da466" level="file"><did><unittitle>TML, 44-82 - Accutane</unittitle><unitdate type="inclusive">2002 September</unitdate><container altrender="Record Storage Box (Paige)" id="7cb910cf7be5e162b138150140e99b33" label="mixed materials [A0000000075921]" type="box">79</container><container id="bab1a1732538416c5ab0d418074bf247" parent="7cb910cf7be5e162b138150140e99b33" type="folder">11-12</container></did><accessrestrict id="811a73112a0f3db0c61460c6f50c3a83"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="77f6dda8f57e4d024c751d9255cb8084" level="file"><did><unittitle>TML, 44-50 - Spinal Manipulation</unittitle><unitdate type="inclusive">2002 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="01adb89d6dc42c701d9c90441b581286" label="mixed materials [A0000000075921]" type="box">79</container><container id="9701b5f7642916fb0277e33348ff37ae" parent="01adb89d6dc42c701d9c90441b581286" type="folder">13-15</container></did><accessrestrict id="c6a5678b6a97ed4390bd98a720535a47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="09411c4ec2cd0e10526be529fdbb7c1d" level="file"><did><unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="254220827b0c3046b5657037160044b9" label="mixed materials [A0000000075921]" type="box">79</container><container id="64e93a2cc0541610cfea3bac9805b731" parent="254220827b0c3046b5657037160044b9" type="folder">16-17</container></did><accessrestrict id="1fde5116b8525bf37872775d4c998b9e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2af7784d4333e1386ceb5387b0141573" level="file"><did><unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="8e860aa3d6f5fcef4062f08f9c404dae" label="mixed materials [A0000000075922]" type="box">80</container><container id="327574a06449f578db880a0269ebbce1" parent="8e860aa3d6f5fcef4062f08f9c404dae" type="folder">1-2</container></did><accessrestrict id="b2d240752dac7c5d6b161365b06fbe2d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="45b86f5c46903225f479639e02061c91" level="file"><did><unittitle>TML, 44-17 - Drotecogin - Activated Protein C (Xigris) for Severe Sepsis</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="ad2d9d162289de99df12676908376102" label="mixed materials [A0000000075922]" type="box">80</container><container id="35353bb5efd545d99612042d298e168a" parent="ad2d9d162289de99df12676908376102" type="folder">3-7</container></did><accessrestrict id="c6644b7dd17dbfbedd1d1af2963340f4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2df9fa1b1dadedbd80d056c6d1eb7e1b" level="file"><did><unittitle>TML, 44-78 - Hormone replacement therapy</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="7a98f7c6bc80a1defb730408f1a0082e" label="mixed materials [A0000000075922]" type="box">80</container><container id="8f5e60e9f8bc62961392e3453fc193ea" parent="7a98f7c6bc80a1defb730408f1a0082e" type="folder">8-9</container></did><accessrestrict id="25fbac45d92806e8263c700a8600b817"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="79ecc959704f5a99033f6383c71d5e2b" level="file"><did><unittitle>TML, 44-30 -Bosentan (Tracleer) for pulmonary arterial hypertension</unittitle><unitdate type="inclusive">2002 April 11</unitdate><container altrender="Record Storage Box (Paige)" id="3d2d671c860737ced4e11bf9ea98a5a5" label="mixed materials [A0000000075922]" type="box">80</container><container id="30fd5c778660687fa33b602021f11aa0" parent="3d2d671c860737ced4e11bf9ea98a5a5" type="folder">10-12</container></did><accessrestrict id="c218a513a6535a5ceb72241f53f1083c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ebeb0b87fb29433a1b670b6a4d5aa5fc" level="file"><did><unittitle>TML, 44-45 - Dexmethylphenidate (Focalin) for ADHD</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="17295f7cfeeb94aa5eebe4ddef3e1cb3" label="mixed materials [A0000000075922]" type="box">80</container><container id="22c961fa33e76a8c28b0bb539d40733b" parent="17295f7cfeeb94aa5eebe4ddef3e1cb3" type="folder">13-14</container></did><accessrestrict id="daa9fc43588271721e9668e6387b1ecc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9cf28c7502d38a3253794dc0aff81d12" level="file"><did><unittitle>TML, 44-53 - Droperidol Risk - Arrhythmias</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="7999ccc9155a8ec19656d7f8502b8cb9" label="mixed materials [A0000000075922]" type="box">80</container><container id="70c27f4212506fe2be8c9abc14d3510d" parent="7999ccc9155a8ec19656d7f8502b8cb9" type="folder">15-16</container></did><accessrestrict id="9343665bbaab14cdc391de9fbda39aab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="037a4523e063f09b403c4b86b056b0b9" level="file"><did><unittitle>TML, 44-84 - Herbal Products - Problems with dietary supplements</unittitle><unitdate type="inclusive">2002 September 30</unitdate><container altrender="Record Storage Box (Paige)" id="948736ea191c96b539124edff9861e54" label="mixed materials [A0000000075922]" type="box">80</container><container id="d764c2a3fe20de4cff3fe26a5fc3e9df" parent="948736ea191c96b539124edff9861e54" type="folder">17-19</container></did><accessrestrict id="2fdc328774c9f82ce8ebb61aee7387a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="606c2c7591fb4c21ba3d38fc6c7462b0" level="file"><did><unittitle>TML, 44-96 - Rasburicase</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="07bacc64afee43de42b571bd8a8632db" label="mixed materials [A0000000075923]" type="box">81</container><container id="21bdc1f962d0795f6e0b0307f12ee24e" parent="07bacc64afee43de42b571bd8a8632db" type="folder">1-2</container></did><accessrestrict id="6dd42fdac95221294c398b8dad4d3a7e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b3d8e525fd2c6ceabdefb1c16c80e100" level="file"><did><unittitle>TML, 44-88 - Three beta-interferons for MS</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="ec6cf51ef5ed586ae407eedd4005d7e1" label="mixed materials [A0000000075923]" type="box">81</container><container id="0be0e874b561530195603eea4452f9a8" parent="ec6cf51ef5ed586ae407eedd4005d7e1" type="folder">3-6</container></did><accessrestrict id="de5073ebce08ff223cdc3bac4b44096d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="cd35b74adb66fbee3caa77d502914319" level="file"><did><unittitle>TML, 44-99 - Indications for an implantable cardioverter defibrillator</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="092fcbe87197041fcf00b50479897ec7" label="mixed materials [A0000000075923]" type="box">81</container><container id="a989fccfdc52a3ac132b376a01af63ca" parent="092fcbe87197041fcf00b50479897ec7" type="folder">7-9</container></did><accessrestrict id="44a756d7626a6484624c170f3c9fe601"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="caba3d20cbb6ac2bcf0fffb6486cd172" level="file"><did><unittitle>TML - Drugs for Diabetes - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 September</unitdate><container altrender="Record Storage Box (Paige)" id="4f84216f1bb6b560682b7993466ec4f2" label="mixed materials [A0000000075923]" type="box">81</container><container id="76d06d2bfcdc2b465f89fcb23fdce405" parent="4f84216f1bb6b560682b7993466ec4f2" type="folder">10-13</container></did><accessrestrict id="27fb92f6dcd523eaebbcb18be6a423a5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0cdc8024ee854934a00a2e6cc658127c" level="file"><did><unittitle>TML, 44-87 - Once-a-Week risedronate (Actonel)</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="e1e5fabf6ddb1da984e71cdba1bcb3b7" label="mixed materials [A0000000075923]" type="box">81</container><container id="877a4f9a106d9a02934279490935ac77" parent="e1e5fabf6ddb1da984e71cdba1bcb3b7" type="folder">14-15</container></did><accessrestrict id="3c69c2eda4cf5e33f151894a6dae98fa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="6373e1ea574b03380381b604f8f317ea" level="file"><did><unittitle>TML, 44-48 - Topical Primecrolimus (Elidel) for treatment of atopic dermatitis</unittitle><unitdate type="inclusive">2002 May 27</unitdate><container altrender="Record Storage Box (Paige)" id="60a7535eeb18088840d51fcca7b392ca" label="mixed materials [A0000000075923]" type="box">81</container><container id="9b33029fa0c5fe1aff54e4768706ff97" parent="60a7535eeb18088840d51fcca7b392ca" type="folder">16-17</container></did><accessrestrict id="c8982cc8907e5273994dc146b1a74168"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0a43de1bea99678d0bd3f43b5c8e3aab" level="file"><did><unittitle>TML, 44-107 - Metaglip and Avandamet for type 2 diabetes</unittitle><unitdate type="inclusive">2002 December 23</unitdate><container altrender="Record Storage Box (Paige)" id="d8994f94b4457ead2c11dcdfe59fb5b7" label="mixed materials [A0000000075924]" type="box">82</container><container id="427c23ffa820e95b289b7681b257684f" parent="d8994f94b4457ead2c11dcdfe59fb5b7" type="folder">1-3</container></did><accessrestrict id="77f5cb2d5690ac4fb8b1401da5ce42c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0ad024dbe91f78abe8bfbef002c6b1ff" level="file"><did><unittitle>TML, 44-27 - Desloratadine</unittitle><unitdate type="inclusive">2002 March 18</unitdate><container altrender="Record Storage Box (Paige)" id="96855840c92e1043a2672d8d0524f318" label="mixed materials [A0000000075924]" type="box">82</container><container id="32128d474ed7483697bb49cf62c1bbfa" parent="96855840c92e1043a2672d8d0524f318" type="folder">4-6</container></did><accessrestrict id="36a5c8671473d8ebde644f9ea2a482bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b7991b9a56fe105d30e6587c04553698" level="file"><did><unittitle>TML, 44-41 - Pantoprazole (Protonix IV)</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="d1d73902009a3212de478caacfdb039d" label="mixed materials [A0000000075924]" type="box">82</container><container id="b72c044d20f84ff39398abbcf457c87a" parent="d1d73902009a3212de478caacfdb039d" type="folder">7-8</container></did><accessrestrict id="ecf59515bb41f3b93d8d69d9976e28b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="e886d7140f04a51e798f5685595d8a64" level="file"><did><unittitle>TML, 44-69 - Olmesartan (Benicar) for hypertension</unittitle><unitdate type="inclusive">2002 August 5</unitdate><container altrender="Record Storage Box (Paige)" id="2473a61caea29b283ab3408da1befd98" label="mixed materials [A0000000075924]" type="box">82</container><container id="2f5d82ff495e9b19ec8437ca32fc8551" parent="2473a61caea29b283ab3408da1befd98" type="folder">9-12</container></did><accessrestrict id="74dedc4bdd750d18fabe19b677cbe4fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a62ab234ffcd38be2c7ecb1b5105a478" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="b315ffa5251463d60135942c64e72c6b" label="mixed materials [A0000000075924]" type="box">82</container><container id="e7f7f4cd34e2cbbc36a9b4a5119f6dab" parent="b315ffa5251463d60135942c64e72c6b" type="folder">13-16</container></did><accessrestrict id="a1761f494a6aadd735240b5f6234da0c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="334f7d2fdf7bebf0df4dbded68f76c8d" level="file"><did><unittitle>TML, 44-44 - Pegfilgrastin (Neulasta) for prevention of febrile neutropenia</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="a7eab17a48105d50b3fddbd92a725b00" label="mixed materials [A0000000075924]" type="box">82</container><container id="929aedcc5d70030a61e2b342b534560f" parent="a7eab17a48105d50b3fddbd92a725b00" type="folder">17-19</container></did><accessrestrict id="a69e5af2889f08c295264781d0dc1080"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f777550cceb72905734014265970ba2d" level="file"><did><unittitle>TML, 45-25 - Adalimumab (Humira) for rheumatoid arthritis</unittitle><unitdate type="inclusive">2003 March 31</unitdate><container altrender="Record Storage Box (Paige)" id="c49ab66875cedff2a43f5704a514734e" label="mixed materials [A0000000075925]" type="box">83</container><container id="99925d06fc56721e46908bbfe3a8a778" parent="c49ab66875cedff2a43f5704a514734e" type="folder">1-3</container></did><accessrestrict id="843488d272c7cd2629b6cfaf3ea233ef"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="755a5cb278c5674c278d62217583d0dc" level="file"><did><unittitle>TML, 45-31 - Alefacept (Amevive) for treatment of psoriasis</unittitle><unitdate type="inclusive">2003 April 14</unitdate><container altrender="Record Storage Box (Paige)" id="e678498afdf3592fcfe94ffcc6841245" label="mixed materials [A0000000075925]" type="box">83</container><container id="c45f4b8692768d270d1c23bba417adbd" parent="e678498afdf3592fcfe94ffcc6841245" type="folder">4-6</container></did><accessrestrict id="a72cbce0a6c64d80126a119167b5dc50"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9a2ad2a43a1bd9b6c3ff840aca327639" level="file"><did><unittitle>TML, 45-43 - Alprazolam XR for panic disorder</unittitle><unitdate type="inclusive">2003 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="208967f5499af10890c36a81adad00df" label="mixed materials [A0000000075925]" type="box">83</container><container id="14b5359f6d633bda28494658222173a5" parent="208967f5499af10890c36a81adad00df" type="folder">7</container></did><accessrestrict id="7facc30ebfc92bd3e698021dbdeb21fe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="32827b05df08c432fb2cbb3d952c316a" level="file"><did><unittitle>TML, 45-15 - Aripiprazole (Abilify) for schizophrenia</unittitle><unitdate type="inclusive">2003 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="2125aa398202291ad258dcac64793d65" label="mixed materials [A0000000075925]" type="box">83</container><container id="9b7d2ceec7c746809b1442b2313dc130" parent="2125aa398202291ad258dcac64793d65" type="folder">8-10</container></did><accessrestrict id="e9db4aba5feb72c13178e46e3f2599e5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2dcb5260bf184933786c79514811276a" level="file"><did><unittitle>TML, 45-5 - Augmentin XR</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="161a81f1a346471f7cf0f441d02377ea" label="mixed materials [A0000000075925]" type="box">83</container><container id="6ade303e0b33cbaae33b5f02a56ec108" parent="161a81f1a346471f7cf0f441d02377ea" type="folder">11-13</container></did><accessrestrict id="352c7f8bef5faa523d50be8830568d03"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="6719542efa0dd7e6ff2199fb0fc45784" level="file"><did><unittitle>TML, 45-50 - Blue Light (Clearlight) for acne vulgaris</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="5585a33055a2b0d9a1dbe4a2277ce965" label="mixed materials [A0000000075925]" type="box">83</container><container id="571fea90ea3f200625eb2dec7ac8c75b" parent="5585a33055a2b0d9a1dbe4a2277ce965" type="folder">14-15</container></did><accessrestrict id="dd3798d0577bb9e1fc29332ed3c1ed16"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="face99254c656f96b64bf580e5f85bcf" level="file"><did><unittitle>TML, 45-57 - Bortezomib for multiple myeloma</unittitle><unitdate type="inclusive">2003 July 21</unitdate><container altrender="Record Storage Box (Paige)" id="b755a38abb375b097923b193c5cec638" label="mixed materials [A0000000075925]" type="box">83</container><container id="a61cdd6724bf36c265f9a7cabb9d7c2d" parent="b755a38abb375b097923b193c5cec638" type="folder">16-18</container></did><accessrestrict id="5b737b9395121e3828a6f6fa407666da"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9ec231ed3611900061caae3128c95513" level="file"><did><unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="2a4aea188f711a05f7ef211d125985b5" label="mixed materials [A0000000075925]" type="box">83</container><container id="6b7141c3ae5f3b1797befbe42fae8ce0" parent="2a4aea188f711a05f7ef211d125985b5" type="folder">19</container></did><accessrestrict id="e0dca88a43ebdabbfbf835cde2da0a4f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c6404194bb02ecf2496bacd146a0cc60" level="file"><did><unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="5cde6cd2a8c6362b81d7964b6f7d6c69" label="mixed materials [A0000000075926]" type="box">84</container><container id="f48e7c29e16182d7a549e605a90c83e4" parent="5cde6cd2a8c6362b81d7964b6f7d6c69" type="folder">1-3</container></did><accessrestrict id="ff3d2237bfc8f29c4712b54bf885e9be"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2ddbc741772355d7dce54b4b63ef6749" level="file"><did><unittitle>TML, 45-97 - Efalizumabe (Raptiva) for treatment of psoriasis</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="170a706d343dfe7d643ca3de8376f9ea" label="mixed materials [A0000000075926]" type="box">84</container><container id="8a31cce1b6908178d0b92ae8907d0a12" parent="170a706d343dfe7d643ca3de8376f9ea" type="folder">4-5</container></did><accessrestrict id="6eb237f5b70a5174ed44b4dc845e1439"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0f45b082b3a08c7cce74229a00644b02" level="file"><did><unittitle>TML, 45-97 (45-333) - Eletriptan (Replax) for migraine</unittitle><unitdate type="inclusive">2003 April 28</unitdate><container altrender="Record Storage Box (Paige)" id="7afb0240cb31ea06c3abda5dcdf607b3" label="mixed materials [A0000000075926]" type="box">84</container><container id="8d9e445f79514af848f796009e9eafa9" parent="7afb0240cb31ea06c3abda5dcdf607b3" type="folder">6-8</container></did><accessrestrict id="f517a35e209156fcce5cddbc43b68b14"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="94948e6e42424f89ec840de91511a768" level="file"><did><unittitle>TML, 45-49 - Enfuvirtide (Fuzeon) for HIV infection</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="2111bed3ecb0e2f1ed7048562b2b5775" label="mixed materials [A0000000075926]" type="box">84</container><container id="2f138c41401e878d71e6d800a1db5c64" parent="2111bed3ecb0e2f1ed7048562b2b5775" type="folder">9-11</container></did><accessrestrict id="a3551a188d335a0b903727fcd2a48fa4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="48f4b3c522fa705a3ae202735e45ac3b" level="file"><did><unittitle>TML, 45-89 - Growth hormone for normal short children</unittitle><unitdate type="inclusive">2003 November 10</unitdate><container altrender="Record Storage Box (Paige)" id="2d1b5e5a31616d9cdafca018394d8d11" label="mixed materials [A0000000075926]" type="box">84</container><container id="de71e72f53c5f1f71670ba371c6f6bd3" parent="2d1b5e5a31616d9cdafca018394d8d11" type="folder">12-14</container></did><accessrestrict id="3229644ce53e8795f97a65d5d61f18e8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="780d425bdbd53ceafd83133223d279a7" level="file"><did><unittitle>TML, 45-67 - Omalizumab (Xolair) for Asthma</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="bc4a4da8d49a6012999f597dd836191a" label="mixed materials [A0000000075926]" type="box">84</container><container id="bcded81f50247b28311ff576d070d20e" parent="bc4a4da8d49a6012999f597dd836191a" type="folder">15-18</container></did><accessrestrict id="12994eea68e1f09108df54e255ae8cff"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3e27a4c127b0269848618ade1805962f" level="file"><did><unittitle>TML, 45-7 - Oxalipatin</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="62fb04e6804e603ed734cedcfd2ecea7" label="mixed materials [A0000000075926]" type="box">84</container><container id="501d1e228351b8980696d6d2c1c9d104" parent="62fb04e6804e603ed734cedcfd2ecea7" type="folder">19</container></did><accessrestrict id="319e1cb1c4d5a539efc2e6af94af005a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="732aaf61ce82ace45c4354ea0038b752" level="file"><did><unittitle>TML, 45-7 - Oxalipatin</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="bce052c198077303b9d553793b093b8b" label="mixed materials [A0000000075927]" type="box">85</container><container id="3bbe2dc6bf538816f31cc4f74519ca46" parent="bce052c198077303b9d553793b093b8b" type="folder">1-2</container></did><accessrestrict id="c716c8d0ab4facf419cf7e7c4082202e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c4617feb74a721aa21a7112babed977f" level="file"><did><unittitle>TML, 45-38 - Oxbutynin trandermal (Oxytrol) for overactive bladder</unittitle><unitdate type="inclusive">2003 May 12</unitdate><container altrender="Record Storage Box (Paige)" id="6f12b472cfeaf61dc8fd40976254b8ea" label="mixed materials [A0000000075927]" type="box">85</container><container id="9a854fe90d9db460f0e19c10f2e591a0" parent="6f12b472cfeaf61dc8fd40976254b8ea" type="folder">3-4</container></did><accessrestrict id="09ded828b852ae6c86297bc23c88adc0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="8486f3e9d9968bc9f1dce0df7483cd4b" level="file"><did><unittitle>TML, 45-54 - Rapid tests for HIV infection</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="53f6ea5621607f9ac952632396f2726d" label="mixed materials [A0000000075927]" type="box">85</container><container id="2975796d81a9df556deaf127b3d06db2" parent="53f6ea5621607f9ac952632396f2726d" type="folder">5-8</container></did><accessrestrict id="9d74192e21e6502b4dff990dec4cbb50"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e54b07dbb6cb8e75aad0e568c11cae0a" level="file"><did><unittitle>TML, 45-77 - Vardenafil (Levitra) for erectile dysfunction</unittitle><unitdate type="inclusive">2003 September 29</unitdate><container altrender="Record Storage Box (Paige)" id="dc83670b054b8ed2f71367cf6527ea6c" label="mixed materials [A0000000075927]" type="box">85</container><container id="5dbdcd21868e1da787a84bfaabf930cc" parent="dc83670b054b8ed2f71367cf6527ea6c" type="folder">9-12</container></did><accessrestrict id="f6350ccd6ef35a9adb3c39e7c7bf3a3c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="fdd62d893c6f422fd7c183e65efa7835" level="file"><did><unittitle>TML, 45-11 - Atomoxetine (Strattera)</unittitle><unitdate type="inclusive">2003 February 3</unitdate><container altrender="Record Storage Box (Paige)" id="20388b047977b4e5c8ee45e9095f273b" label="mixed materials [A0000000075927]" type="box">85</container><container id="0768e381e4f768b4d5f75ff1592798f7" parent="20388b047977b4e5c8ee45e9095f273b" type="folder">13-15</container></did><accessrestrict id="36610a7149adbc1f92cfdc7751128db1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="35402d0a4356ba61f6f491a96f89217a" level="file"><did><unittitle>TML, 45-15 - Buprenorphine - an alternative to methadone</unittitle><unitdate type="inclusive">2013 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="787a78bd7842ebc285e968eac2a4d653" label="mixed materials [A0000000075927]" type="box">85</container><container id="656e66cbab317a7446361a5cb48eb5d8" parent="787a78bd7842ebc285e968eac2a4d653" type="folder">16-20</container></did><accessrestrict id="136a1315a2303fa111e5d01cb0517e7d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3fc7a0238f453d851bcf8a694afaf2ab" level="file"><did><unittitle>TML, 45-74 - Agalsidase beta (Fabrazyme) for Fabry disease</unittitle><unitdate type="inclusive">2003 September 15</unitdate><container altrender="Record Storage Box (Paige)" id="805095bb347d8f6cd59108cae20fba77" label="mixed materials [A0000000075928]" type="box">86</container><container id="1320531397478f228fbd0233a42421e6" parent="805095bb347d8f6cd59108cae20fba77" type="folder">1-3</container></did><accessrestrict id="aab1089a7327f8fc78a2fc319190599a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="5569c52b23e7d7eeddf53f7c2b84a996" level="file"><did><unittitle>TML, 45-39 - Eplerenone (Inspra)</unittitle><unitdate type="inclusive">2003 May 12</unitdate><container altrender="Record Storage Box (Paige)" id="513b7e1eda6ae7fc7a14552948c9b125" label="mixed materials [A0000000075928]" type="box">86</container><container id="75c51af0e45f0392dcf9f6d0f9090ad6" parent="513b7e1eda6ae7fc7a14552948c9b125" type="folder">4-6</container></did><accessrestrict id="4fc1e68dd96cabb133f171a2e6a52471"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="19fc064c09e3806caaddbb51b70e4090" level="file"><did><unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="8f000f0a8a672ca9547439c875ca4971" label="mixed materials [A0000000075928]" type="box">86</container><container id="a876a5bab7ac297f2778f426602c2250" parent="8f000f0a8a672ca9547439c875ca4971" type="folder">5A-6A</container></did><accessrestrict id="60b6213d43e89633056c4a067f8c54e8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f0a8b264973dfe8db5fe8da9b49f6e58" level="file"><did><unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="8e2ccd4eff31fab54cde119900adc654" label="mixed materials [A0000000075928]" type="box">86</container><container id="8ee5332a26aca4878907950430cfd29f" parent="8e2ccd4eff31fab54cde119900adc654" type="folder">7-9</container></did><accessrestrict id="7a45da012d9d8375ab9c62d057d20b13"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d1e93fdc68ebf64e073b0d53c908f073" level="file"><did><unittitle>TML, 45-101 - Tadalafil (Cialis) for Erectile dysfunction</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="e3c5606909f044079e7c2e0c1faecfd2" label="mixed materials [A0000000075928]" type="box">86</container><container id="8a7b6755a625b74afb519b1d0d85d692" parent="e3c5606909f044079e7c2e0c1faecfd2" type="folder">10-11</container></did><accessrestrict id="a187e298156d35ecb24bf62acbaa2162"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="bf6ed6095bb9e6efdcac9a21b49e00e9" level="file"><did><unittitle>TML, 45-95 - Tattoo Removal</unittitle><unitdate type="inclusive">2003 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="35a38315f8efd7568922cdc6f4a9864a" label="mixed materials [A0000000075928]" type="box">86</container><container id="e8896d5b451e1bfa3e70e2f4f5c3455b" parent="35a38315f8efd7568922cdc6f4a9864a" type="folder">12-13</container></did><accessrestrict id="1cb8774dfbec0195c1be0234b77205c6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a857cbd537b23d5351b0c89499d70d8e" level="file"><did><unittitle>TML, 45-51 - Priloscec, Nexium and stereoisomers</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="ed03440a4f047495672f8f21998b0c3c" label="mixed materials [A0000000075928]" type="box">86</container><container id="9b35c81027fc063919fc4bd789172c3c" parent="ed03440a4f047495672f8f21998b0c3c" type="folder">14</container></did><accessrestrict id="4b2308536bb701384ee28edb8995985a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1ed11b7c73752bdb0689383a30c1baf5" level="file"><did><unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="e4c70c1adc965ca3b5615b302f8facf2" label="mixed materials [A0000000075928]" type="box">86</container><container id="541bfa9b2d19aa05a0e0b47edca6a268" parent="e4c70c1adc965ca3b5615b302f8facf2" type="folder">15-16</container></did><accessrestrict id="4ae7a8a3386cf59e0586622b1db28e61"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c48f05a528d95bdfee4855de30cb54e2" level="file"><did><unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="6002a88a01efa67b38d2e99412b492e1" label="mixed materials [A0000000075929]" type="box">87</container><container id="0ed25875bc163f9bfd10656c7214f6d2" parent="6002a88a01efa67b38d2e99412b492e1" type="folder">1</container></did><accessrestrict id="d1a19b29c41ed450efa6dd0a35b030ad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3e6aff84359c7cdd06669d9d72f8c12a" level="file"><did><unittitle>TML, 45-21 - Montelukast (Singulair) for allergic rhinitis</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="66fd40596f537a3c560f7db7efa7370e" label="mixed materials [A0000000075929]" type="box">87</container><container id="4e705150afb588d4b0fb2cf7dc7d4085" parent="66fd40596f537a3c560f7db7efa7370e" type="folder">2-4</container></did><accessrestrict id="2b573db89b3a7e7ffb7bbe4571d64e85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="7d40fbe976113721e79b64dd1d00e27d" level="file"><did><unittitle>TML, 45-3 - OTC Loratadine</unittitle><unitdate type="inclusive">2003 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="2003a27c9f65a8844a246a678b7c536a" label="mixed materials [A0000000075929]" type="box">87</container><container id="39034c2b4c5842c2f7d162e3987416e3" parent="2003a27c9f65a8844a246a678b7c536a" type="folder">5</container></did><accessrestrict id="68d83db5324a44659c1dd3f51c2e2864"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1823eedc9d0074c8a4265ac61efdfda5" level="file"><did><unittitle>TML, 45-41 - Insect repellents</unittitle><unitdate type="inclusive">2003 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="0a280d35f4b3c8e1bbf174a5451816e9" label="mixed materials [A0000000075929]" type="box">87</container><container id="fcdd77c85f6345522ff3eeaab53e1894" parent="0a280d35f4b3c8e1bbf174a5451816e9" type="folder">6-8</container></did><accessrestrict id="fd9f974ca565c85df29a51348d8fb4a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2f3bcea3a484b983f63233e648e58d71" level="file"><did><unittitle>TML, 45-81 - Rosuvastatin - a new lipid-lowering drug</unittitle><unitdate type="inclusive">2003 October 13</unitdate><container altrender="Record Storage Box (Paige)" id="c4fa9ff51b36bed4cb688ad4e1ccb4bd" label="mixed materials [A0000000075929]" type="box">87</container><container id="721ca5c83510941372cb2503c60b2d5e" parent="c4fa9ff51b36bed4cb688ad4e1ccb4bd" type="folder">9-12</container></did><accessrestrict id="43bf4f6f81d3fbdf04c68bbc454e9040"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ba56ad48c3bef0d702fff7fdda72fa22" level="file"><did><unittitle>TML, 45-35 - Insulin-sensitizing drugs for polycystic ovary syndrome</unittitle><unitdate type="inclusive">2003 April 28</unitdate><container altrender="Record Storage Box (Paige)" id="61e7941110eafa3b81f16deda9755b3a" label="mixed materials [A0000000075929]" type="box">87</container><container id="8a057e5aa182726fb2a72db9cd39be97" parent="61e7941110eafa3b81f16deda9755b3a" type="folder">13-15</container></did><accessrestrict id="68c074ca5c7b85d99e37109be8f03f26"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3d9fbb15ae7446c6c645d70bd47fbf3b" level="file"><did><unittitle>TML, 45-73 - Memantine for Alzheimer's disease</unittitle><unitdate type="inclusive">2003 September 15</unitdate><container altrender="Record Storage Box (Paige)" id="5f0fb0394f82853a5a366c3bfcf6773b" label="mixed materials [A0000000075929]" type="box">87</container><container id="0929d277e11c5d8f97e38fe6cf5beb8a" parent="5f0fb0394f82853a5a366c3bfcf6773b" type="folder">16-18</container></did><accessrestrict id="349dea74056b705fe12a6e58b6be4a61"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="11bdec471c430a38763f1ea9a86eab38" level="file"><did><unittitle>TML, 45-58 - Treatment of heat injury</unittitle><unitdate type="inclusive">2003 July 21</unitdate><container altrender="Record Storage Box (Paige)" id="01737a74c64ec426c6b2c135feec63b3" label="mixed materials [A0000000075930]" type="box">88</container><container id="e0913f383826b820bad847134bf3e47c" parent="01737a74c64ec426c6b2c135feec63b3" type="folder">1-2</container></did><accessrestrict id="b32e89185eafe8ec72db09448de5ce28"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="806d8942533d66de734e65e88b3304ee" level="file"><did><unittitle>TML, 45-90 - Atazanavir (Reyataz) and Emtricitabine (Emtriva) for HIV infection</unittitle><unitdate type="inclusive">2003 November 10</unitdate><container altrender="Record Storage Box (Paige)" id="eb08b3a71b57828487cb33d8efd2359d" label="mixed materials [A0000000075930]" type="box">88</container><container id="c509581fc03cf9b84cf140b3c164126a" parent="eb08b3a71b57828487cb33d8efd2359d" type="folder">3-6</container></did><accessrestrict id="d90cbf0a7351c28f0b2d1347edc27949"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="04dee614a81cacb32c43ef5b0a88af03" level="file"><did><unittitle>TML, 45-88 - Aldurazyme (Laronidase)</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="e6a22eb47b3f83c17fdb04871211198a" label="mixed materials [A0000000075930]" type="box">88</container><container id="4266b2167f541b232688d8ad72763f0c" parent="e6a22eb47b3f83c17fdb04871211198a" type="folder">7-8</container></did><accessrestrict id="b53a56596e6cd54c520d93ec764edd68"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9233509af152396c7a0be4f4a4690cec" level="file"><did><unittitle>TML, 45-46 - Drug Interactions</unittitle><unitdate type="inclusive">2003 June 9</unitdate><container altrender="Record Storage Box (Paige)" id="6a528459110ac28cb330292fc625e83d" label="mixed materials [A0000000075930]" type="box">88</container><container id="a8429d1ad20d0f7dee773f005bf09774" parent="6a528459110ac28cb330292fc625e83d" type="folder">9-12</container></did><accessrestrict id="7b355cfd23bf5faae7008b6d8dfcd613"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="95a2b9eb73be12648888070a03ead474" level="file"><did><unittitle>TML, 45-85 - Lowering Plasma Homocystein</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="3fbb5d869aeb5aa4ed2f8cccb80aacf9" label="mixed materials [A0000000075930]" type="box">88</container><container id="ce36d6c2e63b222ed1c20b9d47122178" parent="3fbb5d869aeb5aa4ed2f8cccb80aacf9" type="folder">13-17</container></did><accessrestrict id="150bc9e4636bdbb6ef444d31120758f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="dad27947e40b662edd3cc5a90a0be625" level="file"><did><unittitle>TML, 45-83 - Lp-Pla2 - A new marker of Vasular Risk</unittitle><unitdate type="inclusive">2003 October 13</unitdate><container altrender="Record Storage Box (Paige)" id="c2fbb458a274463fbc474cd13f4389e6" label="mixed materials [A0000000075930]" type="box">88</container><container id="909062b9c3b3ee12ac1a9a889f02754f" parent="c2fbb458a274463fbc474cd13f4389e6" type="folder">18-19</container></did><accessrestrict id="7bacb749d5cace7b77c6d20686088469"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e617e6eea5f9996628c705dd200e1ffa" level="file"><did><unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="c525fc1b6d3e8c5169a81549d681d302" label="mixed materials [A0000000075930]" type="box">88</container><container id="c483018fb6e52e56e08b502fa737d507" parent="c525fc1b6d3e8c5169a81549d681d302" type="folder">20</container></did><accessrestrict id="8c291adc86b1ece8d63fe68ecf028b3e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9fd8a0d9db61f711e261afe6ec4c49ea" level="file"><did><unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="92d009ce1fdce2830ea8dcb7b0ce5bc1" label="mixed materials [A0000000075931]" type="box">89</container><container id="ef933dbe44854d65069abd71f0d8cd85" parent="92d009ce1fdce2830ea8dcb7b0ce5bc1" type="folder">1-4</container></did><accessrestrict id="bce92c80f15ffaccbaa401c6170b83ed"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="edaf8bc319227fe95dce9ce1973f3621" level="file"><did><unittitle>TML, 45-86 - Iodine-131 - Tositumomab (Bexxar) for treatment of Lymphoma</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="51800d747cfc7a8662a3d9c05c14da5c" label="mixed materials [A0000000075931]" type="box">89</container><container id="f6430cca01d02ce7da9e9fe3c55828e9" parent="51800d747cfc7a8662a3d9c05c14da5c" type="folder">5-9</container></did><accessrestrict id="a9e5f083314a82f3692a841eac51a5ca"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f8dc69e4bf109c9986cc722051633070" level="file"><did><unittitle>TML, 45-27 - Pneumococcal Conjugate Vaccine</unittitle><unitdate type="inclusive">2003 March 31</unitdate><container altrender="Record Storage Box (Paige)" id="4a86a64c9ede330cb29053931e4f8c31" label="mixed materials [A0000000075931]" type="box">89</container><container id="8199bf1436f13ab697892b07911b60c7" parent="4a86a64c9ede330cb29053931e4f8c31" type="folder">10-11</container></did><accessrestrict id="e59f218612780c21cd1831f3c38ec08e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="cc9f06be346fedef1f6102477bee9cb2" level="file"><did><unittitle>TML, 45-78 - Influenza Prevention</unittitle><unitdate type="inclusive">2003 September 29</unitdate><container altrender="Record Storage Box (Paige)" id="a1f5b5cce5c71f1b3802c6cdd739dfb3" label="mixed materials [A0000000075931]" type="box">89</container><container id="9eda95cbc01bd9046611984eca875bf7" parent="a1f5b5cce5c71f1b3802c6cdd739dfb3" type="folder">12-14</container></did><accessrestrict id="cc6daf505d9a0ea7ee4c3ea324aa8478"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="39d9d76dedec7d6057d3eb65d8744ded" level="file"><did><unittitle>TML, 45-19 - Peginterferon alfa (Pegasys) for Chronic Hepatitis C</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="a48ccc0e829d2572f9f710ad0519addd" label="mixed materials [A0000000075931]" type="box">89</container><container id="7aff4319055f4390a0fc49df46ccc09f" parent="a48ccc0e829d2572f9f710ad0519addd" type="folder">15-16</container></did><accessrestrict id="4cfe15ffe7bdd2742771ed54d3c1d07c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="efd0e7eb3789a0bc30a68f63ca9b430c" level="file"><did><unittitle>TML, 45-55 - Pegvisomant (Somavert) for Acromegly</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="351a8c2d2ed84a0e3d2a697558118a53" label="mixed materials [A0000000075931]" type="box">89</container><container id="22bd5b3c18cbf28718e536884ed4edd8" parent="351a8c2d2ed84a0e3d2a697558118a53" type="folder">17-20</container></did><accessrestrict id="565dbbbdc9cf527d50ca1536a406a58f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e809ce901af88811ad1fd0cb5bc5882c" level="file"><did><unittitle>TML, 45-9 - Teriparatide for Osteoporosis</unittitle><unitdate type="inclusive">2003 February 3</unitdate><container altrender="Record Storage Box (Paige)" id="d0522204862a57c6736daf3a074752c4" label="mixed materials [A0000000075932]" type="box">90</container><container id="4f9d91f2ca72b62b6e1dc1550a0dcfc1" parent="d0522204862a57c6736daf3a074752c4" type="folder">1-4</container></did><accessrestrict id="662bdc9f7dbb54b08b4950ea34c176c4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="acd944256fa6e191f50b1c636b7b7bf4" level="file"><did><unittitle>TML, 45-70 - Testim and Striant - two new testosterone products</unittitle><unitdate type="inclusive">2003 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="fe11c9adad8d7c0ae9b897feaa10ed59" label="mixed materials [A0000000075932]" type="box">90</container><container id="079833b1857573599cf06d3edeea0d47" parent="fe11c9adad8d7c0ae9b897feaa10ed59" type="folder">5-8</container></did><accessrestrict id="56655a641344d4055a005097ec27c5cb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="fbdf4b7f30d77eaf33b84599e0a5e6e6" level="file"><did><unittitle>TML, 45-1 - Smallpox vaccine</unittitle><unitdate type="inclusive">2003 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="949d7efa876818cfec2a353e10812630" label="mixed materials [A0000000075932]" type="box">90</container><container id="9e73d24095904faf453537d68bbabe9b" parent="949d7efa876818cfec2a353e10812630" type="folder">9-12</container></did><accessrestrict id="df814d1bfcebe53223f1d57c2a6776e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d9642438ec124cd82d8e135b0198ede7" level="file"><did><unittitle>TML, 45-69 - Minimal surgery for treatment of GERD</unittitle><unitdate type="inclusive">2003 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="6d8797bce2115eaec04adefee2296c9e" label="mixed materials [A0000000075932]" type="box">90</container><container id="997f4ee1d41a7dd6c2b926cb741429e6" parent="6d8797bce2115eaec04adefee2296c9e" type="folder">13-16</container></did><accessrestrict id="572b2a0e74e3c89c9169b31576cc0b55"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0e7f3c8cc41ff780e30caa2e1cd3c245" level="file"><did><unittitle>TML, 45-23 - Drug-eluting Stents</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="f0efc9ad13e9158e872dd1bd9b8eacfa" label="mixed materials [A0000000075932]" type="box">90</container><container id="b10485109e3e06234aeee0d1aa193869" parent="f0efc9ad13e9158e872dd1bd9b8eacfa" type="folder">17-19</container></did><accessrestrict id="91472bcb765db5980f76960bca69f7bb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="4cbcc7808efc65afe1e68d84b33f1bea" level="file"><did><unittitle>TML, 45-23 - Drug-eluting Stents</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="93f9d62b73d133c70e09acfc61ee9f11" label="mixed materials [A0000000075933]" type="box">91</container><container id="0a937cfbf5e5b9f4466a46bd9a067f4d" parent="93f9d62b73d133c70e09acfc61ee9f11" type="folder">1</container></did><accessrestrict id="ad37cdcd99a2044624e749e1cd39779d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f9a9c4fc1896553a888be142b1758016" level="file"><did><unittitle>TML, 45-61 - Omeprazole (Prilosec) (OTC)</unittitle><unitdate type="inclusive">2003 August 4</unitdate><container altrender="Record Storage Box (Paige)" id="7df3a304de5b185bb7a32a153d43de65" label="mixed materials [A0000000075933]" type="box">91</container><container id="422c60d5349434d0690fe9570cca2be8" parent="7df3a304de5b185bb7a32a153d43de65" type="folder">2-3</container></did><accessrestrict id="d9a5d8493c3334bb1cda4ff7afb8a52c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="839fb8691411f959bd1aac5c4ebf7d26" level="file"><did><unittitle>TML, 45-29 - Nitazoxanide (Alina) - a new anti-protozoal agent</unittitle><unitdate type="inclusive">2003 April 14</unitdate><container altrender="Record Storage Box (Paige)" id="e3d62f8a465453f84ec51539831de0a0" label="mixed materials [A0000000075933]" type="box">91</container><container id="2afbb3e12108ab6a3972544eabe4057a" parent="e3d62f8a465453f84ec51539831de0a0" type="folder">4-5</container></did><accessrestrict id="ba825ee552c2bf91acd8b458e0a15d2d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="55365ce4b3ea2d58db64e9416965cb4e" level="file"><did><unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="ba2e765b25359f4ffeebba96eb15626a" label="mixed materials [A0000000075933]" type="box">91</container><container id="1b7617a9d017bd294d178bae18477d10" parent="ba2e765b25359f4ffeebba96eb15626a" type="folder">6-17</container></did><accessrestrict id="0ed20f41fac45d1a638a3740752cb703"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="668d7e7e07b5750eb2c823e11c095964" level="file"><did><unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="c5c606eba648382ec03cbfffa7281fd0" label="mixed materials [A0000000075934]" type="box">92</container><container id="a34f9148a28277dad26e25f872b247dd" parent="c5c606eba648382ec03cbfffa7281fd0" type="folder">1-4</container></did><accessrestrict id="c2b71f78c735a86ad9547e6e3d24546c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c171f13c04b5ef1cf3b3fe5e96a9ef03" level="file"><did><unittitle>TML - Weight Loss - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 December</unitdate><container altrender="Record Storage Box (Paige)" id="66f90a419eb052f733dea77bfd87294b" label="mixed materials [A0000000075934]" type="box">92</container><container id="398286921d1c431b60fd73de7d42906a" parent="66f90a419eb052f733dea77bfd87294b" type="folder">5-13</container></did><accessrestrict id="6dd9eece4a3c89e40bca2442781a600d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ee60c4bf66a25475983425024da14c39" level="file"><did><unittitle>TML - Heart Failure - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 April</unitdate><container altrender="Record Storage Box (Paige)" id="5ac89e7469c1bd535406e1882d2ea5bc" label="mixed materials [A0000000075934]" type="box">92</container><container id="669d081198819e1f6c296d2d306da1b3" parent="5ac89e7469c1bd535406e1882d2ea5bc" type="folder">14-18</container></did><accessrestrict id="957488be5b6a3b3f5fb3aca8638e23b6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0be1e684fc9e69b20bc9867cc0b7288f" level="file"><did><unittitle>TML - Drugs for rheumatoid arthritis - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="a938c8cc3fb715f91ab45deaa4946626" label="mixed materials [A0000000075935]" type="box">93</container><container id="d8e0cb222660fdd27e7a5c41f287ca4b" parent="a938c8cc3fb715f91ab45deaa4946626" type="folder">1-7</container></did><accessrestrict id="fea0a477360238ce0c79c9e79ad6d39a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c0978c508033828e366f1d55950a308e" level="file"><did><unittitle>TML - Drugs for Psychiatric Disorders</unittitle><unitdate type="inclusive">2003 July</unitdate><container altrender="Record Storage Box (Paige)" id="fb2708925136590945ef6c9bc2dc5973" label="mixed materials [A0000000075935]" type="box">93</container><container id="f0d34d1a3074d5bcb8d373f67e952432" parent="fb2708925136590945ef6c9bc2dc5973" type="folder">8-18</container></did><accessrestrict id="03781a219ff982acf63e0290b3b87f0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a9906d72f32382fa1bb39c1ccd388091" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="67613eeddd7ef1f758ec3a041efd13ee" label="mixed materials [A0000000075935]" type="box">93</container><container id="c323f0de36ac3d89f07431a993943f7d" parent="67613eeddd7ef1f758ec3a041efd13ee" type="folder">19</container></did><accessrestrict id="a19ba7012ef7e238dc26e208ad0c53df"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9d1257d4a4ba512b1aa0bb0a4c07fdcd" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="2da2ab635fb7b75411c02e5e3b7f9713" label="mixed materials [A0000000075936]" type="box">94</container><container id="4012c5d5516cbea6adf198446875d6c5" parent="2da2ab635fb7b75411c02e5e3b7f9713" type="folder">1-4</container></did><accessrestrict id="2097ee7f9bd39cd5ea6f974d3df6ff1f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="380c664090534851fbc806e0558fde2f" level="file"><did><unittitle>TML - Assisted Reproduction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 October</unitdate><container altrender="Record Storage Box (Paige)" id="0c2aed2774ea9873e6361f52c206c60a" label="mixed materials [A0000000075936]" type="box">94</container><container id="4584f9a68e17c36b6168329d24c6300e" parent="0c2aed2774ea9873e6361f52c206c60a" type="folder">5-13</container></did><accessrestrict id="69fb416fcc934ed0c8b1f96140cd08e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="dfe820ca0d9eb165533f652cbc41ee32" level="file"><did><unittitle>TML - Drugs for Hypertension - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 February</unitdate><container altrender="Record Storage Box (Paige)" id="01da152dfebb1734ca3f0a157e866161" label="mixed materials [A0000000075936]" type="box">94</container><container id="66ab94b59b76d29bd0aac0c866513e5d" parent="01da152dfebb1734ca3f0a157e866161" type="folder">14-17</container></did><accessrestrict id="5a63fa0917343ef8eb141521fcb9e24e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3ce9ce08c457fba44042e2deea5066f7" level="file"><did><unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="f3807ad6e6f2689ce19b6d86121e5fd2" label="mixed materials [A0000000075936]" type="box">94</container><container id="f4a162950c8ec0289959c8666a947cc4" parent="f3807ad6e6f2689ce19b6d86121e5fd2" type="folder">18</container></did><accessrestrict id="43bc17de19e0d00f4e7031362b3b3efc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d475b54c5095880adce7b8263966fe2d" level="file"><did><unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="fdddac65e005538163dcf561b8b380de" label="mixed materials [A0000000075937]" type="box">95</container><container id="f1e79d4ab682fa0d9c01adbba46dcd15" parent="fdddac65e005538163dcf561b8b380de" type="folder">1-8</container></did><accessrestrict id="d727ecc0d3636f553591f418559bc721"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a6efb00d5c63c6a2ccedf6563ae43110" level="file"><did><unittitle>TML - Drugs for Epilepsy - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 May</unitdate><container altrender="Record Storage Box (Paige)" id="cfc82d45a9cdc2cfb0b10fdfa43de083" label="mixed materials [A0000000075937]" type="box">95</container><container id="cae6f4bc2b78573d6d27127fbfa07656" parent="cfc82d45a9cdc2cfb0b10fdfa43de083" type="folder">9-14</container></did><accessrestrict id="ae7bd45c44b6a19a25f101af3b5a211a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="5a5ba60bec4d0b97fddcd00799fd7626" level="file"><did><unittitle>TML - Drugs for Lipid Disorders - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 August</unitdate><container altrender="Record Storage Box (Paige)" id="58a05cc67b85170338ef2c8c66536256" label="mixed materials [A0000000075937]" type="box">95</container><container id="a7f28c81fb2c6efd9f0f2ee782fc2524" parent="58a05cc67b85170338ef2c8c66536256" type="folder">15-18</container></did><accessrestrict id="334e64660b4fc298f4d1c26e9a76a343"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3c1aea5febbafdf8b5e437a8e97b9218" level="file"><did><unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="679648b7d7aeb66d2ec76438112a2af6" label="mixed materials [A0000000075937]" type="box">95</container><container id="c23e4a41da28d442acaa2994b4484678" parent="679648b7d7aeb66d2ec76438112a2af6" type="folder">19</container></did><accessrestrict id="7cdf942787e0cbed8326189a2020f299"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ddf6b73987ce0637989f66584610c6ea" level="file"><did><unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="007d5affde00b730c8954226b4210ca9" label="mixed materials [A0000000075938]" type="box">96</container><container id="7a2d25f843631d5bb8db53610f970616" parent="007d5affde00b730c8954226b4210ca9" type="folder">1</container></did><accessrestrict id="2b960cecbba771988110df8a9cd33742"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0ca468433bcdc6006e7fb9b0ef21814e" level="file"><did><unittitle>TML, 45-93 - Which SSRI</unittitle><unitdate type="inclusive">2003 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="1899ae75463cdd9106faef83a89245da" label="mixed materials [A0000000075938]" type="box">96</container><container id="f3fbc0ecef1f7e0a78cdb5c6d996e5d8" parent="1899ae75463cdd9106faef83a89245da" type="folder">2-5</container></did><accessrestrict id="72e10bfbf01df945876de61f8480a08b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1e5a72f232d4e116685aff32e9ed9f87" level="file"><did><unittitle>TML - Drugs for Allergic Disorders - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 November</unitdate><container altrender="Record Storage Box (Paige)" id="19d421e19529df76e5d68194e2a9527a" label="mixed materials [A0000000075938]" type="box">96</container><container id="4682d3894466011dc522da1a122c972b" parent="19d421e19529df76e5d68194e2a9527a" type="folder">6-9</container></did><accessrestrict id="ce922dcf8bde445758a34a54106e0ec6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="7621ca9e85272fb03e367f6102650bf9" level="file"><did><unittitle>TML - Drugs for Pneumonia - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 September</unitdate><container altrender="Record Storage Box (Paige)" id="ca7937a54762848f139f0a49709a6fbc" label="mixed materials [A0000000075938]" type="box">96</container><container id="84d6d3b078885d17c35d0313cfe71a9d" parent="ca7937a54762848f139f0a49709a6fbc" type="folder">10-17</container></did><accessrestrict id="429d1928e15342d8a9639e6b6a92e6d4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="68e729c691bb49c8be35f332fbb1e32b" level="file"><did><unittitle>TML - Antimicrobial Prophylaxis for Surgery - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="c5a780fbadc515c0973dc649a70481a8" label="mixed materials [A0000000075939]" type="box">97</container><container id="ae0e9d9cc5a09139b30fda6060b4efc4" parent="c5a780fbadc515c0973dc649a70481a8" type="folder">1-10</container></did><accessrestrict id="084a4278da0f4581918db07f8eb825b4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="07f19737b5f6d3009e9e85a8b0528533" level="file"><did><unittitle>TML - Drugs for Cardiac Arrhythmias - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="d3a36272f1e24d536a152b382319243f" label="mixed materials [A0000000075939]" type="box">97</container><container id="965f024222699493aa353ee7b31bb035" parent="d3a36272f1e24d536a152b382319243f" type="folder">11-18</container></did><accessrestrict id="8f26a61c71898392ee05f246c39c61b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="c099bb967206188345dcdbf9c2975e6d" level="file"><did><unittitle>TML - Advice for Travelers - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="92fe06dec92853cf9d7daffc27ace4f6" label="mixed materials [A0000000075940]" type="box">98</container><container id="37dec633d9de0770a3ba6a0565349dd4" parent="92fe06dec92853cf9d7daffc27ace4f6" type="folder">1-9</container></did><accessrestrict id="e0b7814bc924716eb27275e9522cf9ae"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="237497500e700200226282634e319af9" level="file"><did><unittitle>TML - Drugs for Migraine - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="1ea956a175c4825dcec03c9d564f0c7a" label="mixed materials [A0000000075940]" type="box">98</container><container id="5ef57c5e82088ab57c585e04e68091c0" parent="1ea956a175c4825dcec03c9d564f0c7a" type="folder">10-15</container></did><accessrestrict id="00d75b64dab2398628516bc88ce53406"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="423b8c383be805c9a485a8fecfe9ddb1" level="file"><did><unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 December</unitdate><container altrender="Record Storage Box (Paige)" id="cb28506e8cef46186123e6c91f4b0f8b" label="mixed materials [A0000000075940]" type="box">98</container><container id="a6fd58e176cabb382973d4df6102ffaa" parent="cb28506e8cef46186123e6c91f4b0f8b" type="folder">16</container></did><accessrestrict id="98f8b37e529ccb193a51c645e7d19af9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="26700edc7d4dff9bb83e29c005e8dedd" level="file"><did><unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 December</unitdate><container altrender="Record Storage Box (Paige)" id="4ab76b83d9e62b857311ec19fa9c2f1e" label="mixed materials [A0000000075941]" type="box">99</container><container id="5304186fd58645db116140fbd8870e4b" parent="4ab76b83d9e62b857311ec19fa9c2f1e" type="folder">1-5</container></did><accessrestrict id="ff906c4305f7b289ec47141f34c41d10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="bef1ef630d26c3d4f70cc63b2da9dbfa" level="file"><did><unittitle>TML - Drugs for Sexually transmitted infections - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 October</unitdate><container altrender="Record Storage Box (Paige)" id="a69338e0f6a4b8c8d4010389bee5d031" label="mixed materials [A0000000075941]" type="box">99</container><container id="146d17ee86cb1a4269e1802e85eb6c0f" parent="a69338e0f6a4b8c8d4010389bee5d031" type="folder">6-12</container></did><accessrestrict id="6db6900a0738aa418a1db1239ba995f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="ef8b77a4a9168df66dbaa1d35328f051" level="file"><did><unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 June</unitdate><container altrender="Record Storage Box (Paige)" id="11ac05b16a6482dbe9d315f55b0b9976" label="mixed materials [A0000000075941]" type="box">99</container><container id="c55c60f448a64e801a8512bcd58953ec" parent="11ac05b16a6482dbe9d315f55b0b9976" type="folder">13-18</container></did><accessrestrict id="d4257f7e3e2891eb7db697e7bd0a7fc7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="4122c98e47eb1d53ed958233e91ca5d6" level="file"><did><unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 June</unitdate><container altrender="Record Storage Box (Paige)" id="2d233d82b908fe7192e8c073e26ef294" label="mixed materials [A0000000075942]" type="box">100</container><container id="c576cf3a16a749357821eac686b80b31" parent="2d233d82b908fe7192e8c073e26ef294" type="folder">1-3</container></did><accessrestrict id="4ac25a41ad51ce40a2b44624b0c6f458"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="1db0c21858cc9e616d5906c203e6860d" level="file"><did><unittitle>TML, 46-22 - Abarelix (Plenaxis) for advanced prostrate cancer</unittitle><unitdate type="inclusive">2004 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="68fb337eb64cd279a4fe77fe9136c02a" label="mixed materials [A0000000075942]" type="box">100</container><container id="089d3c8162f199065ca5818d0977c09d" parent="68fb337eb64cd279a4fe77fe9136c02a" type="folder">4-5</container></did><accessrestrict id="d7dfc37db7d6c404c6134b6250ab6400"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="7f8aea6a2a9125acc397a2b721ccebdb" level="file"><did><unittitle>TML, 46-9 - Daptomycin (Cubicin) for skin and soft tissue infections</unittitle><unitdate type="inclusive">2004 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="649240e4cea5e4c0e2b55eace7b398d1" label="mixed materials [A0000000075942]" type="box">100</container><container id="91d8d2c466dbf3398445f7be9056844a" parent="649240e4cea5e4c0e2b55eace7b398d1" type="folder">6-8</container></did><accessrestrict id="8b64bb10092754b7b8a4c90c8deb7337"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="08fbdaa8a0871e1576f4bafb794f57f9" level="file"><did><unittitle>TML, 46-10 - Emergency Contraception OTC</unittitle><unitdate type="inclusive">2004 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="0a93942cd841118932650e508e79d949" label="mixed materials [A0000000075942]" type="box">100</container><container id="2511f03cf595831596806152201ee651" parent="0a93942cd841118932650e508e79d949" type="folder">9-10</container></did><accessrestrict id="00f05ef1f3a72bb3da4ce317cb793c27"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="9ea3892837eec8429d01fe1dc14e6b41" level="file"><did><unittitle>TML, 46-5 - Lasik and its alternatives - an update</unittitle><unitdate type="inclusive">2004 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="b182889b632103f41cca37d0037058da" label="mixed materials [A0000000075942]" type="box">100</container><container id="7ff27ac3314ff42ab5991fa86edb1530" parent="b182889b632103f41cca37d0037058da" type="folder">11-14</container></did><accessrestrict id="7815c3c9e1b402b4a02ed5022e168609"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="f1703fc66140060139d86d70ac0c3846" level="file"><did><unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle><unitdate type="inclusive">2004 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="e77456a147d4b18d93b8fc594390feae" label="mixed materials [A0000000075942]" type="box">100</container><container id="8e87071aacad17672d457cc0a122cd03" parent="e77456a147d4b18d93b8fc594390feae" type="folder">15-18</container></did><accessrestrict id="dc0cf1e8ca62aefc4f65bdca678ea19e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="e8f33c13c32daa15598a2e144e9f900f" level="file"><did><unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle><unitdate type="inclusive">2004 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="400a270feb3f085868d845909043a817" label="mixed materials [A0000000075943]" type="box">101</container><container id="c39a0acd5d7298a45a78349ba01186e7" parent="400a270feb3f085868d845909043a817" type="folder">1</container></did><accessrestrict id="81a1621d7a2a2452c30a530869fc9bea"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="f1258ee39d7e2cce0fa124be57ed0634" level="file"><did><unittitle>TML - Choice of Antibacterial Drugs - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 March</unitdate><container altrender="Record Storage Box (Paige)" id="52e8522b43792ef5c7da278b4685abc2" label="mixed materials [A0000000075943]" type="box">101</container><container id="e2c96f20c2974a12abf26f53056d8b1f" parent="52e8522b43792ef5c7da278b4685abc2" type="folder">2-8</container></did><accessrestrict id="d14f31516858f5ff1d6ab38316a1acdf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="dcf6c003359f1d37afb6b89504a47763" level="file"><did><unittitle>TML - Drugs for Peptic Ulcers - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 February</unitdate><container altrender="Record Storage Box (Paige)" id="94d1070f8e002eb2f79f16390e65ac84" label="mixed materials [A0000000075943]" type="box">101</container><container id="c823a8c247edb28709dc851e8a52589f" parent="94d1070f8e002eb2f79f16390e65ac84" type="folder">9-17</container></did><accessrestrict id="ee022307e7bb1d19942f259293477255"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="0ba4f3a6cf74e6af72c13dc1e491dbd6" level="file"><did><unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 January</unitdate><container altrender="Record Storage Box (Paige)" id="32beec1f1ce5b024578e348d63d22620" label="mixed materials [A0000000075943]" type="box">101</container><container id="de1a81be6528874241b7856690f12c0c" parent="32beec1f1ce5b024578e348d63d22620" type="folder">18-19</container></did><accessrestrict id="cae76792326d54b966f74999980f0522"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="499346d5020cece037a74d774986c858" level="file"><did><unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 January</unitdate><container altrender="Record Storage Box (Paige)" id="b330d235c1d8c63fa1724264e20bea4e" label="mixed materials [A0000000075944]" type="box">102</container><container id="a94df22f4bbb1c9126b1f06f7624690c" parent="b330d235c1d8c63fa1724264e20bea4e" type="folder">1-4</container></did><accessrestrict id="78b76f282a6087796d952eea7ca3851b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="e2ff3268992aa759f09a842e60822ffb" level="file"><did><unittitle>TML - Drugs for Pain - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 July</unitdate><container altrender="Record Storage Box (Paige)" id="adb91d8697af7bb4e67d363e42fbaabc" label="mixed materials [A0000000075944]" type="box">102</container><container id="bb91fc22c12851f7e3b83d2c013ebb71" parent="adb91d8697af7bb4e67d363e42fbaabc" type="folder">5-14</container></did><accessrestrict id="04e11af6b467a1e7c10d7574675c44fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c></dsc>
</archdesc>
</ead>
